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Abstract 
In nature, the main role of double-stranded DNA is storage of genetic information. 
However, once a DNA oligonucleotide is freed from its confining complementary strand, 
it can fold into complex three-dimensional structures that support catalytic activities. 
These catalytic single-stranded DNA oligonucleotides are called deoxyribozymes. Up to 
now, there are no known deoxyribozymes in nature, and the only method to identify them 
is in vitro selection. Since the identification of the first deoxyribozyme in 1994, many 
deoxyribozymes have been found to catalyze various chemical reactions, of which the 
substrates can be either oligonucleotides or small molecules. 
Our lab has recently reported the first DNA-hydrolyzing deoxyribozyme, 10MD5, 
which catalyzes the sequence-specific hydrolysis of a DNA phosphodiester bond. The 
DNA hydrolysis by 10MD5 proceeds with kobs = 2.7 h
1
 and rate enhancement of 10
12
 
over the uncatalyzed P–O bond hydrolysis. However, 10MD5 has a sharp pH optimum 
near 7.5, with greatly reduced yield and rate when the pH is changed only by 0.1 units in 
either direction. Therefore, 10MD5 was optimized via reselection, leading to variants 
with broader pH tolerance. The reselection experiments and the follow-up 
characterization were described in Chapter 2. An artificial phylogeny constructed with 
sequences of the reselected variants suggested three mutations, T16R, G19Y and C30T, 
are strongly correlated with the broader pH tolerance. The reselected variants with 
broader pH tolerance were also found to suffer from relaxed site specificity, which could 
only be restored by expanding the “recognition site” beyond ATG^T (as in the parent 
10MD5) to TATG^TT. These findings reflected functional compromises of the initial 
family of DNA-hydrolyzing deoxyribozymes. Additionally, a reselected variant, 9NL27, 
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showed unique Zn
2+
-only hydrolysis activity, even though it differed from 10MD5 by 
only five out of 40 nucleotides. Evaluation of the five mutations in 9NL27 showed that 
only two nucleotide mutations in the 10MD5 sequence, T16A and G19C, were sufficient 
to convert the heterobimetallic 10MD5 deoxyribozyme into a monometallic 
deoxyribozyme that required Zn
2+
 alone. 
Systematic selection experiments were performed to establish broad generality of 
ssDNA-hydrolyzing deoxyribozymes and to identify a complete set of deoxyribozymes 
that can collectively cleave any arbitrarily chosen single-stranded DNA substrate at any 
predetermined site. These selection experiments were described in Chapter 3. 
Comprehensive selection experiments were performed, including in some cases a key 
selection pressure to cleave the substrate at a predetermined site. These efforts led to 
identification of numerous new DNA-hydrolyzing deoxyribozymes, many of which 
require merely two particular nucleotides at the cleavage site (e.g. X^G, X= A, T, C, or 
G) while retaining WatsonCrick sequence generality beyond those nucleotides along 
with useful cleavage rates. These results established experimentally that broadly 
sequence-tolerant and site-specific deoxyribozymes were readily identified for hydrolysis 
of single-stranded DNA. However, further selection experiments did not lead to 
identification of many new sequence-general deoxyribozymes due to various problems. 
The efforts toward the complete set of ssDNA-hydrolyzing deoxyribozymes were 
stopped because of the limited application of ssDNA-hydrolyzing deoxyribozymes alone. 
Finally, current efforts to achieve double-stranded DNA hydrolysis were described in 
Chapter 4. A targeted selection approach was designed to identify dsDNA-hydrolyzing 
deoxyribozymes, in which the deoxyribozyme pool would be conjugated to a dsDNA-
  iv 
binding protein, dHax3-TALE. The protein would recognize and bind to a specific region 
in the double-stranded DNA substrate, while the deoxyribozyme would catalyze the site-
specific hydrolysis of the substrate. The ligation and capture steps were validated, and the 
selection conditions were determined. However, the key challenge of the selection 
approach was the requirement of a site-specific and efficient bio-conjugation method to 
link the deoxyribozyme pool with the TALE protein. Four conjugation strategies were 
designed, based on disulfide exchange reaction, FBDP-tyrosine reaction, PTAD-tyrosine 
reaction, or N-terminal threonine oxidation. After comprehensive assays, the strategies 
based on PTAD-tyrosine reaction and N-terminal threonine oxidation showed high site-
specificity and promising reaction yields. 
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 1 
Chapter 1: Introduction to Enzymes—Natural and Artificial 
1.1 Natural Enzymes 
The history of using enzymes can date back to the time when fermentation was 
discovered as a process for brewing and bread-making in ancient Egypt. Since then, the 
efforts towards understanding fermentation processes have never stopped. However, it 
was not until the 19th century that scientists raised the questions of whether the living 
organism or some chemical substance was responsible for the fermentation process. In 
1833, Anselme Payen and Jean Persoz discovered the first enzyme, diastase, which 
liquefied starch paste and converted it into sugar.
1
 Decades later, German scientist 
Wilhelm Kühne introduced the term “enzyme” to describe the substances significant in 
fermentation processes. Later on, the term was also used to describe other substances, 
such as peptin and trypsin.
1
 Most importantly, in 1897, Eduard Buchner reported the 
preparation of a cell-free press juice from brewer’s yeast, which caused carbon dioxide 
and ethyl alcohol to form in solutions of sugars. He concluded that the substance he 
prepared was protein and named it zymase.
1
 Buchner’s studies led new insights to natural 
catalysis and opened a new era of enzyme research. Since then, scientists have gained 
better understanding of what enzymes are and how they function. 
As we all know now, an enzyme is a substance that acts as a catalyst in living 
organisms, regulating the rate at which chemical reactions proceed without itself being 
altered in the process.
2
 In nature, enzymes are involved in almost every biological 
process in living organisms. Most of the cellular machineries are made of enzymes. 
Enzymes function by lowering the activation energy of the reaction, resulting in greatly 
 2 
 
Figure 1.1 Enzymes and activation energy. (Adapted from Ref. 3) . Enzymes and activation energy. The total energy levels in the diagram on the right are 
normalized to illustrate the lower activation energy. Reprinted from Ref. 3 with permission. 
increase reaction rate (Figure 1.1).
3
 Most enzymes are protein, but since the 1980s, 
certain RNA molecules have been found to catalyze reactions.
4,5
 The catalytic RNA 
molecules are called ribozymes. 
1.1.1 Protein Enzymes 
1.1.1.1 Structural Components of Protein 
Proteins are macromolecules made of long chains of amino acid monomers. There are 
20 natural amino acids that differ from each other in the structure of side chains. The 
different side chains contribute to different properties of proteins (Figure 1.2).
6
 For 
example, the side chains of several amino acids (valine, leucine, alanine, etc.) are entirely 
hydrocarbon, which prefer clustering together in a polar solvent to minimize the amount 
of surface areas exposed to the solvent. The repulsion of hydrophobic side chains from 
polar solvents provides a driving force for proteins to fold into three-dimensional 
structures. The side chains of several amino acids (serine, tyrosine, lysine, etc.) can form 
 3 
 
Figure 1.2. 20 Natural amino acids. Proline is highlighted in blue. The side chains of amino acids 
are highlighted in red. (a) Nonpolar amino acids. (b) Polar amino Acids. (c) Acidic amino acids. 
(d) Basic amino acids. 
hydrogen bonds with other amino acid side chains, polypeptide backbone, and external 
ligands. The hydrogen bonding interaction helps lowering the overall energy of folded 
protein. Additionally, Noncovalent electrostatic interaction can occur between 
negatively-charged amino acids (aspartic acid and glutamic acid) and positively-charged 
amino acids (lysine, arginine, etc.). This type of interaction can occur both intramole-
cularly and intermolecularly, and is important in stabilizing protein binding interactions. 
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Figure 1.3. Four levels of protein structure. (a) Protein primary structure. (b) Protein secondary 
structure, including -helix (left) and -sheet (right). (c) Tertiary structure of a globin chain. (d) 
Quaternary structure of hemoglobin. Reprinted from Ref. 7c with permission. 
The long chains of amino acids form different levels of complex structures in proteins 
(Figure 1.3).
7
 The amino acid sequence of the peptide chain is the primary structure. The 
secondary structure occurs when the sequences of amino acids are linked by hydrogen 
bonding. The most common secondary structures are -helices and -sheets (Figure 
1.3b). The -helix structure is stabilized by a hydrogen bonding network between the 
carbonyl oxygen atom of one amino acid (i) and the nitrogenous proton of another amino 
acid (i + 4). Each turn of the helix has 3.6 amino acid residues and a translation along the 
helical axis of 5.4 Å. The -sheet structure consists of fully extended polypeptide chains 
linked together by hydrogen bonding between the amide bonds of adjacent peptide 
strands. The tertiary structure is determined by the side chains of amino acids and other 
 5 
adjacent segments of the main chain (Figure 1.3c). The different properties of amino acid 
side chains drive the long polypeptide chains to fold into complex three-dimensional 
structures. For example, each subunit of hemoglobin is made of eight or nine -helical 
segments and an equal number of nonhelical regions between the helices. Formation of 
the structure of the subunit is driven by several types of interactions between different 
segments, such as noncovalent electrostatic interactions, hydrogen bonding, and 
hydrophobic interactions. The heme group is linked to a particular histidine residue on 
the peptide chain. The incorporation of heme group also stabilizes the tertiary structure of 
the subunit.
8
 Finally, the quaternary structure is the arrangement of protein subunits into a 
large protein molecule (Figure 1.3d). Many proteins require more than one folded 
polypeptide chains associated to function, and the individual polypeptide chain is referred 
as a subunit of the large protein. For example, hemoglobin is a heterotetramer of two  
subunits and two  subunits, and each subunit contains a heme group. The affinity of the 
heme for oxygen depends on the quaternary structure of the protein. Oxygen binding 
causes changes in hydrogen binding and noncovalent electrostatic interactions in the 
protein, leading to a compression of the overall size of the molecule, and a rotation of 
dimer relative the other subunit dimer. These changes in quaternary structure enable 
hemoglobin to bind oxygen reversibly.
9
 
1.1.1.2 Structure, Function, and Mechanism of Protein Enzymes 
Protein enzymes catalyze a huge reservoir of biochemical reactions that constitute the 
chemical basis of life. They are more impressive catalysts compared to synthesized 
small-molecule catalysts. Protein enzymes are able to catalyze reactions with extremely 
 6 
high substrate selectivity, stereospecificity and rate under mild conditions. The typical 
rate constants (kcat) of protein enzymes range from about 10 to 10
7
 s
1
, and the range of 
rate enhancements is 10
6
 to10
24
.
10
 Many enzymes are diffusion limited, and their rates are 
near the diffusion rate constants for enzyme-substrate binding of 10
7
 to 10
8
 M
-1
 s
-1
.
10a
 
These enzymes indeed approach “catalytic perfection”. According to several enzyme 
databases, there are already over 6000 protein enzymes identified from different species, 
and all of those enzymes can be generally classified into six categories: oxidoreductases, 
transferases, hydrolases, lyases, isomerases, and ligases.
11
 
Protein enzymes adopt complex three-dimensional structures, a small portion of 
which are responsible for binding substrates and catalyzing chemical reaction. These 
small pocket-like structures are known as active sites. The substrate specificity of a 
protein enzyme arises from the interaction between the substrate and particular amino 
acid side chains in the active site. The identity and arrangement of these amino acids 
define the stereochemistry, hydrophobicity, and electrostatic characteristics of the active 
site, and eventually define what type of substrate can bind to the active site. For example, 
chymotrypsin is a serine protease that catalyzes the hydrolysis of proteins at the 
carboxamide groups of aromatic amino acid residues, such as phenylalanine, tyrosine and 
tryptophan. Structural studies revealed a deep cleft that recognizes substrate side chains 
(Figure 1.4).
12
 The cleft is formed by a series of hydrophobic amino acids, so 
chymotrypsin prefers bulky hydrophobic side chains.  
The amino acid side chains in the active site of an enzyme are also responsible for 
catalyzing the specific reaction. The side chains can act as acids or bases to donate or 
accept protons. They can perform both general acid and base catalysis and specific acid 
 7 
Table 1.1. Normal pKa values of acidic and basic amino acid side chains 
Amino Acids Normal pKa 
Aspartic acid 3.71 
Glutamic acid 4.15 
Cysteine 8.14 
Tyrosine 10.10 
Arginine 12.10 
Lysine 10.67 
Histidine 6.04 
 
 
Figure 1.4. A closer look at the active site of chymotrypsin. Ser195, His 57 and Asp102 in the 
catalytic triad are labeled. The deep cleft interacting with aromatic side chain is highlighted in 
blue. Reprinted from Ref. 12b. 
 
and base catalysis. The normal pKa values of acidic and basic amino acid side chain 
groups are listed in Table 1.1. It is noteworthy that the pKa values of amino acid side 
chains are not fixed. They can shift drastically depending on the microenvironmental 
interactions. For example, the pKa of the catalytic lysine residue (Lys115) in acetoacetate 
decarboxylase shifts from 10 to as low as 6.
13
 The shift is caused by desolvation effect of 
the protein core. Protein enzymes can also perform nucleophilic or electrophilic catalysis, 
where chemical bonds form between the substrate and the enzyme to activate the 
substrate further. The side chains of serine, tyrosine, cysteine, lysine, and histidine are 
 8 
common nucleophilic catalysts in enzymatic phosphoryl transfer reactions. The 
carboxylic acid groups of aspartic acid and glutamic acid are commone nucleophilic 
catalysts in enzymatic glycosyl transfer reactions. The -amino group of lysine can effect 
electrophilic catalysis by reacting with a carbonyl group of the substrate to form a more 
reactive imine. 
 In many cases, protein enzymes require additional molecules to catalyze reactions, 
and those additional molecules are known as cofactors. There are more than 25 biological 
molecules acting as cofactors in nature, and they can be classified into two types, 
coenzymes and metal ion cofactors. Most coenzymes form noncovalent interactions with 
the enzymes, such as hydrogen bonding and hydrophobic interaction. However, in some 
cases, coenzymes form covalent bonds with the enzyme. For example, the heme groups 
of the electron transfer protein cytochrome c bind to the protein by two thioester bonds to 
the cysteine residues.
6
 One of the most common functions of coenzymes is to provide the 
locus for redox chemistry to occur in the active site. A famous example is the flavin 
chemistry. Flavins are a family of cofactors very important to oxidoreductases, 
dehydrogenases and electron transfer proteins. Flavins can exist in three different redox 
states: oxidized, semiquinone, and fully reduced (Figure 1.5).
14
 Therefore, they can 
participate in redox reactions as either one- or two-electron mediator, making the flavin-
containing enzymes very versatile in terms of substrates and type of reactions. In 
solution, the equilibrium of the different flavin species is pH-dependent, as shown in 
Figure 1.5. However, the equilibrium can change drastically when flavin is bound to 
specific proteins, due to stabilization or destabilization of protein-flavin interactions. 
 9 
 
Figure 1.5. Redox and acid-base equilibria of ﬂavins. Reprinted from Ref. 14 with permission. 
Table 1.2. Common metal cofactors. Reprinted from Ref. 15 with permission 
Metal Type of Enzymes Role of metal 
Redox 
active? 
Mg 
Kinases, phosphatases, 
phosphodiesterases 
Binding of 
phosphates/polyphosphates 
No 
Zn 
Metalloproteases, 
dehydrogenases 
Lewis acid carbonyl activation No 
Fe 
Oxygenases (P450, non-heme) 
[FeS] Clusters 
Binding & activation of oxygen 
Electron transport, hydratases 
Yes 
Cu Oxygenases Activation of oxygen Yes 
Mn Hydratases Lewis acid Yes 
Co Vitamin B12 coenzyme Homolysis of Co-carbon bond Yes 
Mo Nitrogenase Component of Mo/Fe cluster Yes 
 
The other common type of enzyme cofactor is metal ion. Many protein enzymes bind 
one or more metal ions, and these enzymes are known as metalloenzymes. Metal ions in 
active sites can have either structural or catalytic function. The common metal ion 
cofactors are summarized in Table 1.2.
15
 For example, magnesium is the most common 
metal ion cofactor, which typically presents in enzymes involving phosphate or 
pyrophosphate substrates, because magnesium ions chelate polyphosphates. Zinc can 
play critical structural role in “zinc-finger” proteins, or act as Lewis acid to coordinate 
 10 
and activate carbonyl groups for nucleophilic attack. Another common role that metal ion 
plays is as a redox reagent. For example, in cytochrome c oxidase, iron and copper ions 
of different oxidation states serve as the redox centers for electron transport.
16
  
1.1.1.3 Applications of Protein Enzymes 
Besides the essential biological roles, protein enzymes also play important industrial 
roles. Protein enzymes have a huge variety of food applications, especially in the baking, 
brewing and dairy industries. Protein enzymes are also greatly involved in other 
industries, such as detergent production, textile manufacture, pulp and paper processing, 
and so on.
17
 In pharmaceutical industry, protein enzymes are also used as therapeutic 
agents and important drug targets. Additionally, they serve as biocatalysts in industrial 
organic synthesis. 
1.1.2 Ribozymes 
1.1.2.1 Ribozymes and Their Biological Functions 
A ribozyme is an RNA molecule that is capable of catalyzing specific chemical 
reaction. Ribozymes were first discovered independently in the 1980s by Thomas Cech 
and Sidney Altman for RNA splicing and the catalytic RNA component of RNase P, 
respectively.
4,5
 Since then, several classes of natural ribozymes have been discovered to 
catalyze RNA transesterification
18,19
, RNA hydrolysis
20
, and peptidyl transfer
21
 (Figure 
1.6). A brief summary of major classes of natural ribozymes is shown in Table 1.3.
22
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Table 1.3 Major Classes of ribozymes. Adapted from Ref. 22 with permission. 
Class Ribozyme Function Size (nucleotides) 
Cleaving ribozymes 
Self-cleaving Hammerhead Gene control (?) 
Processing of multimeric 
transcripts during rolling-
circle replication 
65 
 Hairpin 75 
 Varkud Satellite 155 
 Hepatitis Delta Virus 85 
 CoTC Transcription termination (?) 190 
 CPEB3 Splicing regulation (?) 70 
 glmS Gene control 170 
Trans-cleaving RNase P tRNA processing 140-500 
Splicing ribozymes 
 Group I intron Self-splicing 200-1500 
 Group II intron Self-splicing 300-3000 
Peptidyl transfer ribozymes 
 LSU rRNA Peptidyl transfer ~2900 
CoTC, co-transcriptional cleavage. The symbol (?) indicates an unconfirmed function. 
 
Figure 1.6. Three types of reactions catalyzed by natural ribozymes. (a) Transesterification. (b) 
Hydrolysis. (c) Peptidyl transfer. 
1.1.2.2 Structural Components of Ribozymes 
The notion that RNA could be catalytic was initially very surprising, because 
ribozymes lack the chemical diversity of functional groups compared to protein enzymes 
that consist of 20 amino acids. Additionally, the secondary structures of protein enzymes 
position the side chains of amino acids on the outside of the structures, while secondary 
structures of RNA, such as base-paired duplexes, place the chemical groups of the 
nucleobases on the interior of the structures. It was also thought to be very difficult for 
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Figure 1.7 Common secondary and tertiary structural elements in RNA. (a) Secondary structural 
elements in RNA. (b) Tertiary structural elements in RNA. Reprinted from Ref. 24 with 
permission. 
RNA molecules to form complex tertiary structure because of high density of negative 
charge and flexibility of the phosphate backbone. Despite all the potential challenges, 
ribozymes can still achieve significant rate enhancements. For example, ribozymes can 
accelerate phosphoryl transfer reactions by 10
5
- to 10
11
-fold over the background rates.
23
 
Similar to protein enzymes, ribozymes can fold into complex structures. Watson–
Crick base-pairing interactions make it relatively easy for RNA molecules to form 
secondary and tertiary structures, such as duplexes, hairpins, pseudoknots, and so on 
(Figure 1.7).
24
 However, RNA misfolding is also possible due to the similar chemical 
nature of all monomers. Due to the polyanionic nature of RNA molecules, they bind to 
metal ions very well. Metal ions can bind to RNA via strong interactions, which require 
removal of some water molecules from the first and/or second shell. A hydrated metal ion 
can bind with solvated RNA to form a transient diffuse binding interaction. RNA 
molecules can also chelate metal ions through functional groups such as phosphate 
 13 
 
Figure 1.8. Three types of transesterification reactions catalyzed by natural ribozymes. (a) 
Transesterification reaction catalyzed by small nucleolytic ribozymes. (b) Transesterification 
reaction catalyzed by Group II intron. (c) Transesterification reaction catalyzed by Group I 
introns. 
 
oxygens. RNA-bound metal ions can play important roles both structurally and 
catalytically. For example, some metal ions stabilize the active tertiary structure through 
electrostatic interactions, while some metal ions directly participate in acid-base catalysis 
by activating the nucleophile, stabilizing the leaving group. In addition, metal ions can 
modify the pKa of a functional group.
25
 For example, coordination of metal ions to 
nucleobases causes large pKa shifts for both amino and imino protons.
25
 The activated 
functional groups can then participate in catalysis. 
1.1.2.3 Ribozyme Catalyzed Transesterification Reaction 
The majority of natural ribozymes catalyze transesterification reactions. There are 
mainly three types of transesterification reactions (Figure 1.8). The first type is generally 
catalyzed by small nucleolytic ribozymes, and the reactions involve the nucleophilic 
attack of the 2ʹ-OH on the adjacent 3ʹ-P (Figure 1.8a). The second type is similar to the 
first one, except that the reaction occurs in Group II introns, and the 2ʹ-OH is located 
 14 
elsewhere in the introns (Figure 1.8b). The third type occurs in Group I introns, where the 
3ʹ-OH of a guanosine molecule attacks the 3ʹ-P (Figure 1.8c). 
Hammerhead ribozymes are one of the most well-studied self-cleavage ribozymes. 
They are found in several of the viroids
26
 and satellite RNAs
27
 associated with plant RNA 
viruses and other species, which replicate via a rolling circle mechanism. The 
hammerhead ribozymes share a motif of three base-paired stems flanking a central core 
of 15 conserved nucleotides, as shown in Figure 1.9.
28
 The conserved central bases are 
essential for ribozyme activity. Many experiments have been performed to determine the 
catalytic mechanism of hammerhead ribozyme and the role of divalent metal ions in the 
reaction. For example, sulfur substitution for the scissile phosphate oxygens shows 
inversion of configuration of the phosphate during the reaction, indicating that the 
reaction proceeds by “in-line” attack of the nucleophile, rather than “adjacent” attack.29 
Additionally, it has been shown that the reduced cleavage activity can be rescued by 
 
Figure 1.9. Three-dimensional structure of the hammerhead ribozyme. The letters with outlines are 
the 15 highly conserved nucleotides. The red arrow and letters indicate the self-cleavage site. 
Adapted from Ref. 28c with permission. 
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Figure 1.10. Two possible mechanisms for hammerhead ribozyme catalysis. (a) One-metal-ion 
mechanism. In this mechanism, the hydroxide ion coordinated with the metal ion acts a Brønsted 
base by accepting the proton from 2ʹ-OH. (b) A two-metal-ion mechanism. The metal ion at Site 
A acts as a Lewis acid accepting electrons from the 2ʹ-oxygen, which weakens the OH bond and 
makes the OH bond break more readily. The metal ion at Site B also acts as a Lewis acid by 
accepting electrons from 5ʹ-oxygen, which weakens the OP bond and makes this oxygen a better 
leaving group. Reprinted from Ref. 32 with permission. 
addition of a thiophilic metal ion when sulfur is substituted for the pro-Rp nonbridging 
oxygen of the scissile phosphate. The observation suggests a direct coordination 
interaction between a metal ion and the phosphate oxygen in the transition state.
29,30
 
Additionally the reaction rate increases linearly with pH, indicating that the nucleophile 
is activated by a hydroxide ion.
31
 Either a metal ion hydroxide deprotonates the 2ʹ-OH 
directly, or a metal ion coordinates to the 2ʹ-OH increases the acidity of the group.31-32 
The metal ion coordinated to the pro-Rp oxygen can perform either of these functions. 
There are some experimental observation of a two-metal ion mechanism for hammerhead 
ribozyme catalysis, but a debate still continues over the number of divalent metal ions 
directly involved in catalysis (Figure 1.10). Unfortunately, none of the structural 
determination efforts resulted in a clear conclusion, because none of the metal ions was 
close enough to the scissile phosphate to play a direct role in catalysis. However, 
cryocooling hammerhead ribozyme crystals revealed a metal ion directly coordinated to 
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Figure 1.11. Secondary and tertiary structure of the HDV ribozyme cleavage product. 
Important bases are shown as letters. P1P4 denote base-paired stems, L denotes loops, and J 
denotes joining regions between two helices. Reprinted from Ref. 37c with permission. 
the pro-Rp oxygen of the scissile phosphate, but no metal ion was found near the leaving 
group.
33
 Several observations strongly suggested that the original crystal structures only 
represented an initial ground state of the ribozyme that must undergo a conformation 
change before catalysis.
34
 One of the metal ion binding sites located near the three-helix 
junction was subsequently found to inhibit catalysis when occupied.
35
 Finally, the 
previous demonstration of the labile phosphate in the in-line attack of the 2ʹ-oxygen was 
proved to be not completely correct. It was later shown that a change in the conformation 
of the A9 phosphate occurred, which was consistent with the observation that a metal ion 
coordinated to this phosphate bound with higher affinity in the transition state than the 
ground state.
28c,36
  
Besides hammerhead ribozymes, there are many more ribozymes that catalyze 
transesterification reactions. Some of these ribozymes have relatively small sizes and 
simple structures (hairpin ribozymes and HDV ribozyme), but some of them are 
relatively large in size (Group I and Group Introns). All these ribozymes have unique 
structure features that are essential to their catalytic abilities. For example, the HDV 
 17 
ribozyme is extremely stable, because the ribozyme fold into a stable double pseudoknot 
containing five helical stems (Figure 1.11).
37
 Metal ions also play different roles in 
transesterification reactions catalyzed by other ribozymes. For example, metal ions may 
not play a central role in catalysis by the hairpin ribozyme,
38
 but Mg
2+
 ions are 
coordinated directly with the Tetrahymena thermophila Group I ribozyme and participate 
in the catalytic mechanism to activate the nucleophile and stabilize the leaving group.
39
 
1.1.2.4 Ribozyme Catalyzed Hydrolysis Reaction 
RNase P was one of first two natural ribozymes discovered in the 1980s.
5
 It was first 
discovered as the molecule responsible for the processing of the 5ʹ end of tRNA in 
bacteria.
40
 It is later shown that RNase P is a ribonucleoprotein complex
41
 and its 
catalytic subunit is the RNA component, instead of the protein component.
5
 In contrast to 
other natural ribozymes, RNase P catalyzes RNA cleavage in trans with multiple-
turnover capability. RNase P accepts various RNA molecules as substrates. Besides all of 
the different pre-tRNAs, RNase P processes 4.5S RNA,
42
 bacteriophage 80-induced 
RNA,
43
 the 3ʹ-terminal structure of the turnip yellow mosaic virus genomic RNA,44 
tmRNA,
45
 the mRNA from the polycistronic his-opron,
46
 the pre-C4 repressor RNA from 
bacteriophages P1 and P7
47
 and some transient structures adopted by riboswitches.
48
 
Although not all RNase P substrates have been well characterized, they likely contain 
similar structural features that mimic tRNAs. 
The protein components in RNase P also differ drastically among different organisms 
in the number of protein subunits. Even though the RNA component of RNase P is 
sufficient for catalysis in vitro, both RNA and protein components are required for 
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Figure 1.12. Structure of the RNA component of bacteria RNase P. (a) Secondary structure 
diagram of Thermotoga maritima P RNA. The RNA component is formed by two independently 
folded domains (S and C), each of which contains a universal module formed by CRs. Universally 
conserved nucleotides are denoted in color with bold uppercase letters; nucleotides conserved in 
bacteria are shown in black typeface, either in uppercase or lowercase letters (conserved or highly 
conserved, respectively). The CRs in the vicinity of the active site are shown in red, whereas the 
CRs in the S domain are shown in cyan. (b) Diagrams of two views of the structure of the RNA 
component of T. maritime RNase P. Secondary structure elements are colored as in panel a. 
Reprinted from Ref. 52c with permission. 
function in vivo. The RNA components of RNase P vary in size across different 
organisms. The RNA component is generally much larger in bacteria and smaller in 
eukarya, where the secondary structural elements are possibly replaced by protein 
components.
49
 The RNA subunits from different organisms all share some common 
structural features, including a conserved core with similar secondary structures.
50
 Five 
regions of RNase P RNA were found to be conserved (known as conserved regions I to V 
or CR-I to CR-V).
51
 These regions fold into two conserved modules with high sequence 
conservation (Figure 1.12).
52
 In bacteria, three types of RNase P molecules have been 
discovered,
53
 which are A (for ancestral), B (for Bacillus), or C types. Most bacteria have 
A or B types of RNase Ps. The RNA component of bacterial RNase P consists of two 
folded domains, the larger catalytic domain (or C domain) and the smaller specificity 
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Figure 1.13. tRNA recognition by bacteria RNase P. (a) Schematic of the interaction between 
tRNA and P RNA. (b) tRNA recognition by the S-domain. (c) Recognition of tRNA CCA region 
by the C-domain. Adapted from Ref. 54 with permission. 
domain (or S domain), as shown in Figure 1.12.The C domain recognizes the acceptor 
stem and 3ʹ-CCA region of tRNA and catalyzes the hydrolysis of the 5ʹ leader of pre-
tRNA, and the S domain is involved in the substrate recognition through interaction with 
the TC and D loops of pre-tRNA (Figure 1.13).54 The acceptor stem of tRNA docks on 
the P RNA (Figure 1.13a) and makes a series of interactions, including base stacking in 
the TC and D loops of tRNA and the S-domain (Figure 1.13b), Aminor interaction, 
ribose zipper, and stacking interactions between the 5ʹ and 3ʹ ends of tRNA and C-
domain (Figure 1.13c). The protein component of bacteria RNase P is located near the 5ʹ 
end of mature tRNA, but is not close enough to interact with it directly.
54
 The protein 
makes extensive contacts with the pre-tRNA leader to discriminate among RNA 
molecules and position the pre-tRNA for optimal catalysis. 
RNase P is a metalloenzyme. In fact, three metal ions have been observed in the 
 20 
 
Figure 1.14. (a) A diagram of the interactions in the active site. (b) A proposed mechanism of 
RNase P catalysis. Adapted from Ref. 54 with permission. 
crystal structure of T. maritima holoenzyme complex. 
54
 One metal ion (M3) is involved 
in stabilization of the interaction between C-domain and 3ʹ CCA of tRNA (Figure 1.13c). 
The other two metal ions are involved in catalysis at the active site. One of these two 
metal ions (M1) is trapped between tRNA 5ʹ end and the conserved uridine U52 of the P 
RNA (Figure 1.14). The remaining metal ion (M2) is in close proximity to G51, the 3ʹ 
end of the leader and the 5ʹ end of tRNA. Structural studies together with biochemistry 
results allow the proposal of a plausible cleavage mechanism (proposed transition state 
shown in Figure 1.14b).
54
 The M1 ion directly coordinates with the scissile phosphate 
oxygens of the tRNA substrate and enables a hydroxyl ion to perform SN2 nucleophilic 
substitution. The M2 ion stabilizes the transition state and mediates the proton transfer to 
the 3ʹ scissile oxygen during product release. 
1.1.2.5 Ribozyme Catalyzed Peptidyl Transfer Reaction 
Most natural ribozymes catalyze phosphate cleavage reactions, either via 
transesterification mechanism or hydrolysis mechanism. However, the most abundant 
natural ribozyme is the ribosome, the ribozyme that catalyzes protein synthesis. Bacterial 
 21 
ribosome consists of three RNA molecules (rRNAs) and over 50 proteins. It has two 
subunits, the larger 50S subunit and the smaller 30S subunit. The catalytic center of the 
ribosome, the peptidyl transferase center (PTC), is located in the 50S subunit. The high-
resolution crystal structure of the large ribosomal subunit has revealed that the peptidyl 
transferase center is composed of 23S rRNA.
21e,f
 This finding implies that the peptide 
bond formation is catalyzed by RNA. 
The reaction catalyzed by the peptidyl transferase center of the ribosome is the 
aminolysis reaction of an ester bond, in which the -amino group of A-site aa-tRNA 
attacks the carbonyl carbon of the ester bond linking the peptide moiety and peptidyl-
tRNA at P-site (Figure 1.6c). The ribosome can increase the rate of peptide bond 
formation by 10
6107-fold. Currently, no crystallographic data has shown any 
involvement of metal ions in the active site of ribosome, so it is likely that ribosome is 
not a metalloenzyme. Additionally, the reaction catalyzed by ribosome is pH-insensitive, 
and no nucleobases have shown to be critical for catalysis.
55
 However, only one 
functional group, the 2ʹ-OH group of A76 of peptidyl-tRNA at P-site, was found to play 
important roles in the catalysis.
56
 Recently, a systematic analysis of the kinetic isotope 
effects at five positions within the reaction center of a peptidyl-transfer RNA mimic has 
been reported.
57
 According to the analysis, a new mechanism is proposed, in which both 
the formation of the tetrahedral intermediate and proton transfer from the nucleophilic 
nitrogen occur in the rate-limiting step (Figure 1.15, red pathway). The reaction is not 
fully concerted because the breakdown of the tetrahedral intermediate occurs in a 
separate fast step. The analysis also suggests that the ribosome not only positions the 
substrate in close proximity, it also changes the rate-limiting transition state to accelerate 
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Figure 1.15. Different mechanisms of ribosome catalyzed peptide bond formation. Ground states 
are shown in black, intermediates in grey and transition states in blue. The ribosomal reaction 
may be fully stepwise with two intermediates, like uncatalyzed reaction (black pathway). 
Alternatively, one of these steps may be concerted, with only one intermediate (red and orange 
pathways) or the reaction may be fully concerted with no intermediates (green). The identities of 
B1 and B2 are uncertain; the 2ʹ-OH may be one, both or neither. Reprinted from Ref. 57 with 
permission. 
the reaction. Other mechanisms have also been proposed with supports of computational 
modeling and KIE/KSIE results (Figure 1.15 green and orange pathways).
58
 However, the 
exact mechanism of ribosome catalysis is still an unsolved puzzle. 
1.2 Artificial Enzymes  
Scientists in enzyme-related fields have always been playing two intertwined roles. 
One role is to gain thorough knowledge of the natural enzymes about their structure, 
mechanism and evolution. The other role is to obtain artificial enzymes for new or better 
catalytic activities to fulfill research and industrial needs. Here, artificial enzymes are 
defined as all enzymes that are not naturally produced. The first part of this introduction 
has highlighted the magnificent achievements scientists have accomplished to understand 
natural enzymes. The second part of the introduction demonstrates how scientists have 
been playing their role to obtain artificial enzymes.  
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Artificial enzymes can be classified into different families. There are the family of 
small molecule catalysts widely used in organic synthesis, the family of bio-mimetic 
enzymes, the family of engineered/designed protein enzymes, and the family of artificial 
nucleic acid enzymes. In this part of the introduction, only the engineered/designed 
protein enzymes and artificial nucleic acid enzymes are discussed. 
1.2.1 Engineered/Designed Protein Enzymes 
Natural protein enzymes are fascinating biological catalysts, but some of them have 
significant limitations that prevent them from certain applications. For example, many 
natural protein enzymes have poor selectivity, low stability in organic solvents, slow 
reaction rates, and substrate or product inhibition. To overcome these limitations, new 
and improved protein enzymes are needed. Currently, several approaches have been 
established to identify new protein enzymes, such as directed evolution, in vitro protein 
selection and rational design. 
1.2.1.1 Enzyme Engineering via Directed Evolution 
Natural protein enzymes have gone through billions of years of evolution to achieve 
their proficient catalytic activities. Therefore, the most straightforward way to improve a 
natural enzyme is to force it through evolution again to achieve better catalytic activity. 
In fact, directed evolution is a well-established method mimicking natural selection. 
During a directed evolution experiment, a selection pressure is applied to a library of 
variants of a protein enzyme target, so the variants with desired properties can be 
identified. Directed evolution is an iterative strategy, and each cycle involves two stages: 
diversity generation and screening/selection. 
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Figure 1.16. Two types of methods to generate diversity libraries: random mutagenesis (left) and 
gene recombination (right). Reprinted from Ref. 59 with permission. 
The likelihood of success of directed evolution largely depends on the size of the 
diversity library. The more variants one evaluates, the bigger chance he has to identify a 
variant with the desired property. Many methods have been used to generate the diversity 
library, and they can be classified in two categories: random mutagenesis and gene 
recombination (Figure 1.16).
59
  
Random mutagenesis, as its name suggests, takes advantage of improper DNA 
replication or inadequate repair of DNA damage to generate variant genome. It can 
introduce mutations including transitions, transversions, insertions, deletions and 
inversions to the genome. One of the simplest and most popular random mutagenesis 
methods is error-prone PCR, which takes advantage of the fallibility of DNA polymerase 
to generate random base pair substitutions.
60
 However, error-prone PCR has several 
drawbacks. Because of the redundancy of genetic codes, this method limits the actual 
protein diversity it can introduce. From a single amino acid, an average of fewer than six 
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other amino acids can be obtained, rather than all 19 possible mutations.
61
 Besides, DNA 
polymerases used in RCR reactions have mutational biases that also limit protein 
diversity. Additionally, because the error rate of DNA polymerase is kept low to maintain 
active function of protein library, usually only 13 mutations per 1000 base pairs, it is 
unlikely that the mutations will occur next to each other. The limitation of error-prone 
PCR mutagenesis may be overcome by site-directed mutagenesis or saturation 
mutagenesis methods.
62
 
Gene recombination refers to the exchange of blocks of genetic material among two 
or more DNA molecules. Gene recombination can introduce mutations such as 
homologous recombination, non-homologous recombination, reciprocal recombination or 
site-specific recombination.
59
 DNA shuffling is the first discovered homologous 
recombination method.
63
 DNA shuffling involves the digestion of a gene into random 
fragments and the reassembly of each other base on sequence homology. Although DNA 
shuffling is a powerful tool, it has limitations. DNA shuffling method requires the 
presence of zones of relatively high sequence homology surrounding regions of 
diversification. It is also significantly biased towards regions of higher homology and 
fragments introduced by the digestion enzyme. Numerous methods, such as degenerate 
oligonucleotide gene shuffling (DOGS), have been designed to complement DNA 
shuffling methods.
64
 
The screening/selection step in directed evolution is the step where undesired variants 
are eliminated and desirable variants are identified or enriched. This step can be done 
through high-throughput screening or selection. The screening method is usually more 
straightforward but limited by its throughput (10
2
-10
4
 variants tested individually), while 
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Figure 1.17. Schematic of the PACE system. Host cells continuously flow through a lagoon, where 
they are infected with selection phages (SP) encoding library members. Functional library 
members induce production of pIII from the accessory plasmid (AP) and release progeny capable 
of infecting new host cells, whereas non-functional library members do not. In creased 
mutagenesis is triggered through induction of the mutagenesis plasmid (MP). Reprinted from 
Ref. 65b with permission. 
selection method can be ultrahigh throughput (10
6
 to > 10
12
 variants tested in parallel), 
but has to be specific to the given enzyme or activity. There are several recent advances 
in developing ultrahigh selection methods.
65
 One of them is an impressive continuous 
evolution system established by the Liu group.
65b
 In the phage-assisted continuous 
evolution (PACE) system (Figure 1.17), E. coli host cells continuously flow through a 
fixed-volume vessel (‘the lagoon’) containing a replicating population of phage DNA 
vectors (‘selection phage’) that encode the genes of interest. Because the average 
residence time of host cells in the lagoon is less than the time required for E. coli 
replication, mutations only accumulate in the evolving selection phage population, the 
only DNA that can replicate faster than the rate of lagoon dilution. PACE achieves 
continuous selection by linking the desired activity to the production of infectious 
progeny phage containing the evolving genes. Only phage vectors that are able to induce 
sufficient pIII protein production from the accessory plasmid will propagate and persist in 
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the lagoon. The pace system can perform 200 rounds of protein evolution over the course 
of 8 days, and was able to evolve t7 RNA polymerase for better activities successfully. 
Directed evolution is a powerful tool to improve activities of protein enzymes, it also 
suffers from significant disadvantages. For example, all directed evolution processes have 
known targets of interest as the origin of evolution. In most cases, the known targets may 
be evolvable, and the resulting enzymes may exceed the parent enzyme. But in some 
cases, such as to alter the substrate selectivity of the target enzyme, directed evolution 
can lead to complete relaxation of selectivity of the enzyme. Therefore, other methods of 
identifying new protein enzymes are also needed.  
1.2.1.2 In Vitro Selection from a Protein Library 
In contrast with enzyme engineering through directed evolution, in vitro selection 
from random protein library does not require a known target or specific structural 
information of enzymes, thus suitable for selecting genuinely new enzymes. However, 
although the idea of in vitro selection for protein enzymes sounds very appealing, the 
execution of protein selection is limited in several ways. The first limitation is related to 
the size of the random protein library. Protein enzymes consist of 20 amino acids, so a 
random library of proteins containing n amino acids has 20
n
 possible sequence 
combinations. Even if n is as small as 20, the number of sequence combinations is over 
10
26
, not to mention a typical protein enzyme has more than 20 amino acids. Therefore, it 
is very difficult for bench-scale selection experiments to survey a reasonable fraction of 
the random protein library. Another big limitation of constructing random protein library 
is the aggregation problem. Random proteins consisting of 20 amino acids tend to 
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aggregate and precipitate, so it is very challenging to construct a functional library of 
random proteins. Alternatively, it has been suggested that reducing 20 amino acids to 12 
amino acids can potentially increase the solubility of the random protein library and 
increase the chance of identifying functional protein.
66
 The 12 amino acids include five 
primitive amino acids encoded by GNN codons (Ala, Gly, Val, Asp, and Glu), which 
show high solubility,
67
 and amino acids encoded by ANN codons (Ser, Thr, Arg, Met, Ile, 
Asn, and Lys). However, the problem still remains that random proteins are hard to fold 
into meaningful structures to function. Finally, in order to perform selection with a 
random protein library, the protein sequence information has to be linked with the desired 
function. More importantly, the sequence information of active protein enzyme has to be 
transferred from one round of selection to the next. The two requirements significantly 
narrow down the methods feasible for in vitro protein selections. Currently, a few 
methods have been developed to identify new enzymes from protein libraries, including 
mRNA display, 
68
 ribosome display,
69
 and DNA display
70
. The most widely used method 
is mRNA display. 
The mRNA display method enables the covalent linkage between the protein and the 
mRNA that encodes it (Figure 1.18). In an mRNA display selection, a DNA library that 
encodes the randomized protein library is first generated. A minimum number of codons 
are chosen to be randomized to virtually assure that every single mutant has a unique 
sequence. Typically a randomized library of only 10
13
 proteins are used in an mRNA 
display selection, which means only 11 to 15 amino acids can be randomized in the target 
protein. The DNA library is processed to introduce constant primer binding regions for 
PCR amplification, and then transcribed in to an mRNA library. Puromycin molecules 
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Figure 1.18. mRNA display selection procedures for RNA ligases. Reprinted from Ref. 68c with 
permission. 
are introduced to the 3ʹ termini of the mRNA molecules, so that the translated protein 
products are linked to the mRNAs that encode them. Subsequently, each mRNA 
molecule is reverse-transcribed into cDNA using a modified primer that contains 
substrate A. The cDNA-mRNA-protein complex is then incubated with substrate B. After 
the cDNA sequences encoding active protein catalysts are selectively enriched, they are 
PCR amplified for next cycle of selection experiment. When reasonable activity is 
observed, the cDNA sequences will be cloned and sequenced, and the active protein 
enzymes will be further characterized. 
Currently no enzyme has been identified from a fully random protein library. The 
only two successful examples of in vitro selections for protein enzymes are the two RNA 
ligases successfully identified from two partially-randomized protein libraries constructed 
from non-catalytic scaffolds.
71
 Strictly speaking, these two enzymes are still identified 
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from directed evolution processes, because they both have known targets as origins, even 
though they are not catalytic. In vitro selection for protein enzymes from a random 
protein library is very appealing but still extremely challenging. Scientists are still 
seeking ways to improve the selection processes and alternative strategies to identify 
genuinely new protein enzymes. 
1.2.1.3 Designing Protein Enzymes 
Both directed evolution and in vitro selection are based on accelerated evolution, 
while rational design of protein enzymes depends extensively on our understanding of 
enzyme structure and mechanism. Early attempts of rational design of protein enzymes 
were based on known structures, and were usually associated by site-directed 
mutagenesis. Scientists could then alter catalytic activities of protein enzymes. These 
studies led to the formation of the field of protein engineering. Modern studies of enzyme 
design are highly assisted by computational modeling.
72
 
Designing an enzyme starts with making models of how an enzyme could facilitate 
catalysis of a given substrate (Figure 1.19). A constellation of amino acids residues are 
positioned in a catalytic active site to maximize the transition-state stabilization. The 
constellation of amino acids with specific structure is termed as “theozymes”.73 
Theozymes are subsequently docked into diverse protein scaffolds, and in silico 
optimization are then performed by a combinatorial search for amino acid substitutions 
that improve transition-state binding. Finally, the designs are filtered on the basis of their 
catalytic geometry, transition-state binding energy, and shape complementary between 
the designed pocket and the transition state. The top ranking designs are eventually 
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Figure 1.19. Computational design of a protein enzyme. Reprinted from Ref.72b with permission. 
synthesized and characterized. Some of the winning hits will undergo further engineering 
by directed evolution for improved activities. Recently, artificial biocatalysts have been 
generated for several reactions, including carbon-carbon bond cleavage via 
retroaldolization,
74
 proton transfer from carbon,
75
 and a Diels–Alder cycloaddition.76 All 
of the designed biocatalysts have actual structures very similar to the designed structures, 
showing some promises in computational design of protein enzymes.  
However, encouraged by the achievements of computational design of enzymes, one 
must also realize that our current designing power is still far behind what nature has 
achieved in billion years of evolution. Most computationally designed enzymes provide 
rate enhancements of less than 10
6
. The level of activity designed enzymes have achieved 
are not much higher than those of catalytic antibodies developed 15-25 years ago,
77
 and 
are barely comparable with the least proficient natural enzymes. Furthermore, only a 
small fraction of computational designs show modest catalytic activity, the majority of 
the designs are not active. In some cases, the engineered variants of the designed 
enzymes may completely abandon the designed active site structures in favor of new 
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active sites to achieve bigger rate enhancements.
78
 There are many possible reasons for 
the failure of computational design. It is likely that natural enzymes have minimized the 
potential conformational motions to achieve higher rate enhancements. Natural enzymes 
have also achieved better management of water molecules in the active site. The fine-
tuned microenvironments also cause significant pKa shift of the amino acids. These 
intricate changes are not yet achievable by computational designs. 
Computational design of protein enzymes has reached a point where we have seen 
what can be achieved and we need to figure out how to improve this method, but 
obviously a long way is still ahead of us. With our understanding of protein enzyme 
structure and function becoming more thorough and our computational algorithm 
becoming more powerful, computational design of protein enzymes will be more 
applicable for obtaining useful new enzymes. 
1.2.2 Artificial Nucleic Acid Enzymes 
The discovery of natural RNA catalysts in the 1980s has demonstrated nucleic acids 
can function as catalysts. Since then, scientists have been exploring the catalytic power of 
nucleic acids. It has been proved that both RNA and DNA can be catalytic, and methods 
to identify artificial nucleic acid enzymes have been established. These methods are 
typically based on accelerated evolution, and are greatly assisted by polymerase chain 
reaction (PCR) technology. As a result, numerous artificial RNA and DNA enzymes have 
been identified to catalyze a great reservoir of chemical reactions. Additionally, artificial 
nucleic acid enzymes are increasingly applicable in various areas ranging from chemistry 
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Table 1.4. Selected examples of catalytic activities of artificial ribozymes 
Reaction type References 
P–O bonds 
RNA cleavage [80ac] 
RNA ligation [80dh] 
RNA phosphorylation [80i, j] 
RNA capping [80km] 
RNA polymerization [80l] 
C–C bonds 
Diels–Alder reaction [81ad] 
Aldol reaction [81e] 
Claisen condensation [81f] 
biphenyl isomerization [81g] 
C–N bonds 
amide bond formation [82a, b] 
N-glycosidic bond formation [82ce] 
N-alkylation [82f] 
C–O bonds 
acyl transfer [83ac] 
aminoacyl transfer [83dg] 
Carbonate ester hydrolysis [83h] 
C–S bonds 
Michael addition [84a] 
S-acylation [84b] 
S-alkylation [84c] 
C–H bonds 
alcohol oxidation [85a] 
aldehyde reduction [85b] 
 
to biology. These enzymes have been used as analytical sensors, catalysts for small-
molecule synthesis, and potential pharmaceutical agents. 
1.2.2.1 Artificial Ribozymes 
The first artificial ribozyme is identified in 1990.
79
 It is a mutant from wild-type 
Tetrahymena ribozyme that catalyzes single-stranded DNA cleavage. Since then, 
numerous artificial ribozymes have been identified to catalyze various chemical reactions 
(Table 1.4).
80,81,82,83,84,85
 Artificial ribozymes are typically identified through the process 
of in vitro selection The general concept of in vitro selection for artificial ribozymes is to 
force a library of RNA molecules through accelerated evolution under a specific selection 
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pressure (usually associated with desired catalytic activity), so that the RNA molecules 
which are able to catalyze the desired reaction can be readily enriched and amplified. 
Unlike in vitro protein selection, in vitro RNA selection is more plausible and 
straightforward. A library of fully random 20-mer RNA library has only 4
20
 = 10
12
 
possible sequence combinations, compared to 10
26
 possible sequence combinations of a 
random 20-mer protein library. Starting with the same 10
13
 molecules, an in vitro RNA 
selection experiment covers all the possible sequences, while in vitro protein selection 
can only cover a tiny fraction. Additionally, in contrast to laborious protein expression 
procedure and potential problems such as insolubility and low yield, a random RNA 
library can be reliably obtained by in vitro transcription. More importantly, protein 
libraries have to be linked to mRNAs to enable protein sequence amplification, but RNA 
molecules can be easily amplified using polymerase chain reaction based methods during 
in vitro RNA selections.  
The RNA library is typically generated by large-scale in vitro transcription of a 
corresponding DNA library. The DNA library can be synthesized using combinatorial 
solid-phase synthesis method, so that each nucleotide in the designed DNA sequence has 
a predetermined probability of being any of the four monomers (A, T, G and C). 
Combinatorial solid-phase synthesis method has been used to generate both fully random 
libraries as well as biased (partially-randomized) libraries. Once the DNA library is 
synthesized, the RNA library can be transcribed in vitro using RNA polymerases such as 
T7 RNA polymerase.
86
 
The in vitro RNA selection is usually an iterative experiment in which enrichment of 
catalytic RNA sequences and amplification of these RNA sequences are repeated. For 
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example, in a selection experiment to identify RNA-ligating ribozymes, the initial 
random RNA library is conjugated to one of the two RNA substrates, and the resulting 
conjugate is incubated with the other RNA substrate under desired selection conditions to 
allow the ligation reaction to occur. Because the ligation product has a higher molecular 
weight, the active RNA sequences can be selectively enriched from the inactive 
sequences, either by methods based on molecular weight difference or methods based on 
gaining of desired function that is specific to the second RNA substrate. The enriched 
catalytic RNA sequences are then reverse transcribed into DNA, and the DNA sequences 
are finally amplified by PCR to generate the DNA library for next round of selection. The 
selection rounds continues until catalytic RNA sequences dominate the library 
population, and individual RNA sequence will be cloned, sequenced and further 
characterized. 
Unlike natural ribozymes, our understanding of structures and mechanism of artificial 
ribozyme is still very minimal. Although a lot of artificial ribozymes have been 
identified, only two artificial ribozyme, the Pb
2+
-dependent RNA-cleaving “leadzyme”87 
and a ribozyme for Diels–Alder reaction,88 have crystal structures, providing us detailed 
knowledge about their structures and functions. However, much work remains to be done 
for us to understand artificial ribozymes more thoroughly. 
1.2.2.2 Deoxyribozymes 
In addition to artificial ribozymes, scientists have also been exploring catalytic 
abilities of DNA due to the chemical similarities between DNA and RNA. In fact, DNA 
is considered to be a better choice as artificial enzyme than RNA, because DNA is 
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Table 1.5. Selective examples of catalytic activities of deoxyribozymes. 
Reaction type References 
P–O bonds 
RNA cleavage [89, 90af] 
RNA ligation [91] 
DNA phosphorylation [92a] 
DNA capping [92b] 
DNA ligation [92c, d] 
DNA hydrolysis [92ej] 
RNA hydrolysis [92k] 
nucleopeptide linkage [92ln] 
tyrosine dephosphorylation [92o] 
Tyrosine phosphorylation [92p] 
C–C bonds 
Diels–Alder reaction [93a] 
thymine dimer photoreversion [93b] 
C–O bonds 
Oxidative DNA cleavage [93c, d] 
Carbonate ester hydrolysis [93e] 
C–N bonds 
DNA deglycosylation [93f] 
aromatic amide hydrolysis [93e] 
reductive amination [93g] 
P–N bonds 
phosphoramidate cleavage [93h] 
 
chemically more stable than RNA, and a DNA library is more straightforward and 
cheaper to produce with a higher yield. Additionally, a DNA library can be amplified 
directly by PCR, making the in vitro DNA selection experiment much simpler than the 
RNA selection that requires additional transcription and reverse transcription steps. 
DNA has been proved to be as catalytic as RNA, and the catalytic DNA sequences 
are called deoxyribozymes. Since the first deoxyribozyme that catalyzes RNA cleavage 
identified in 1994,
89
 many more deoxyribozymes have been identified to catalyze various 
chemical reactions (Table 1.5).
90,91,92,93
 Deoxyribozymes are considered to be completely 
artificial, because they have not been found in nature. 
The in vitro selection experiments for deoxyribozymes are very similar to those for 
artificial ribozymes, except that RNA selections require the transcription from DNA 
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Figure 1.20. DNA hydrolysis reaction. 
library to RNA library at the start of a round and the reverse transcription from RNA 
back to DNA at the end of a round. Similar to artificial ribozymes, even though many 
deoxyribozymes are identified, little are known about their detailed structures and 
mechanisms. There is only one crystal structure reported currently for the 10–23 
deoxyribozyme, but the complex is inactive, and the substrate:enzyme ratio is 2:2.
94
 
Although the resulting structure was an interesting four-way junction, no detailed 
knowledge could be gained about DNA catalysis. 
1.3 Site-Specific DNA Hydrolysis 
DNA hydrolysis is the reaction in which the nucleophilic attack of water at the DNA 
phosphodiester bond results the cleavage of the bond, forming a hydroxyl product and a 
phosphate product (Figure 1.20). Given the fact that the main biological role of DNA is 
to preserve genetic information, it is not surprising that the phosphodiester bond is far 
more stable than other common biological functional groups such as amides or esters. 
The half life of DNA at near-physiological conditions ranges from ~4000 years
95
 to 30 
million years
96
 to over 10 billion years.
97
 In nature, DNA hydrolysis is an important 
biological reaction which facilitates the synthesis, manipulation and repair of DNA. In 
 38 
biological labs, DNA hydrolysis is an important tool for scientists to manipulate DNA 
molecules from small oligonucleotides to genomes. DNA hydrolysis reactions are usually 
catalyzed by DNA nucleases with different levels of sequence specificities. 
Restriction endonuclease is one of the most important tools in recombinant DNA 
technology. Currently, thousands of different restriction endonucleases have been 
isolated, which collectively recognize and cleave more than 300 different restriction sites. 
The restriction sites are usually 4 to 8 bases long, and most of them are palindromic. For 
example, EcoRI is an E. coli. restriction enzyme that recognizes the sequence of 5-
G^AATTC-3and 3-C^TTAAG-5 and cleaves between two G^As on both strands. 
There are four types of natural restriction enzymes. Type I restriction enzymes recognize 
specific DNA sequences but cleave at sites that are far (at least 1000 bp) away from the 
recognition site. Type II restriction enzymes recognize and cleave directly within the 
recognition sites. Type III restriction enzymes recognize specific sequences but cleave at 
sites a short distance (within 25 bp) from recognition sites. Type IV enzymes target 
modified DNA, such as methylated and hydroxymethylated DNA substrates. 
Restriction endonucleases hydrolyze phosphodiester bonds forming a free 3-
hydroxyl group and a 5-phosphate group, and they typically catalyze the hydrolysis 
reaction via two mechanisms: covalent intermediate mechanism (Figure 1.21a) or direct 
hydrolysis mechanism (Figure 1.21b).
98
 In either mechanism, the reaction takes place by 
an in-line displacement path (Figure 1.21c). In the first type of mechanism, a nucleophile 
on the enzyme attacks the phsphoryl group to form a covalent intermediate, which is then 
hydrolyzed by water. Scince the configuration undergo two in-line displacements, the 
overall configuration of the phosphate group remains unchanged. In direct hydrolysis 
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Figure 1.21. Hydrolysis mechanisms of restriction endonucleases. (a) Covalent intermediate 
mechanism. (b) Direct hydrolysis mechanism. (c) Schematic of in-line displacement. Adapted 
from Ref. 98. 
mechanism, the phosphoryl group is attacked directly by a water molecule, and the final 
configuration of phosphate group will be inverted. Restriction endonucleases usually 
require Mg
2+
 or other divalent metal ions for activities, and it has been suggested that 
divalent metal ions help to activate a water molecule and position it so that the water 
molecule can attack the phosphate.
98
 The recognition of restriction enzymes is generally 
achieved by specific interactions among amino acids, cognate DNA nucleotides, and 
possibly metal ions.
98
 
The development of artificial restriction enzymes has always been an appealing but 
challenging target for scientists. For a long time, DNA could not be hydrolyzed without 
using naturally occurring nucleases. However, several catalysts have been developed to 
overcome this obstacle. In the 1990s, it has been found that rare earth metals are 
remarkably active for hydrolysis of phosphodiester bonds.
99
 For DNA hydrolysis, Ce(IV) 
ion is especially active. Only 10 mM Ce(IV) can decrease the half life of dinucleotides to 
only several hours.
100
 However, the hydrolysis by Ce(IV) on a polynucleotide is random 
without any sequence specificity. Later on, artificial restriction enzymes have been 
prepared by linking DNA-hydrolyzing metal ions with DNA-recognizing motifs either 
covalently or non-covalently to achieve target-specific hydrolysis.
101
 Another way of 
designing artificial restriction enzymes is by fusing a natural or engineered DNA-binding 
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domain to a nuclease domain. Zinc-finger nucleases (ZFNs) are the most commonly used 
artificial restriction enzymes, but zinc-finger domains are extremely difficult to engineer 
to recognize all the possible restriction sites.
102
 Alternatively, TAL effector nucleases 
(TALENs) have also been developed and shown to be widely applicable,
103
 because each 
TAL effector repeat recognizes a single base pair compared to each zinc-finger protein 
recognizing a DNA triplet. Currently TALENs are increasingly applied for standard gene 
editing experiments.  
1.4 Thesis Research Focus 
Recently, our group has reported the identification of 10MD5, the first 
deoxyribozyme to hydrolyze a single-stranded DNA substrate sequence-specifically with 
formation of 5-phosphate and 3-hydroxyl termini.92e The identification of DNA-
hydrolyzing deoxyribozymes suggests that deoxyribozymes have significant potentials as 
practical DNA-cleaving enzymes. This thesis reports the identification of new 
deoxyribozymes that hydrolyze single-stranded DNA substrates and efforts toward 
identification of deoxyribozymes that hydrolyze double-stranded DNA substrates. 
Chapter 2 details the reselections (in vitro evolution) of 10MD5 for improved pH 
tolerance and faster rate, as well as the systematic biochemical characterization and 
mutagenesis studies of reselected 10MD5 variants. Chapter 3 presents the establishment 
of an in vitro selection approach for sequence-general DNA-hydrolyzing deoxyribozymes 
and the identification of new DNA-hydrolyzing deoxyribozymes that recognize only two 
substrate nucleotides. Chapter 4 outlines the current efforts toward targeting intact 
double-stranded DNA substrates for hydrolysis. 
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Chapter 2: In Vitro Evolution of the 10MD5 Deoxyribozyme and the 
Characterizations of 10MD5 Variants
1
 
2.1 Introduction 
In this project, in vitro evolution (reselection) experiments of the first DNA-
hydrolyzing deoxyribozyme 10MD5
1
 are designed. The goal is to identify 10MD5 
variants with improved catalytic properties such as broader pH tolerance and faster rate, 
so that the DNA-hydrolyzing deoxyribozymes can be potentially applied as artificial 
restriction enzymes. 
Most deoxyribozymes catalyze reactions with nucleic acid substrates, because the 
WatsonCrick base-pairing interactions among nucleic acid molecules provide 
deoxyribozymes with inherent substrate binding capabilities. Besides the most studied 
RNA cleavage reaction, deoxyribozymes have been identified to catalyze several other 
reactions involving nucleic acid substrates, such as RNA ligation, DNA ligation, DNA 
cleavage and so on. DNA cleavage is an interesting but challenging reaction. The DNA 
phosphodiester bond is extremely stable, and its cleavage plays important roles in the 
synthesis, manipulation, and repair of DNA. In nature, DNA cleavage is catalyzed by 
nucleases in hydrolytic pathways, but deoxyribozymes have been identified to cleave 
DNA substrate in other pathways as well (Figure 2.1). In 2000, a deoxyribozyme with N-
glycosylase activity has been reported.
2
 The deoxyribozyme catalyzes the site-specific 
                                                 
1
 The material described in this chapter has been published. 
(i) Xiao, Y.; Chandra, M.; Silverman, S. K. Functional Compromises Among pH Tolerance, Site 
Specificity, and Sequence Tolerance for a DNA-Hydrolyzing Deoxyribozyme. Biochemistry 2010, 49, 
9630-9637. 
(ii) Xiao, Y.; Allen, E. C.; Silverman, S. K. Merely Two Mutations Switch a DNA-Hydrolyzing 
Deoxyribozyme from Heterobimetallic (Zn
2+
/Mn
2+
) to Monometallic (Zn
2+
-only) Behavior. Chem. 
Commun. 2011, 47, 1749-1751 
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Figure 2.1. Three DNA cleavage mechanisms. (a) Hydrolytic pathway. (b) Deglycosylation 
pathway followed by -eliminations. (c) Possible oxidative cleavage pathway based on Ref. 2b. 
depurination of a DNA substrate. The following two spontaneous -eliminations result in 
the DNA strand excision with two phosphate products (Figure 2.1b). Another Cu
2+
-
dependent deoxyribozyme has been identified to catalyze DNA cleavage via an oxidative 
mechanism (Figure 2.1c).
3
 In 2008, it has been demonstrated that certain structural 
assemblies of G-quadruplexes are capable of performing site-specific self-cleavage in the 
hydrolytic pathway (Figure 2.1a).
4
 Although the cleavage mechanism of these G-
quadruplesxes is highly desired, the structural requirement of the complex is too high to 
be practically useful. 
Recently, the identification of a deoxyribozyme that catalyzes the sequence-specific 
hydrolysis of a single-stranded DNA substrate has been reported.
1
 The deoxyribozyme, 
named as 10MD5, hydrolyzes the DNA phosphodiester bond with the formation of 5-
phosphate and 3-hydroxyl products (Figure 2.2). The DNA hydrolysis catalyzed by 
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Figure 2.2. DNA hydrolysis catalyzed by the 10MD5 deoxyribozyme. The cleavage site is marked 
by the green line, and the substrate recognition site is highlighted in blue. 
10MD5 proceeds with kobs value of 2.7 h
1
, achieving a rate enhancement of 10
12
 over the 
unanalyzed PO bond hydrolysis. The 10MD5 deoxyribozyme has several interesting 
characteristics. In particular, 10MD5 is a heterobimetallic enzyme that depends on both 
Zn
2+
 and Mn
2+
. The 10MD5 deoxyribozyme is both sequence-specific and site-specific. It 
recognizes a relatively short four-nucleotide substrate sequence ATG^T. As long as the 
WatsonCrick base-pairing is retained between the substrate and enzyme, the 10MD5 
deoxyribozyme tolerates any substrate nucleotide variations beyond the ATG^T region 
(Figure 2.2). However, 10MD5 suffers from some limitations. It has a sharp pH 
dependence optimal near 7.5, with greatly reduced rate and yield when the pH is changed 
by only 0.1 unit in either direction. 10MD5 also has a relatively sharp Zn
2+
 concentration 
dependence optimal near 1 mM, with reduced rate and yield when the Zn
2+
 concentration 
is changed by only 0.5 mM in either direction. This chapter focuses on a series of 
reselection experiments designed to identify 10MD5 variants that have broader pH 
tolerance and faster rates. The follow-up biochemical and mutagenesis studies of the 
reselected 10MD5 variants are also extensively discussed. 
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Figure 2.3. Activity profiles of the three reselections threads. Gold arrows denote the reselection 
rounds that were cloned. (A) The first reselection thread in which the pH was first decreased to 7.2 
and then increased to 7.8. (B) The second reselection thread in which the pH was first increased to 
7.8 and then decreased to 7.2. (C) The third reselection thread performed at constant pH of 7.5 
with reducing incubation time. 
2.2 Results and Discussion 
2.2.1 Reselections of the 10MD5 Deoxyribozyme 
A series of reselection experiments were designed and performed using a biased pool 
generated by partially randomizing the 40-nucleotide enzyme region of 10MD5 to the 
extent of 25%. Each of the 40 nucleotides had a 75% chance to maintain the A/T/G/C 
identity presented in 10MD5 and a 25% chance of randomly being one of the remaining 
three nucleotide identities. The reselection effort was split into three different threads in 
which a comprehensive reselection strategy was applied. In all three reselection 
experiments, the first three rounds were performed at pH 7.5, with 16% pool cleavage 
yield after overnight incubation at round 3 (Figure 2.3). 
2.2.1.1 Reselections of the 10MD5 Deoxyribozyme for Improved pH Tolerance 
To foster broader pH tolerance, two reselection threads were performed in parallel 
starting in round 4, and the subsequent rounds were performed at varying pH values of 
7.2 and 7.8. In one reselection thread (Figure 2.3A), the pH was first decreased to 7.2 and 
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then increased to 7.8. In the second reselection thread (Figure 2.3B), the pH was first 
increased to 7.8 and then decreased to 7.2. In both cases, the overall pool cleavage yield 
dropped sharply when the pH was changed from 7.5. Selection rounds were continued 
with decreasing incubation time to 2 h and then 10 min while continuing to vary the pH. 
Individual deoxyribozymes were cloned from round 8 of the first reselection thread (33% 
pool cleavage yield in 2 h at pH 7.2) and round 9 of the second reselection thread (25% 
pool cleavage yield in 2 h at pH 7.2). In general, the pool cleavage yields were higher at 
pH 7.8 than at pH 7.2, probably because the nucleophilic attack of water was assisted by 
deprontonation which increased with increasing pH. 
2.2.1.2 Reselection of the 10MD5 Deoxyribozyme for Faster Rate 
In the third thread, the reselection rounds were performed at constant pH of 7.5 with 
decreasing incubation time. The incubation time in each round was progressively 
decreased from 14 h to 2 h to 10 min to 1 min, and the reselection activity profile was 
shown in Figure 2.3C. Individual deoxyribozymes were cloned from round 8 (28% pool 
cleavage yield at pH 7.5 in 10 min). 
2.2.2 Cloning and Sequences of the Reselected 10MD5 Variants 
2.2.2.1 Initial Survey of Clones from Three Reselection Threads 
Individual clones from the first two reselection threads were assayed for their DNA 
cleavage activities at pH 7.2, 7.5, and 7.7. Each clone was initially tested as a PCR 
product prepared from the miniprep DNA. Of the 11 clones from the first thread, 10 
clones functioned well at all three pH values. Additionally, 18 out of 18 clones from the 
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Figure 2.4. PAGE images of DNA cleavage activities of 10MD5 and a reselected variant, 9NL27, at 
pH 7.2, 7.5, and 7.7. t = 0, 15 min, 2 h, and 22 h. 
second thread also functioned well at all three pH values. A representative assay result 
demonstrating broader pH tolerance was shown in Figure 2.4. 
However, none of the 31 clones from the third reselection thread had substantial 
improvement in kobs relative to 10MD5, even though several rounds of selection pressures 
of reduced incubation time were applied. The observation indicated that faster variants of 
10MD5 were inaccessible in the sequence space by the reselection approach. 
2.2.2.2 Hydrolysis Sites of the New Clones 
With only one exception, all of the new clones identified from all three threads led to 
the same DNA cleavage products as the parent 10MD5 deoxyribozyme (as seen in Figure 
2.4). One specific clone that was derived from the first reselection thread and named as 
8NJ1 had a different DNA hydrolysis site than 10MD5 and all of the other reselected 
variants. 8NJ1 was also unique in having a pH optimum noticeably lower than 7.5 
(Figure 2.5A). Based on the PAGE shift comparison of 8NJ1 cleavage and 10MD5 
cleavage (Figure 2.5B) as well as MALDI mass spectrometry results (see Table 2.1), 
8NJ1 catalyzed the cleavage of the DNA substrate at a site that was six nucleotides to the 
5ʹ end of the 10MD5 cleavage site, leaving a 3ʹ-phosphate other than 5ʹ-phosphate. The 
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Figure 2.5. Characterizations of the 8NJ1 deoxyribozyme. (A) Cleavage activities of 8NJ1 at three 
different pH values. t = 7 min, 15 min, 30 min, 1 h, 2 h, 5 h, and 20 h. The final yields at pH 7.2, 7.5 
and 7.8 are 71%, 33%, and 25%. (B) Comparison of the cleavage sites of 8NJ1 and 10MD5. The 
cleavage site of 10MD5 is marked in green, and the cleavage site of 8NJ1 is marked in red. The 
8NJ1 deoxyribozyme catalyzes the hydrolysis of the DNA substrate with formation of 3ʹ-phosphate 
and 5ʹ-hydroxyl products. 
sequencing result showed that 8NJ1 differed from 10MD5 at 19 out of the 40 enzyme 
region nucleotides (See Figure 2.6 caption for 8NJ1 sequence), although the reselection 
pool was only 25% partially randomized. One must be aware that 25% was only an 
average value, but the actual pool had a wide distribution centered on an average of 10 
out of 40 mutations. These findings indicated that 8NJ1 was essentially unrelated to 
10MD5 and somehow evolved from the partially randomized pool to cleave at the new 
substrate site. 
2.2.2.3 Artificial Phylogeny of the Reselected 10MD5 Variants 
All of the active clones from three reselection threads were sequenced. In particular, 
11 clones from the first thread, 18 clones from the second thread, and 31 clones from the 
third thread were sequenced, leading to 7, 14, and 31 unique sequences, respectively. 
Aside from 8NJ1 from the first thread and 9NL12 from the second thread (for which 14 
out of 40 nucleotides were different from the parent 10MD5 sequence), all other clones 
had 11 or fewer mutations relative to the parent 10MD5 deoxyribozyme. The sequence 
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Figure 2.6. Artificial phylogeny of reselected 10MD5 variants using all unique sequences from the 
three reselection threads. Shown are the sequences of the 40-nt enzyme regions of the 
deoxyribozymes. The gray boxes denote the three variable regions (one 2-nt and two 5-nt regions) 
identified within the enzyme region. The T16 and G19 positions are colored red, and the two 
nucleotides which are uniformly mutated in clones from the two reselection threads for broader 
pH tolerance. The C30 position is colored green, which is consistently mutated to T in those 
clones. The sequences of the 40-nt enzyme regions of the two deoxyribozymes not included here 
are 8NJ1, 5′-CGATCGATGACTGTGCGCGGTTCCTCAAGAGTATTAGCCA-3′, and 9NL12, 5′-GCCTCG-
CATAGTGGGGGTCTTTGCCATAGTTGTCTCCCCA-3′ (mutations from 10MD5 are underlined). 
relationship and uniformly retained hydrolysis site strongly suggested that all of the 
reselected 10MD5 variants were functionally related. An artificial phylogeny was 
 61 
constructed using the sequences of all variants except 8NJ1 and 9NL12 (Figure 2.6), 
revealing conserved and nonconserved regions in the enzyme region. 
The artificial phylogeny revealed three nonconserved nucleotide regions: one 2-nt 
region and two 5-nt regions (gray boxes in Figure 2.6). These three regions showed 
substantial variability, whereas most other nucleotides were highly conserved. Although 
all of the 10MD5 variants collectively shared the three nonconserved regions, the variants 
from specific reselection threads showed different mutation patterns. For clones from the 
third reselection thread in which no pH alternation was applied, all three regions varied 
with no obvious correlations. However, for clones from the first two reselection threads 
in which selection pressure for pH tolerance was applied, two nucleotides, both of which 
were in the central 5-nt nonconserved region (red nucleotides in Figure 2.6), were always 
mutated: T16 was always mutated to a purine (T16R) and G19 was always mutated to a 
pyrimidine (G19Y). The only exception, 9NL10, had T16C but retained parent nucleotide 
G19. Additionally, a single C30T mutation was also observed in 20 out of 21 clones 
evolved for pH tolerance. In contrast, none of the clones from the third thread had the 
C30T mutation, probably because they were not selected for broader pH tolerance. In 
summary, the artificial phylogeny revealed three nonconserved regions in the 10MD5 
variants. It was possible that the T16R, G19Y, and C30T mutations were strongly 
correlated with the improved pH tolerance of the 10MD5 variants. 
Further assays were performed to determine the dispensability of the three 
nonconserved regions. Deleting all nucleotides of any of the three blocks led to < 4% 
cleavage yield after 20 h (Figure 2.7a-c). Mutating the 2-nt block from CT to AC (as 
suggested by the most commonly observed mutations in the phylogeny) led to poor 
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Figure 2.7. Cleavage activities of block deletants and block mutants of 10MD5 based on the 
artificial phylogeny. (a) Activity of the 2-nt deletant. (b) Activity of the first 5-nt deletant. (c) 
Activity of the second 5-nt deletant. (d) Activity of the 2-nt mutant, CT to AC. (e) Activity of the 
first 5-nt mutant, GTGCG to AGCTT. (f) Actvity of the second 5-nt mutant, CTCAA to TATGG. t 
in (ac) = 7, 15, 30 min, 1, 2, 5, and 20 h. t in (df) = 0, 7, 15, 30 min, 1, 2, 5, and 20 h. 
cleavage activity (10% in 20 h, Figure 2.7d). Mutation of the first 5-nt block from 
GTGCG to AGCTT led to retention of good cleavage yield but with substantially reduced 
rate (kobs = 0.18h
1
, Figure 2.7e). Mutation of the other 5-nt block from CTCAA to 
TATGG led to only 1.5% cleavage in 20 h (Figure 2.7f). The conclusion was that none of 
the three nucleotide blocks were dispensable for catalysis despite the clear lack of 
phylogenetic conservation. Individual deoxyribozyme variants needed to be investigated 
in more detail. 
2.2.3 Initial Analysis of Four New 10MD5 Variants 
In order to evaluate the roles of the three nucleotides T16, G19, and C30, several 
deoxyribozymes were examined, which contained mutations at these three nucleotides. 
Four deoxyribozymes evolved for broader pH tolerance were chosen for further 
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Figure 2.8. Activity profiles of the four deoxyribozymes 9NL1, 9NL12, 9NL27, and 9NL33 at three 
different pH values 7.2, 7.5, and 7.8. The kobs values of 9NL1 at pH 7.2, 7.5, and 7.8 were 0.56, 
3.99, and 2.49 h
1
; The kobs values of 9NL12 at pH 7.2, 7.5, and 7.8 were 0.43, 1.29, and 1.31 h
1
; 
The kobs values of 9NL27 at pH 7.2, 7.5, and 7.8 were 0.67, 3.13, and 2.20 h
1
; The kobs values of 
9NL33 at pH 7.2, 7.5, and 7.8 were 0.42, 1.00, and 0.93 h
1
. 
characterization: 9NL1, 9NL12, 9NL27, and 9NL33. Each deoxyribozyme had a different 
set of mutations, but these deoxyribozymes all shared the common T16R, G19Y, and 
C30T mutations (Figure 2.6). The four deoxyribozymes were prepared by solid-phase 
synthesis and assayed for DNA cleavage activity at several pH values, confirming their 
broader pH tolerance and revealing their similar cleavage yields and rates (Figure 2.8). 
2.2.4 Characterization of 9NL27 for pH Tolerance 
A more comprehensive survey of the pH tolerance of 9Nl27 was performed at pH 
values ranging from 6.8 to 8.1. Although 10MD5 had a sharp pH dependence optimal at 
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Figure 2.9. Broader pH tolerance of 9NL27 as compared with the parent 10MD5 deoxyribozyme. 
(A) Kinetic plots of 10MD5 (black) and 9NL27 (red) at pH 7.20, 7.50, and 7.70. kobs values of 
9NL27 at pH 7.20, 7.50, and 7.70 were 0.093, 0.88, and 1.43 h
1
. The stated pH values were 
measured for the 1 M HEPES buffer, and the actual pH values for the three incubation buffers 
containing metal ions were 6.93, 7.25, and 7.42.
1
 (B) Final cleavage yield from curve fits as a 
function of pH. Error bars represent the range of values from two independent experiments. The 
dashed gray lines mark the three pH values from which panel A were derived. 
7.47.5, 9NL27 had noticeably broader pH tolerance than 10MD5 (Figure 2.9), 
consistent with the selection pressure applied during its identification. The 9Nl27 activity 
dropped sharply below 7.2, which was the lowest pH value at which the selection rounds 
were performed, but 9NL27 was still more active than 10MD5 at pH < 7.5. Similarly, 
9NL27 was more active than 10MD5 at pH > 7.5 up to about 7.8, when physical Zn
2+
 
precipitation was noticeable. Overall, the results indicated that the selection pressure for 
improved pH tolerance was effective, and a collection of pH-tolerant variants of 10MD5 
were readily identified. It was interesting that 9NL27 had merely five mutations relative 
to the parent 10MD5 deoxyribozyme (Figure 2.6), yet showed different activity profiles 
at different pH values. 
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Figure 2.10. Relaxed site specificity observed for 9NL27 when substrate nucleotides outside 
ATG^T were systematically changed, even though WatsonCrick base pairing to the 
deoxyribozyme was maintained. % miscleavage refers to the percentage of total product that 
corresponds to miscleavage. t = 0, 15 min, 2 h, and 22 h. 
2.2.5 Characterization of 9NL27 and Other Variants for Site Specificity 
The 10MD5 deoxyribozyme has a recognition site of ATG^T, meaning that it is able 
to cleave any DNA substrate sequences containing any variations beyond the ATGT 
region.
1
 Because 9NL27 has only five mutations relative to 10MD5, it was initially 
presumed that 9NL27 would share the same recognition site. Surprisingly, when substrate 
nucleotides outside ATG^T were systematically changed (A↔T, G↔C), and the 9NL27 
binding arms were covaried to maintain WatsonCrick base pairing, substantial DNA 
cleavage activity was still observed, but unexpectedly with noticeably relaxed site 
specificity (Figure 2.10). The miscleavage of the DNA substrate (56% of the overall 
cleavage product) occurred one nucleotide to the 5ʹ end of the original ATG^T site, i.e., 
at AT^GT site, with the formation of 5ʹ-phosphate and 3ʹ-hydroxyl. The miscleavage site 
was assessed by gel migration position and further confirmed by mass spectrometry 
analysis (see Table 2.1). 
The cleavage activity of 9NL27 was then examined when additional substrate 
nucleotides beyond ATG^T were retained unmutated (Figure 2.11). The site specificity 
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Figure 2.12. Assay of pH tolerance of 9NL27 when the substrate sequence was varied. The top 
experiments were performed with the parent substrate. The bottom experiments were performed 
with the substrate with same variations as in Figure 2.10 and 2.11, except the nucleotides were 
TATG^TT at the cleavage site. 
was mostly restored when more substrate nucleotides were unmutated, i.e., when the 
recognition site was expanded from ATG^T to either ATG^TT (only 6.1% miscleavage) 
or TATG^T (only 10% miscleavage). Retaining one additional substrate nucleotide, 
TATG^TT, led to complete restoration of site specificity (< 0.5% miscleavage, similar to 
10MD5). The pH tolerance of 9NL27 was not influenced when the substrate recognition 
site was expanded (Figure 2.12). Together, these observations indicated that 9NL27 
suffered from reduced site specificity as compared to 10MD5. The relaxation of site 
specificity could only be restored if the substrate recognition site is expanded. 
 
Figure 2.11. Expansion of the recognition site beyond ATG^T restored the site specificity of 
9NL27. t = 0, 15 min, 2 h, and 22 h. The substrate sequence was varied in the same way as in 
Figure 2.10, and the retained nucleotides are denoted here. 
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Figure 2.13. Sequence specificity of 9NL27 outside of the expanded recognition site. The substrate 
nucleotides outside of ATG^T or TATG^TT were systematically varied to three alternative base 
identities (Tsn = A↔G, T↔C; Tv1 = A↔C, T↔G; Tv2 = A↔T, G↔C). In all cases, Watson-Crick 
base pairing was retained between the DNA substrate and the deoxyribozyme. 
Furthermore, the sequence specificity of 9NL27 outside the expanded recognition site 
was examined with substrates that had systematic variations (Figure 2.13). Similar to 
10MD5, 9NL27 was fully sequence-specific outside of its recognition site. Besides 
9NL27, the 9NL1, 9NL12, and 9NL33 deoxyribozymes were also found to have 
substantially reduced site specificity that could only be restored by expansion of their 
recognition site from ATG^T to TATG^TT (Figure 2.14). The observation of relaxed site 
specificity for 9NL27 was very similar to the relaxed site specificity of 10MD5 when the 
WatsonCrick base pairing was substantially disrupted within the ATG^T site between 
the DNA substrate and the enzyme. 
2.2.6 Confirmation of DNA Cleavage Sites and Hydrolytic Cleavage Mechanism for 
9NL27 and Other Variants 
Mass spectrometry method was used to confirm that the DNA cleavage sites were as 
assigned on the basis of gel migration positions (Table 2.1). MALDI-MS assays were 
performed on the site-specific cleavage products using the parent substrate along with 
each of the new deoxyribozymes 9NL27, 9NL1, 9NL12, 9NL33, and 8NLJ1. 
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Figure 2.14. Relaxation and restoration of site specificities of 9NL1, 9NL12, and 9NL33 
deoxyribozymes. The results shown here are similar to the results shown in Figure 2.11 for 9NL27. 
Additionally, non-specific cleavage products from 9NL27 were also studied. In all cases, 
the mass spectrometry results were consistent with hydrolytic DNA cleavage at 
correspondingly assigned cleavage sites. 
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Table 2.1. MALDI mass spectrometry analysis of the DNA cleavage products by the 
deoxyribozymes. L and R respectively denote the 5ʹ and 3ʹ cleavage products. 
deoxyribozyme  mass 
L calcd. 
mass 
L found 
L error, % 
(found –  calcd.) 
mass 
R calcd. 
mass 
R found 
R error, % 
(found –  calcd.) 
10MD5 
a,b
  6418.9 6420.9 +0.03 3741.3 3742.6 +0.03 
9NL1 
a
  6418.9 6417.4 –0.02 3741.3 3739.9 –0.04 
9NL12 
a
  6418.9 6415.9 –0.05 3741.3 3740.6 –0.02 
9NL27 
a
  6418.9 6411.0 –0.12 3741.3 3735.2 –0.16 
9NL33 
a
  6418.9 6418.1 –0.01 3741.3 3739.8 –0.04 
8NLJ1 
a
  4630.8 4635.8 +0.11 5529.4 5536.0 +0.12 
9NL27 
c
 clv 6477.0 6475.6 –0.02 3710.3 3710.8 +0.01 
 misclv 6147.8 6146.8 –0.02 4039.5 4039.9 +0.01 
a
 Data obtained using the indicated deoxyribozyme and the parent DNA substrate, for which site-
specific cleavage is observed. 
b
 Data for the parent 10MD5 deoxyribozyme and DNA substrate is from 
1
 and is provided for 
comparison. 
c 
Data obtained using 9NL27 and the DNA substrate for which ATG^T was retained, but all other 
nucleotides were changed by AT or GC. With this substrate, non-site-specific cleavage is 
observed (Figure 2.10 and Figure 2.11). Tabulated are values for L and R products as for 10MD5 
when non-site-specific. 
2.2.7 Functional Compromises of the 10MD5 Family of Deoxyribozymes 
Sequence specificity in the DNA cleavage catalyzed by the 10MD5 family of 
deoxyribozymes is inherent due to the overall WatsonCrick “binding arms” design (as 
shown in Figure 2.2). In contrast, the other three functional characteristics such as pH 
tolerance, site specificity, and substrate sequence tolerance are not automatically gained 
by the deoxyribozyme design. The results from systematic biochemical characterization 
of the 10MD5 family of deoxyribozymes have shown that although 9NL27 has a broader 
pH tolerance than 10MD5 (Figure 2.9), consistent with the selection pressure applied 
during its identification, this pH tolerance comes at the expense of site specificity (Figure 
2.10). In order to restore the site specificity of 9NL27, the substrate sequence tolerance 
has to be reduced, i.e., the recognition site has to be expanded (Figure 2.11). These 
observations can be used to develop a unified perspective on the functional compromises 
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Figure 2.15. Functional compromises of the 10MD5 family of deoxyribozymes among pH 
tolerance, site specificity, and sequence tolerance. 
 
Figure 2.16. Assays of 10MD5 and 9NL27 with Zn
2+
 and Mn
2+
, or with Zn
2+
 alone. t = 0, 15 min, 2 
h, and 22 h in the PAGE image. kobs values (top to bottom): 1.56, 0.45, and 0.96 h
1
. 
of DNA-catalyzed DNA cleavage, revealing that the three characteristics of pH tolerance, 
site specificity, and sequence tolerance are balanced among each other (Figure 2.15). 
One of the most important implications of the functional compromises is that such 
compromises may force choices about which of the characteristics are most important in 
a new DNA-hydrolyzing catalyst. The functional compromises are observed not only for 
the 9NL27 deoxyribozyme, they are also observed for 9NL12, which was the sequence-
unrelated variant, indicating the compromises are a more general phenomenon. Because 
all of the three characteristics are of practical importance, the potential functional 
compromises should also be taken into consideration during new efforts for DNA-
hydrolyzing deoxyribozymes. 
2.2.8 Zn
2+
-Only Hydrolysis of 9NL27 and the Mutagenesis Studies of 10MD5 
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Figure 2.17. DNA hydrolysis assays of 10MD5 mutants at pH 7.5 with 1 mM Zn
2+
 ± 20 mM Mn
2+
. t 
= 0, 15 min, 2 h, and 22 h. For each of assays 18, gray circles denote nucleotides unmutated from 
those found in the parent 10MD5 deoxyribozyme, and red rectangles denote nucleotides mutated in 
the 9NL27 deoxyribozyme. 
9NL27 and 10MD5 differ at only five out of 40 nucleotides in the enzyme region. 
Both 10MD5 and 9NL27 have comparable DNA hydrolysis activities in the presence of 1 
mM Zn
2+
 and 20 mM Mn
2+
, but their catalytic activities change under other ionic 
conditions. In the presence of 1 mM Zn
2+
 alone, 10MD5 is essentially inactive (< 0.5% 
DNA hydrolysis in 22 h as shown in Figure 2.16), but 9NL27 still functions with only a 
3-fold reduction in kobs relative to activity with both Zn
2+
 and Mn
2+
 (Figure 2.16). 
9NL27 is only a quintuple mutant of 10MD5, but has a completely different metal 
dependence profile than 10MD5. In order to understand the correlation between the five 
mutations (C3A, T16A, G19C, T25C, and C30T) and the unique Zn
2+
-only activity, 
systematic mutagenesis studies on 10MD5 were performed. By examining two quadruple 
mutants in which either C3 or T25 remained unmutated relative to the parent 10MD5 
sequence, the C3A and T25C mutations in 9NL27 were shown to be dispensable for 
Zn
2+
-only activity (assays 1 and 2 in Figure 2.17). The remaining three mutations found 
in 9NL27, T16A, G19C, and C30T, enabled Zn
2+
-only activity (assay 3). It was later 
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Figure 2.18. Assays of the pH tolerances of 9NL27 and 10MD5-AC, each with1 mM Zn
2+
 ± 20 mM 
Mn
2+
. t = 0, 15 min, 2 h, and 22 h. The pH optima of the two deoxyribozymes appear to be slightly 
different. 
shown that the T16A and G19C mutations together were sufficient for Zn
2+
-only activity, 
with at most slight assistance from the C30T mutation. With T16A or G19C alone, no 
cleavage activity was observed (assays 4 and 5), while T16A/G19C double mutant was 
substantially active (assay 6). The T16A/G19C double mutant of 10MD5 was named as 
10MD5-AC. The G19C/C30T double mutant was entirely inactive while the T16A/C30T 
double mutant had only trace activity at long incubation times (only ~2% yield in 22 h; 
assays 7 and 8), suggesting that C30T could substitute only very ineffectively for G19C. 
In a full kinetics experiments, 10MD5-AC was observed to have kobs of 2.5 h
-1
 with Zn
2+
 
and Mn
2+
 and 0.037 h
-1
 with Zn
2+
 alone. The omission of Mn
2+
 led to about 70-fold 
reduction of kobs. 
The pH tolerances of 9NL27 and 10MD5-AC were evaluated, each with Zn
2+
 and 
Mn
2+
 or Zn
2+ 
alone. For each deoxyribozyme, although a combination of Zn
2+
 and Mn
2+
 
supported broad pH tolerance, the tolerance was narrower with Zn
2+
 alone (Figure 2.18). 
Furthermore, the addition of 40 mM Mg
2+
 with 1 mM Zn
2+
 did not improve the pH 
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Figure 2.19. Comparison of Zn
2+
 concentration dependence of 10MD5-AC with the parent 10MD5 
deoxyribozyme. kobs values were as follows. 10MD5-AC: 0.3 mM Zn
2+
, 0.14 h
1
; 0.5 mM Zn
2+
, 0.98 
h
1
; 2.0 mM Zn
2+
, 1.7 h
1
. 10MD5: 0.5 mM Zn
2+
, 0.28 h
1
; 2.0 mM Zn
2+
, 3.2 h
1
 
 
Figure 2.20. Expansion of the recognition site beyond ATG^T to TATG^TT restores the site 
specificity of 10MD5-AC. The observation is similar to the 10MD5 variants with broader pH 
tolerance. In the substrate sequence, the retained nucleotides were denoted, and all of the other 
nucleotides were changed (AT, GC). t = 0, 15 min, 2 h, and 22 h. 
tolerance. Therefore, the single set of mutations T16A/G19C did not simultaneously 
enable Zn
2+
-only activity and broad pH tolerance by the 10MD5 deoxyribozyme. 
It has been reported that the parent 10MD5 deoxyribozyme is sharply dependent on 
Zn
2+
 concentration with an optimum around 1 mM.
1
 The Zn
2+
 concentration dependences 
of the 10MD5-AC deoxyribozyme at pH 7.5, both in the presence and absence of Mn
2+
, 
were examined (Figure 2.19). 10MD5-AC was found to tolerate a substantially broader 
range of Zn
2+
 concentrations than the parent 10MD5, although the presence of Mn
2+
 was 
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also required. A separate effort in the Silverman laboratory to evolve 10MD5 for broader 
Zn
2+
 concentration tolerance also revealed the key T16R and G19Y mutations in the 
resulting variants (Figure S2 in Ref. 6). Like 9NL27, the 10MD5-AC double mutant also 
had an expanded recognition site of TATG^TT instead of the parent ATG^T recognition 
site (Figure 2.20). 
2.3 Summary 
This chapter describes the comprehensive in vitro evolution experiments of the first 
DNA-hydrolyzing deoxyribozyme 10MD5, as well as the systematic biochemical 
characterizations of the 10MD5 reselection variants. Of the three reselection threads, two 
were performed with selection pressures for broader pH tolerance, and the selection 
rounds were incubated under alternating pH values between 7.2 and 7.8 (Figure 2.3A and 
B). The remaining reselection thread had selection pressure for faster rate, and selection 
rounds were done with decreasing incubation time at constant pH 7.5 (Figure 2.3C). 
The first two reselection threads led to the identification of a collection of 
deoxyribozymes with substantial broader pH tolerance than the parent 10MD5 
deoxyribozyme (Figure 2.4), consistent with the selection pressure applied. The third 
reselection thread did not lead to the identification of any enzymes substantially faster 
than 10MD5, suggesting that faster enzymes were not accessible in this reselection pool 
using the designed selection approach. All except one reselection variants retained the 
parent cleavage site. The remaining variant, 8NLJ1, catalyzed the cleavage at a site that 
was six nucleotides away from the 10MD5 site, and it also had a shifted pH dependence 
profile (Figure 2.5). An artificial phylogeny constructed by all the sequences of 10MD5 
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variants revealed three nonconserved nucleotide blocks in the enzyme region (Figure 
2.6). Even though the nucleotide sequences of these three regions were constantly varied, 
they were not dispensable for catalysis (Figure 2.7). It was possible that the 
sugarphosphate backbone was somehow involved in catalysis. A set of three mutations 
T16R, G19Y, and C30T were uniformly observed in the pH tolerant variants, strongly 
suggesting a correlation between these mutations and the broader pH tolerance. 
Among all the variants, 9NL27 had only five mutations in the enzyme region relative 
to the parent 10MD5 deoxyribozyme. 9Nl27 had noticeably broader pH tolerance than 
10MD5 (Figure 2.9), but its site specificity was greatly relaxed (Figure 2.10). Expanding 
the recognition site of 9NL27 from the parent ATG^T to TATG^TT completely restored 
its site specificity (Figure 2.11). Additionally, 9NL27 still had broad pH tolerance (Figure 
2.12) as well as sequence specificity beyond the expanded recognition site (Figure 2.13). 
Similar phenomena were also observed with other variants with broad pH tolerance 
(Figure 2.14), revealing functional compromises of the 10MD5 family of DNA-
hydrolyzing deoxyribozymes among pH tolerance, site specificity, and substrate 
sequence tolerance (Figure 2.15): the increase of pH tolerance came at the price of 
reduced site specificity, and substrate sequence tolerance was reduced when recognition 
site was expanded in order to restore site specificity. These findings inform us of the 
functional compromises we may face in our future efforts toward the identification of 
new DNA-hydrolyzing deoxyribozymes and the development of practical DNA-
hydrolyzing deoxyribozymes. 
While 10MD5 requires both Mn
2+
 and Zn
2+
 to catalyze DNA hydrolysis, 9NL27, the 
quintuply mutated version of 10MD5, can function with Zn
2+
 alone with similar cleavage 
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yield and 3-fold reduction in kobs (Figure 2.16). Systematic investigation on the five 
mutations in 9Nl27 relative to 10MD5 revealed that merely two mutations T16A/G19C 
were sufficient to change the heterobimetallic 10MD5 that depended on both Zn
2+
 and 
Mn
2+
 into a monometallic catalyst that depended on Zn
2+
 alone (Figure 2.17). Both of 
9NL27 and the 10MD5 double mutant, 10MD5-AC, had broader pH tolerance than 
10MD5 when Zn
2+
 and Mn
2+
 were present (Figure 2.18). The pH tolerance of both 
enzymes narrowed with the absence of Mn
2+
. 10MD5-AC also had a broader Zn
2+
 
concentration dependence than 10MD5 (Figure 2.19) and an expanded recognition site of 
TATG^TT similar to other 10MD5 variants with broader pH tolerance (Figure 2.20). 
These findings have several key implications. First of all, The knowledge that 
deoxyribozyme catalyzed DNA hydrolysis can be achieve with only one type of metal 
ion (such as Zn
2+
) urge us to pursue new monometallic deoxyribozyme to catalyze DNA 
hydrolysis, or even other chemical reactions. Secondly, while heterobimetallic catalysis is 
a hallmark of certain natural protein nucleases,
7
 these findings show that nucleic acid 
enzymes can catalyze even very difficult reactions such as DNA hydrolysis with the aid 
of merely one type of metal ion. Most importantly, the findings shed some light on the 
potential mechanism on DNA hydrolysis catalyzed by the 10MD5 family of 
deoxyribozymes. It is plausible that all 10MD5-derived deoxyribozymes share similar 
catalytic mechanisms. The Mn
2+
 possibly plays a noncatalytic structural role, considering 
that it is dispensable for catalysis by 9NL27 and 10MD-AC, whereas Zn
2+
 likely plays a 
key catalytic role. Additionally, nucleotides 16 and 19 of the enzyme region are likely to 
be key participants in metal ion binding during catalysis. However, detailed structural 
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Figure 2.21. Illustration of the in vitro selection procedures for DNA-cleaving deoxyribozymes. 
Three steps are included in a selection experiment, substrate ligation, selection, and PCR 
amplification. 
information is still required to understand the mechanism of deoxyribozyme catalyzed 
DNA hydrolysis. 
2.4 Materials and Methods 
2.4.1 In Vitro Evolution (Reselection) Procedures 
Deoxyribozymes are identified using a procedure known as in vitro selection.
8
 In 
vitro selection is a combinatorial technique driven by accelerated evolution. Discussed 
here are various steps involved in a typical in vitro selection experiment. 
The general procedures of in vitro selection are illustrated in Figure 2.21, taking the 
selection for DNA-cleaving deoxyribozymes as an example. Initially, a random library 
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(also known as new selection pool) or a partially-randomized library (also known as 
reselection pool) is generated by solid-phase synthesis. Each DNA sequence in the pool 
has two fixed regions (brown) required for primer binding during PCR amplification, In 
the case of DNA cleavage, the two regions (also known as binding arms), are responsible 
for the binding of DNA substrates as well. Additionally, Each DNA sequence has a 
random region (green) responsible for the catalysis. Then a DNA substrate (black) is 
ligated to the pool by T4 RNA ligase, and the ligation product goes through a selection 
step during which the connjugate is incubated with cofactors (like metal ions) under a 
specific selection condition. Due to the loss of molecular weight of the cleavage product, 
the active deoxyribozyme can be separated using PAGE and then amplified by PCR. 
Once a selection pool shows sufficient cleavage activity, it can be cloned and sequenced, 
so that individual deoxyribozymes can be further characterized. The described steps are 
the same in both new selection and reselection experiments. The procedures of the 
10MD5 reselections are described in more detail below. 
2.4.1.1 Preparation of the Initial 10MD5 Partially-Randomized Pool. 
The sequence of 10MD5 enzyme region is 25% randomized, i.e., each nucleotide 
position has 75% chance of remaining the same as parent sequence and 25% chance of 
mutating into one of the three other nucleotides. The sequence of the partially 
randomized pool is 5ʹ-CGAAGCGCTAGAACATCGCTAGATAAGTGGGTGCGTTTGCTATAGCTGTCCCT-
CAAAGTACATGAGACTTAGCTGATCCTGATGG-3ʹ. The underlined nucleotides are the designed 
binding arms, and nucleotides in bold are partially randomized. The partially-randomized 
pool was prepared by solid-phase synthesis on an ABI 394 DNA synthesizer, using a 
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minimum 1000 Å pore size controlled pore glass (CPG). All phosphoramidites were 
purchased from Glen Research, and further diluted to a final concentration of 0.1 M. Four 
pre-mixes were made with 75% of the phosphoramidite being one nucleotide identity and 
25% being a mixture of the other three. The composition of 1000 μL of each pre-mix is 
shown below. The synthesized pool was then purified by 8% denaturing PAGE. 
A* = A (799 μL) + G (68 μL) + C(74 μL) + T (59 μL) = 1000 μL 
G* = A (106 μL) + G (735 μL) + C(88 μL) + T (71 μL) = 1000 μL 
C* = A (101 μL) + G (77 μL) + C(755 μL) + T (67 μL) = 1000 μL 
T* = A (116 μL) + G (89 μL) + C(97 μL) + T (697 μL) = 1000 μL 
2.4.1.2 Selection Procedure in Round 1 
Oligonucleotides. All standard oligonucleotides were prepared by solid-phase 
synthesis at IDT (Coralville, IA). The sequence of the DNA substrate during the 
selections is 5′-AAAGTCTCATGTACTTATATGTTCTAGCGCgga-3′, where the final three 
ribonucleotides (lowercase) enable ligation to the pool by T4 RNA ligase. The primers 
used throughout the selections are: primer 1, 5′-AACAACAACAACXCCATCAGGATCAGCTAAGTC-
TCATGTACT-3′ [X denotes hexa(ethylene glycol) to stop Taq polymerase], and primer 2, 5′-
CGAAGCGCTAGAACAT-3′, and the first primer has its 5ʹ end phosphorylated to enable 
ligation to the DNA substrate. The cloning primers are: primer 3, 5′-TAATTAATT-
AATTACCCATCAGGATCAGCT-3′, and primer 4, 5′-TAATTAATTAATTACGAAGCGCTAGAACAT-3′. 
750 pmol of the pool was first phosphorylated in a 50 L reaction including 1 mM 
ATP, 1× PNK buffer A and 1 unit of T4 PNK (Fermentas). After purification by phenol-
chloroform-isoamyl alcohol (25:24:1) extraction and ethanol precipitation, the pool was 
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then ligated to the 1000 pmol of DNA substrate in 30 L reaction containing 50 mM Tris, 
pH 7.5, 10 mM DTT, 5 mM MgCl2, 0.05 mM ATP, and 5 units of T4 RNA ligase 
(Fermentas). The ligation product was purified by 8% denaturing PAGE. Later on, 200 
pmol of the purified product was incubated in 40 L volume containing 70 mM HEPES 
pH 7.5, 150 mM NaCl, 20 mM MnCl2, and 1 mM ZnCl2 for 14 h. The reaction was 
stopped by 40 L of stop solution (80% formamide, 1× TBE containing 89 mM each Tris 
and boric acid, pH 8.3, 50 mM EDTA, and 0.025% each xylene cyanol and bromophenol 
blue), and run on an 8% denaturing gel, and the regions containing active sequences were 
excised based on their migration patterns according to a known standard. The DNA was 
extracted from the gel and amplified by PCR. The PCR reaction was performed in 100 
L volume with 0.25 M of primer 1 and 1 M of primer 2, 0.2 mM each of dATP, 
dTTP, dGTP, and dCTP, 1× Taq buffer and Taq polymerase. The PCR repeated 10 cycles 
of 94 ºC, 30 s; 47 ºC, 30 s; 72 ºC, 30 s. The 10cPCR product was purified by phenol-
chloroform-isoamyl alcohol extraction for long-term storage. 
2.4.1.3 Selection Procedure from Round 2 on 
In round 2, 30 cycles of PCR were done with 1 L of the 10cPCR product in 50 L 
volume with same concentrates of each component in the previous 10cPCR. The 30cPCR 
product was purified by an 8% denaturing PAGE and ligated to 100 pmol of DNA 
substrate in 20 L reaction. After purifying the ligation product by 8% denaturing PAGE, 
selection was performed in 20 L volume with 70 mM HEPES pH 7.5, 150 mM NaCl, 20 
mM MnCl2, and 1 mM ZnCl2 for 14 h. Same PAGE purification and 10cPCR were 
performed as round 1.From round 3 on, the selection procedures in the three selection 
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threads were essentially the same. The key selection reaction for the first two selection 
threads were performed in 20 L with 70 mM HEPES of specific pH value (as indicated 
in Figure 2.3A and B), 150 mM NaCl, 20 mM MnCl2, and 1 mM ZnCl2 for specific 
incubation time (as indicated in Figure 2.3A and B). For the third selection thread, the 
incubation time decreased as shown in Figure 2.3C but the pH remained at 7.5. 
2.4.2 Pool Cloning, Initial Screen of Individual Clones, and Sequencing 
The three reselection threads were clones at specific rounds as indicated in Figure 2.3. 
The 10cPCR product from these selection rounds were diluted 1000-fold and another 
30cPCR was done using 1 L of the diluted pool in 50 L reaction with 0.25 M of each 
primer 3 and primer 4. The PCR products were isolated on a 2% agarose gel and 
extracted by GeneJET gel extraction kit (Fermentas). Invitrogen TOPO TA cloning kit 
was used to insert the cloning PCR products into the plasmid vector. The subcloning 
reaction was done with the addition of 1L of the extracted PCR product, 1L of salt 
solution (Invitrogen), and 1 L of TOPO vector in 6 L volume and the reaction was 
incubated at room temperature for 10 min. Subsequently, 2 L of each subcloning 
reaction was added to each tube of One Shot
®
 chemically competent E. coli cells. The 
cell mixtures were incubated on ice for 15 min, heat-shocked for 45 sec at 42°C, and 
added 250 L of SOC medium. The cells were then shaken horizontally at 220 rpm and 
37 °C for 1 h. Before plating, 40L of X-gal (40 mg/mL in DMF) and 40 Lof 100 mM 
IPTG were spread on the pre-warmed Luria-Bertani (LB) plates containing 100g/mL of 
ampicillin. The cells were finally spread on the LB plates and incubated at 37 °C for 16 h. 
After incubation, 36 white colonies were picked and cultured in 3 mL LB medium 
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containing 50g/mL of ampicillin. The cells were shaken at 220 rpm 37°C for 18 h and 
harvested. The plasmids of the cells were isolated using Fermentas GeneJET miniprep kit. 
A 30cPCR reaction was performed using the miniprep product from individual clones 
in a 200 L reaction containing 0.25 M of primer 1 and 1M of primer 2. After 
purification by 8% denaturing PAGE, half of the PCR product was incubated with 10 nM 
5′-32P-radiolabeled substrate, 70 mM HEPES of pH 7.5 (or other values), 150 mM NaCl, 
1 mM ZnCl2, 20 mM MnCl2 for a specific length of time (based on experimental design). 
The reactions were separated by 20% PAGE and quantified with a PhosphorImager (GE 
Healthcare). 
Sequencing of individual clones was performed at UIUC Core Sequencing Facility 
using M13Rev-24 primer, 5ʹ-AACAGCTATGACCATG-3ʹ. The chromatogram was analyzed by 
Chromas and the sequence alignment was obtained by CLC Sequence Viewer. 
2.4.3 Deoxyribozyme Activity Assay Procedure 
The DNA substrate was 5′-32P-radiolabeled using -32P-ATP and T4 PNK. The 
reaction was performed in a 10 L volume containing 10 pmol of the DNA substrate, 10 
pmol of -32P-ATP, 1× T4 PNK buffer, and 0.5 units of T4 PNK (Fermentas). The sample 
was then incubated at 37 °C and separated by 20% denaturing PAGE. The product was 
extracted with TN buffer (10 mM Tris, pH 8.0, 300 mM NaCl). Individual 
deoxyribozymes prepared by solid-phase synthesis were purified similarly by 8% 
denaturing PAGE and extracted with TN buffer. 
The single-turnover cleavage assays of individual deoxyribozymes were typically 
performed in two steps. A 10 L sample containing 0.2 pmol of DNA substrate and 20 
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pmol of deoxyribozyme was annealed in 5 mM HEPES, pH 7.5 (or other value as 
appropriate), 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min and cooling 
on ice for 5 min. The cleavage reaction was initiated by addition of metal stock solutions, 
so that the 20 L final sample contained 70 mM HEPES, pH 7.5 (or other value), 150 
mM NaCl, 20 mM MnCl2 (or omitted in Zn
2+
-alone assays), and 1 mM ZnCl2. MnCl2 
was added from a 10× stock solution containing 200 mM MnCl2. ZnCl2 was added from 
a 10× stock solution containing 20 mM ZnCl2, 20 mM HNO3, and 200 mM HEPES, pH 
7.5 (or other value). The Zn
2+
 stock was freshly prepared from 100× stock solution of 100 
mM ZnCl2 in 200 mM HNO3. The metal ion stocks were added last to the final sample, 
and the final sample was then divided into 2 L aliquots that were incubated at 37 °C. At 
appropriate times, these aliquots were quenched with 5 L of stop solution. Samples were 
separated by 20% PAGE and quantified with a PhosphorImager. Values of kobs and final 
yield were obtained by fitting the yield versus time data directly to first-order kinetics, 
i.e., yield = Y(1 - e
-kt
), where k = kobs and Y = final yield. When kobs was sufficiently low 
such that an exponential fit was not meaningful, the initial points were fit to a straight 
line, and kobs was taken as the slope of the line. 
2.4.4 Mass Spectrometry Experiment Procedure 
Larger-scale cleavage of the substrate provided the products for MALDI mass 
spectrometry analysis. A 20 L sample containing 100 pmol of substrate and 200 pmol of 
deoxyribozyme was annealed in 5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM 
EDTA by heating at 95 °C for 3 min and cooling on ice for 5 min. The cleavage reaction 
was initiated by addition of metal stock solutions, so that the 20 L final sample 
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contained 70 mM HEPES, pH 7.5, 150 mM NaCl, 20 mM MnCl2, and 1 mM ZnCl2. The 
reaction was incubated at 37 °C for 12 h. After incubation, the reaction was precipitated 
by adding 80 L of water, 10 L of 3M NaCl, and 330 L of ethanol and freezing at 
80 °C. A portion of the crude product was zip-tipped to 3-hydroxypicolinic acid (3-
HPA) matrix and then used for MALDI mass spectrometry analysis. TheMALDI mass 
spectrometry analysis was performed in the mass spectrometry laboratory of the UIUC 
School of Chemical Sciences. 
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Chapter 3: Establishment of Broad Generality of Deoxyribozymes for 
Site-Specific Hydrolysis of Single-Stranded DNA
2
 
3.1 Introduction 
In this project, Comprehensive selection experiments are designed and performed in 
order to develop selection approaches to identify deoxyribozymes that have broad 
substrate-sequence generalities for site-specific DNA hydrolysis. The long term goal is to 
use the sequence-general DNA-hydrolyzing deoxyribozymes as artificial restriction 
enzymes that can be widely applied to manipulate plasmids and genomes. 
Natural restriction endonucleases are known for their capability to catalyze the 
challenging DNA hydrolysis reaction with extremely high specificity. Among all types of 
restriction enzymes, Type II restriction enzymes are the most abundant and well studied, 
which recognize particular substrate nucleotides (also known as restriction site) and 
cleave within those nucleotides. Type II restriction enzymes are widely used in molecular 
biology as tools for genetic engineering. 
Type II restriction enzymes differ from other types of restriction enzymes in more 
simplified subunit organizations. They are usually homodimeric or homotetrameric 
enzymes that do not require ATP or GTP. With few exceptions, they require Mg
2+
 as 
cofactors.
1
 Type II restriction enzymes have a typical restriction site of 48 bp in length, 
most of which are palindromic. Restriction enzymes can produce DNA fragments that 
have ‘blunt’ or ‘sticky’ ends with 3ʹ- or 5ʹ-overhangs of up to 5 nucleotides. All 
restriction enzymes can bind DNA both specifically and non-specifically.
2
 Upon non-
                                                 
2
 Part of the material described in this chapter has been published. 
Xiao, Y.; Wehrmann, R. J.; Ibrahim, N. A.; Silverman, S. K., Establishing Broad Generality of DNA 
Catalysts for Site-Specific Hydrolysis of Single-Stranded DNA. Nucleic Acids Res. 2012, 40, 1778-1786. 
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specific complex formation, counter-ions and water molecules are released from the 
enzyme-DNA interface.
3
 Because of the associated favorable entropy changes, the release 
balances the unfavorable loss of translational and rotational entropies of the enzyme and 
the DNA.
4
 The non-specific interaction between the enzyme and the DNA facilitates the 
one-dimensional linear diffusion along the DNA until reaching target substrate location, 
where the enzyme binds to the DNA specifically to stop the diffusion.
5
 
Similar to the linear diffusion process of a restriction enzyme, the DNA recognition 
process is also energetically favorable. The specific interactions between the DNA and 
the enzyme cause conformational adaptation of the enzyme and the DNA with water and 
counter-ion release, which balances the unfavorable entropy loss due to the 
immobilization of amino acid side chains at the enzyme-DNA interface. Additionally, 
although major distortions of DNA substrates caused by restriction enzymes decrease the 
favorable enthalpy gain because of the base-pair destacking effects, the distortions still 
assist the DNA recognition process.
6,7
 Structurally speaking, most enzymes that produce 
blunt ends or sticky ends with 3ʹ-overhangs approach the DNA substrates from the minor 
groove, while enzymes that produce 5ʹ-overhangs approach the DNA substrate from the 
major groove.
1
 The distortions of DNA substrates caused by restriction enzymes bring 
functional groups of the DNA substrates into positions, so that specific interactions 
required for recognition can occur. The distortions also position the scissile phosphates 
face-to-face with the catalytic center and the 3ʹ-proximal phosphates, so that they can 
support phosphodiester bond hydrolysis.
1
 The specific interactions between enzyme and 
DNA form a highly cooperative hydrogen bond network. The hydrogen bonds between 
amino acids and the nucleobases as well as the sugar-phosphate backbones both 
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contribute to the network. In addition, van der Waals interactions and hydrophobic 
interactions to the nucleobases of the DNA substrates are also important. 
Currently, there are more than 4000 biochemically characterized restriction enzymes 
reported.
8
 They are known to recognize collectively about 300 unique restriction sites. Of 
the huge amount of restriction enzymes, nearly 700 are commercially available to 
recognize about 250 distinct sites.
9
 Because restriction enzymes recognize relatively long 
substrate sequences (48 bp), current restriction enzymes are only covering a very small 
fraction of all possible sites (48 bp construct 4448 possible restriction sites). Therefore 
huge efforts have been made to engineer restriction enzymes that recognize new substrate 
sequences. A characteristic feature of the recognition processes of restriction enzymes is 
its high redundancy, so it is very difficult to change the specificities of restriction 
enzymes in spite of detailed structural information.
10
 Significant progress has been made 
in engineering homing endonuclease through approaches such as computational redesign 
and semi-rational mutagenesis for desired specificity change.
11
 Additionally, another 
approach to generate enzymes with new specificity is established with unorthodox Type 
II restriction enzymes by joining two existing half-site recognition domains into new 
combinations.
12
 This approach has also been extended to other Type II restriction 
enzymes. Although several methods to reengineer the specificities of restriction enzymes 
have been established, these methods are still limited by the number of new restriction 
sites that new variants can recognize. 
Lack of new restriction sites is only one level of the problem. Natural and engineered 
restriction enzymes are perfect tools to manipulate plasmids and phage DNA because of 
their small sizes. However, restriction enzymes are not so applicable with the research 
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Figure 3.1. Double-stranded DNA cleavage achieved by invasion of two ssDNA-hydrolyzing 
deoxyribozymes. 
interests gradually focusing onto genomes of higher animals and higher plants. Genomes, 
especially those of higher living organisms, are so huge that the site specificities of 
restriction enzymes are too low for desired site-selective cleavage. For example, a 
restriction enzyme with 6-bp recognition site should cut DNA statistically once every 4
6
 
= 4096 bp. If a human genome (over three billion base pairs) is treated with this 
restriction enzyme, the number of cleavage it will perform on the genome is nearly one 
million (3 × 10
9 
/ 4096 = 7.3 × 10
5
), making precise genome manipulation impossible. In 
order to cut human genome at only one site, a sequence of at least 16 bp must be 
recognized (4
16
 > 3 × 10
9
).
13
 
The 10MD5 family of deoxyribozymes that catalyze the sequence-specific hydrolysis 
of single-stranded DNA provide us new ideas to develop artificial restriction enzymes. 
Once two ssDNA-hydrolyzing deoxyribozymes invade and bind to each strand of a 
double-stranded DNA, the cleavage of a double-stranded DNA substrate then becomes 
two cleavage reactions that can be catalyzed by the ssDNA-hydrolyzing deoxyribozymes 
(Figure 3.1). The strategy of double-stranded DNA cleavage with ssDNA-hydrolyzing 
deoxyribozymes can be very advantageous, with the presumption that invasion of double-
stranded DNA and binding to each strand are efficient. The WatsonCrick base pairing 
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interactions between the binding arms and the DNA substrate provides these 
deoxyribozymes with inherent sequence specificity. As long as the recognition site is 
retained, the binding arms can be easily customized to target only one out of all possible 
sites on the substrate to achieve precise manipulation. Additionally, a huge collection of 
natural restriction enzymes are needed to cover all possible restriction sites (e.g., 4096 for 
restriction enzymes recognizing 6-bp sites), but for ssDNA-hydrolyzing deoxyribozymes 
such as the 10MD5 deoxyribozyme that recognize only 4 nucleotides, only 4
4
 = 256 
deoxyribozymes are needed to cleave any single-stranded DNA substrate at any 
predetermined site. If the length of recognition site of a deoxyribozyme is shorter, the 
collection of ssDNA-hydrolyzing deoxyribozymes can be even smaller. For example, if 
the recognition site is only two nucleotides, a collection of at most 16 deoxyribozymes 
are needed to cleave at any predetermined site of a single-stranded DNA substrate. With 
short recognition sites and inherent highly customizable binding arms, ssDNA-
hydrolyzing deoxyribozymes can be widely used for precise manipulation of plasmids, 
phage DNA, and even genomes, as long as they efficiently invade a double-stranded 
DNA and bind to both strands. Encouraged by the potential application, a series of in 
vitro selection experiments are designed to identify new ssDNA-hydrolyzing 
deoxyribozymes that have broad substrate sequence generality. Separately, efforts toward 
efficient invasion of double-stranded DNA by deoxyribozymes are also carried out in the 
laboratory, but are not discussed here.  
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Figure 3.2. Selections with DNA substrate that have 0, 1, 3, 6, and 9 unpaired nucleotides between 
the two duplex binding arms. (A) Schematic of the selection experiment. During each selection 
round, the DNA substrate was ligated to the selection pool, but the linkage was not present during 
in trans assays. Black lines denote the binding arms, purple line denotes unpaired nucleotides, and 
brown arrow denotes the ligation site. (B) The DNA substrates used in selections. The purple 
nucleotides are the unpaired nucleotides. 
3.2 Results and Discussion 
3.2.1 Revealing the Optimal Number of Unpaired DNA Substrate Nucleotides for 
DNA-Hydrolyzing Deoxyribozymes 
3.2.1.1 Selections Using DNA Substrates with 09 Unpaired Nucleotides 
Comprehensive selection experiments were designed and performed, in which the 
DNA substrates had various numbers of unpaired nucleotides (Figure 3.2). The purpose 
of the experiments was to reveal the optimal number of unpaired substrate nucleotides in 
the selections to identify sequence-general DNA-hydrolyzing deoxyribozymes. 
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Figure 3.3. Activity profiles of selections with DNA substrates that have 0, 1, 3, 6, and 9 unpaired 
nucleotides. The arrows denote the rounds that were cloned. (A) PA selection with 0 unpaired 
substrate nucleotide. (B) PB selection with 1 unpaired substrate nucleotide. (C) NN selection (black, 
not cloned) and PC selection (red) with 3 unpaired substrate nucleotides. (D) PD selection with 6 
unpaired nucleotides. The incubation time was decreased from 14 h (black) to 10 min (green) to 1 
min (purple). Both round 9 and round 13 were cloned. (E) NP selection with 9 unpaired 
nucleotides. 
A selection (named PA selection) with a DNA substrate that had 0 unpaired 
nucleotide was carried out under standard incubation condition of 1 mM Zn
2+
, 20 mM 
Mn
2+
, and 40 mM Mg
2+
 at pH 7.5 for 14 h. The selection continued 18 rounds, and 0.31% 
pool cleavage was first observed at 13th round. The selection was cloned at 17th round 
with 22% pool cleavage activity (Figure 3.3A). 
Another selection (named PB selection) using a DNA substrate with 1 unpaired 
nucleotide was performed under standard incubation condition. 1.2% cleavage activity 
was first observed at the 8th round, and the selection experiment continued another 9 
rounds. Finally, the selection was cloned at the 13th round with 37% pool cleavage 
activity (Figure 3.3B). 
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Additionally, two selections were performed using a DNA substrate that had 3 
unpaired nucleotides. The first selection experiment was named NN selection (Figure 3.3, 
black line). 4.2% pool cleavage was first observed in round 7, and the pool activity in 8th 
round (34%) was assayed in trans where the substrate was not ligated to the pool. 
Surprisingly, no in trans activity was observed, indicating that the linkage between the 
pool and substrate was required for cleavage activity. Follow-up experiments found out 
that the NN pool of deoxyribozymes were catalyzing the self-cleavage within the 3ʹ 
primer binding region. The undesired cleavage led to the product with lower molecular 
weight, which would migrate similarly as the product from desired cleavage reaction. The 
selection was redesigned to remove the 3ʹ primer binding region and carried out again 
(the redesigned selection was named PC selection). 1.1% pool cleavage was first 
observed at round 8, and the selection was then continued three more rounds and cloned 
at round 11 with 45% pool cleavage activity (Figure 3.3, red line). 
The fourth selection (named PD selection) was carried out with a DNA substrate that 
had 6 unpaired nucleotides. The first eight selection rounds were performed under 
standard incubation condition. 11% pool cleavage was first observed at round 7. Starting 
at round 9, the incubation time was decreased from 14 h to 10 min to 1 min (Figure 3.3 
black line to green line to purple line). Both round 9 (14 h incubation, 43% pool cleavage 
activity) and round 13 (1 min incubation, 18% pool cleavage activity) were cloned. 
The last selection (named NP selection) was performed with a DNA substrate that 
had 9 unpaired nucleotides. 0.49% cleavage was observed for the pool at the 7th round, 
and two more rounds were performed before the selection was cloned at round 9 with 
64% cleavage activity. 
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Figure 3.4. Cleavage activities and sequences of the 17PA clones. (A) Cleavage activities of two 
representative 17PA clones, 17PA1 and 17PA19. t = 0, 2 h, and 20 h. Notice that the cleavages are 
not site-specific for both clones, and the cleavage sites are different based on their PAGE shifts. (B) 
Sequences of the enzyme regions of 17PA1 and 17PA19. 
3.2.1.2 Cloning and Sequences of Selection with 09 Unpaired Substrate Nucleotides 
Individual clones from the PA selection using substrate with 0 unpaired nucleotide 
were assayed for DNA cleavage. Each clone was initially tested as a PCR product 
prepared from miniprep DNA. Out of the 33 clones, 21 showed cleavage activity. Two 
cleavage sites were observed, but neither cleavage was site-specific (Figure 3.4A). 11 
individual clones were sequenced, resulting in only two unique sequences 17PA1 and 
17PA19 (Figure 3.4B). These two clones were further characterized as solid-phase 
synthesized deoxyribozymes for their cleavage activities. 
Individual clones from the PB selection which used a DNA substrate with 1 unpaired 
nucleotide were assayed for DNA cleavage activities. 31 out of 34 clones were able to 
catalyze the cleavage of the DNA substrate uniformly at one site specifically (Figure 
3.5A). 17 active clones were sequenced to give only two different sequences 13PB2 and 
13PB3 (Figure 3.5B). Both 13PB2 and 13PB3 were prepared by solid-phase synthesis 
and then characterized biochemically. 
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Figure 3.5. Cleavage activities and sequences of the 13PB clones. (A) Cleavage activities of two 
representative 13PB clones, 13PB2 and 13PB3. t = 0, 2 h, and 20 h. (B) Sequences of the enzyme 
regions of 13PB2 and 13PB3. 
 
Figure 3.6. Cleavage activities and sequences of the 11PC clones. (A) Activity profiles of two 
representative 11PC clones, 11PC1 and 11PC5. t = 0, 2 h, and 20 h. (B) Sequences of the enzyme 
regions of 11PC1 and 11PC5. 
 
Of the 25 clones from the PC selection using a DNA substrate with 3 unpaired 
nucleotides (NN selection was not cloned), 21 clones showed cleavage activity at a single 
cleavage site (Figure 3.6A). Nine active clones were sequenced, and 2 unique sequences, 
11PC1 and 11PC5, were obtained (Figure 3.6B). Both deoxyribozymes were 
characterized as solid-phase synthesized oligonucleotides. 
Two selection rounds were cloned from the PD selection where a DNA substrate with 
6 unpaired nucleotides was used. 19 clones from 9PD selection were assayed for cleavage 
activities, and 17 of them were active showing two distinctive cleavage sites (Figure 
3.7A, the major cleavage site is shown on the left and the minor site is shown in the 
middle). The cleavage reaction at the major cleavage site was noticeably faster than the 
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Figure 3.7. Cleavage activities and sequences of 9PD and 13PD clones. (A) Activity profiles of three 
representative clones from 9PD and 13PD selections. 9PD1 and 13PD34 cleaved at the major 
cleavage site, while 9PD5 cleaved at the minor cleavage site. For 9PD1 and 9PD5, t = 0, 2 h, and 20 
h. For 13PD1, t = 0, 15 min, 2 h, and 20 h. It was noticeable that clones cleaving at the major site 
were very fast, with reaction completed within 2 h or 15 min. 9PD5 was relatively slower compared 
to the other two clones. (B) The sequences of the enzyme regions of 9PD and 13PD clones. 
cleavage reactions catalyzed by all the clones from other selections, while the cleavage at 
the minor site was much slower. 11 of the active 9PD clones were sequenced, and five 
unique sequences were obtained for the major cleavage site (Figure 3.7B), while only one 
unique sequence was obtained for the minor cleavage site (Figure 3.7B). Only the 9PD5 
clone that cleaved at the minor site was further studied. Additionally, 11 out of 17 clones 
from 13PD were catalytically active with one uniform cleavage site that was the same as 
the major cleavage site observed in 9PD clones (Figure 3.7A, right). Surprisingly, the 
13PD clones were extremely fast, with the cleavage reaction complete in 15 min, 
consistent with the selection pressure applied during their identification. All 11 active 
13PD clones were sequenced, giving three unique sequences, 13PD1, 13PD2, and 
13PD34 (Figure 3.7B). All three deoxyribozymes were studied further as solid-phase 
synthesized oligonucleotides. 
22 clones from NP selection, in which a DNA substrate with 9 unpaired nucleotides 
was used, were assayed for cleavage activities. 21 of them were active, showing three 
different cleavage sites based on the different PAGE shifts (Figure 3.8A). 19 active 
clones were sequenced, giving one unique sequence for the first cleavage site, two unique 
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Figure 3.9. Deglycosylation catalyzed by the 17PA deoxyribozymes. (A) PAGE image of single-
turnover in trans asssays with the 17PA1 and 17PA19 deoxyribozymes. Assigned deglycosylation 
sites are marked on the accompanying substrate sequences. (B) MALDI mass spectrometry data for 
the reaction products of the two deoxyribozyme. The indicated peaks correspond to deglycosylation 
followed by two -elimination reactions, which lead to net excision of a single nucleoside and 
formation of 3ʹ-phosphate + 5ʹ-phosphate termini on the oligonucleotide products. 
 
Figure 3.8. Cleavage activities and sequences of the 9NP clones. (A) Activity profiles of three 
representative clones from 9NP selection. 9NP4 cleaved at the first cleavage site, 9NP12 cleaved at 
the second cleavage site, and 9NP22 cleaved at the third cleavage site. t = 0, 2, and 20 h. (B) Unique 
sequences of the enzyme regions of 9PD and 13PD clones. 
sequences for the second cleavage site, and four unique sequences for the third cleavage 
site (Figure 3.8B). Six clones 9NP4, 9NP12, 9NP22, 9NP23, 9NP29, and 9NP36 were 
characterized in more detail as solid-phase synthesized deoxyribozymes. 
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Figure 3.10. Single-turnover in trans assays of 13PB deoxyribozymes. (A) Cleavage site and PAGE 
image of 13PB2 and 13PB3 deoxyribozymes. t = 7, 15, 30 min, 1, 2, 5, and 20 h. The hydrolysis site is 
between the unpaired C (purple) and first paired G (black), leaving 5ʹ-phosphate and 3ʹ-hydroxyl 
termini. (B) Kinetic plots of 13PB2 and 13PB3. kobs values of 13PB2 and 13PB3 are 0.31 and 0.54 h
1
, 
respectively. The final hydrolysis yields of the two deoxyribozymes are 88% and 86%, respectively. 
3.2.1.3 Initial Characterizations of Deoxyribozymes from PANP Selections 
Single-turnover assays of both 17PA deoxyribozymes were performed using solid-
phase synthesized oligonucleotides. Two non-specific cleavage products were observed. 
Further MALDI mass spectrometry analysis of both cleavage products (Table 3.1 and 
Figure 3.9B) revealed that the 17PA deoxyribozymes were largely catalyzing 
deglycosylation followed by -elimination,14 rather than hydrolysis. However, oxidative 
cleavage mechanism cannot be completely ruled out. 
Except for the 17PA deoxyribozymes, all other deoxyribozymes identified from other 
selections catalyzed DNA hydrolysis reactions, with no evidence of deglycosylation. 
Single-turnover in trans assays were also performed with the 13PB deoxyribozymes 
(Figure 3.10). The 13PB deoxyribozymes were able to catalyze DNA hydrolysis reaction 
with 8090% yield in 20 h. The hydrolysis occurred between the unpaired C and the 
paired G (TC^G), with the formation of 5ʹ-phosphate and 3ʹ-hydroxyl products based on 
MALDI mass spectrometry analysis (Table 3.1). 
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Figure 3.11. Single-turnover in trans assays of the 11PC deoxyribozymes. (A) Cleavage site and 
PAGE image of 11PC1 and 11PC5 deoxyribozymes. t = 7, 15, 30 min, 1, 2, 5, and 20 h. The 
hydrolysis site is within the 5ʹ binding arm TA^T, leaving 5ʹ-phosphate and 3ʹ-hydroxyl termini. (B) 
Kinetic plots of 11PC1 and 11PC5. kobs values of 11PC1 and 11PC5 are 0.11 and 0.13 h
1
, 
respectively. The final hydrolysis yields of the two are 86% and 85%, respectively. 
 
The 11PC deoxyribozymes were also tested for single-turnover in trans cleavage 
activities (Figure 3.11). The hydrolysis products of the two deoxyribozymes were 
confirmed by MALDI mass spectrometry analysis (Table 3.1). Neither of the two 
deoxyribozymes hydrolyzed within the 3 unpaired nucleotides (Figure 3.11A). Instead, 
they cleaved within the 5ʹ binding arm region of the substrate, depicted as TA^TGAT, 
leaving 5ʹ-phosphate and 3ʹ-hydroxyl termini. Both 11PC1 and 11PC5 deoxyribozymes 
were much slower than the 13PB deoxyribozymes, achieving 80-90% hydrolysis in 20 h 
incubation (Figure 3.11B). 
Additionally, the three 13PD deoxyribozymes as well as the only 9PD 
deoxyribozyme were tested in trans under single-turnover condition (Figure 3.12). The 
hydrolysis site of three 13PD deoxyribozymes is within the 6 unpaired substrate 
nucleotides, ACTGC^T, forming 5ʹ-phosphate and 3ʹ-hydroxyl products, but the 
hydrolysis site of 9PD5 is AC^TGCT, leaving 3ʹ-phosphate and 5ʹ-hydroxyl termini 
(Table 3.1, Figure 3.12A). The hydrolysis reactions catalyzed by the 13PD 
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Figure 3.12. Single-turnover in trans assays of 13PD and 9PD deoxyribozymes. (A) Cleavage sites 
and PAGE images of 13PD and 9PD deoxyribozymes. For 13PD deoxyribozymes, t = 0, 30 s, 1, 2, 5, 
10, 20, and 60 min. For the 9PD5 deoxyribozyme, t = 7, 15, 30 min, 1, 2, 5, and 20 h. The hydrolysis 
site of 13PD deoxyribozymes is ACTGC^T (green marker), leaving 5ʹ-phosphate and 3ʹ-hydroxyl 
termini. The hydrolysis site of 9PD5 is AC^TGCT (red marker). (B) Kinetic plots of the 13PD and 
9PD5 deoxyribozymes. Notice that 13PD deoxyribozymes aree extremely fast. kobs values of 13PD 
deoxyribozymes are 1.2, 0.35 and 0.28 min
1
, respectively. 9PD5 was much slower, with a kobs value 
of 0.44 h
1
. The final hydrolysis yields of all four deoxyribozymes are 89%, 87%, 89%, and 84%, 
respectively. 
deoxyribozymes were extremely fast, with kobs values ranging from 0.31.2 min
1
. The 
rate of the fastest deoxyribozyme, 13PD1, was over 60-fold faster than the 10MD5 
deoxyribozyme,
15
 and achieved over 3×10
13
 rate enhancement over the uncatalyzed PO 
bond hydrolysis. However, the 9PD5 deoxyribozyme was much slower. A possible 
explanation for the observation of only one cleavage site in 13PD clones was that 
deoxyribozymes catalyzing hydrolysis at the other site did not survive the stringent time 
pressure (14 h to 10 min to 1 min) applied from 9th round to 13th round (Figure 3.3D). 
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Figure 3.13. Single-turnover in trans assays of the 9NP deoxyribozymes. (A) Cleavage sites and 
PAGE images of 9NP deoxyribozymes. 9NP4 catalyzes hydrolysis at TGTCATC^AG with formation 
of 5ʹ-phosphate and 3ʹ-hydroxyl termini (green marker). 9NP12 and 9NP36 hydrolyze at 
TGTCATCA^G, also with formation of 5ʹ-phosphate and 3ʹ-hydroxyl termini (green marker). 
9NP22, 9NP23, and 9NP29 hydrolyzed at TGTCATC^AG with formation of 3ʹ-phosphate and 5ʹ-
hydroxyl termini (red marker). t = 15, 30 min, 1, 2, 5, 10, 15, 25, and 50 h. (B) Kinetic plots of 9NP 
deoxyribozymes. kobs values are 0.17, 0.17, 0.11, 0.08, 0.25, and 0.22 h
1
, respectively. The final 
hydrolysis yields of all four deoxyribozymes are 82, 87, 89, 83, 60, and 88%, respectively. 
Finally, Single-turnover in trans assays were performed with the 9NP 
deoxyribozymes (Figure 3.13). MALDI mass Spectrometry experiments confirmed three 
hydrolysis products. One was occurring at TGTCATC^AG, leaving 5ʹ-phosphate and 3ʹ-
hydroxyl termini, one was hydrolyzing at the same site, but leaving 3ʹ-phosphate and 5ʹ-
hydroxyl termini, and the remaining site was at TGTCATCA^G, forming 5ʹ-phosphate 
and 3ʹ-hydroxyl products (Table 3.1 and Figure 3.13A). The 9NP deoxyribozymes were 
relatively slow, especially compared to the 13PD deoxyribozymes. They were able to 
catalyze DNA hydrolysis reactions at kobs ranging from 0.080.25 h
1
, with final yields of 
7090% in 50 h (Figure 3.13B). 
3.2.1.4 Substrate Sequence Generality Studies of PANP Deoxyribozymes 
In order to evaluate the substrate sequence generalities of the deoxyribozymes 
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Figure 3.14. Initial assays to determine substrate sequence requirements of 13PB2 and 13PB3. The 
retained substrate nucleotides are denoted above each assay. Purple nucleotide denotes the unpaired 
nucleotide in the substrate and black nucleotides denote the nucleotides in the binding arms. 
Outside the retained nucleotides, the substrate sequences are systematically varied (Tv2, A↔T, 
G↔C), and the binding arms are changed accordingly to maintain WatsonCrick base pairing. t = 
0, 1, 5, and 22 h. (A) Assays of 13PB2 for its substrate sequence requirement. (B) Assays of 13PB3 
for its substrate sequence requirement. 
identified from selections that used DNA substrates with various numbers of unpaired 
nucleotides, systematic experiments were designed and performed to determine the 
substrate sequence requirements of these deoxyribozymes. Because the 17PA1 and 
17PA19 deoxyribozymes did not catalyze hydrolytic DNA cleavage, they were not 
further assayed for substrate sequence requirements. 
Both of the 13PB2 and 13PB3 deoxyribozymes were tested for substrate sequence 
generality. Initially, Tv2 variations (A↔T, G↔C) in the substrate near the unpaired 
nucleotides were introduced, while the WatsonCrick base pairing between the substrate 
and binding arms were still maintained (Figure 3.14). The 13PB2 deoxyribozyme 
tolerated Tv2 variations outside of the C^G (Figure 3.14A), while the 13PB3 
 102 
 
Figure 3.15. Substrate sequence requirement of 13PB2. (A) PAGE image of single-turnover in trans 
cleavage assays of 13PB2 with substrates that have nucleotides beyond C^G systematically varied. t 
= 0, 15 min, 2 h, and 22 h. (B) Kinetic plots of cleavage reactions by 13PB2 with substrates that had 
C or G unpaired. kobs values (h
1
): C^G substrate, Par 0.41, Tv2 0.30, Tsn 0.13, and Tv1 0.32 
deoxyribozyme required one more nucleotide in the 5ʹ binding arm, and only tolerated 
Tv2 variations outside of TC^G (Figure 3.14B).The substrate sequences beyond the 
tolerated regions (C^G for 13PB2, and TC^G for 13PB3) were subsequently varied in 
other fashions such as Tsn (A↔G, T↔C) and Tv1 (A↔C, T↔G). Cleavage assays with 
Tsn and Tv1 substrates confirmed that 13PB2 had a substrate recognition site of C^G and 
13PB3 had a substrate recognition site of TC^G. 
It was quite surprising and interesting that 13PB2 recognized merely two nucleotides 
in the substrate, and further kinetic characterization was performed with 13PB2. The 
13PB2 deoxyribozyme required only C^G at the cleavage site, and all substrate 
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Figure 3.16. Substrate sequence requirements of 11PC1 and 11PC5. The retained substrate 
nucleotides are denoted above the assays. Purple nucleotides denote the unpaired nucleotides in 
the substrate, and black nucleotides denote the nucleotides in the binding arms. Outside the 
retained nucleotides, the substrate sequences are systematically varied (Tv2, A↔T, G↔C), and 
the binding arms are changed accordingly to maintain WatsonCrick base pairing. t = 0, 1, 5, and 
22 h. Notice that the cleavage yields are greatly reduced even when four nucleotides are retained, 
indicating that 11PC1 and 11PC5 have recognition sites longer than four nucleotides. 
nucleotides other than C^G could be varied freely with little reduction in both yield and 
rate, as long as the WatsonCrick base pairing was maintained (Figure 3.15). 
Furthermore, 13PB2 also showed substantial activity with G^G substrate (Figure 3.15B), 
but not all sequence variations were well tolerated. 
11PC deoxyribozymes were also tested for their substrate sequence tolerances. 
Variations of substrate nucleotides outside TAT^G led to great reduction in cleavage 
yield of both 11PC1 and 11PC5 (Figure 3.16), indicating that the substrate sequence 
requirements of these two deoxyribozymes were more than four nucleotides. The exact 
substrate recognition sites of 11PC1 and 11PC5 were not studied further because they 
were much worse than both 10MD5 and 13PB2. 
All three deoxyribozymes identified from the 13PD selection round were tested to 
determine their substrate sequence requirements. The 9PD5 deoxyribozyme was excluded 
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Figure 3.17. Substrate sequence requirement of 13PD1, 13PD2, and 13PD34. The retained 
substrate nucleotides are denoted above the assays. Purple nucleotides denote the unpaired 
nucleotides in the substrate, and black nucleotides denote the nucleotides in the binding arms. 
Outside the retained nucleotides, the substrate sequences are systematically varied (Tv2, A↔T, 
G↔C), and the binding arms are changed accordingly to maintain WatsonCrick base pairing. t = 
0, 5, 20 min, and 22 h. All three deoxyribozymes show little activities when five substrate 
nucleotides are retained, indicating that these three deoxyribozymes have recognition sites longer 
than five nucleotides. 
from this assay because it was much slower than the 13PD deoxyribozymes and was 
cleaving with the formation of undesired products. Similar to 11PC deoxyribozymes, the 
13PD deoxyribozymes were not as sequence-general as 10MD5 or 13PB2. They needed 
to recognize more than five nucleotides at the cleavage site in the substrate (Figure 3.17). 
Their specific recognition sites were not further determined as well. 
Finally, the substrate sequence generalities of all six 9NP deoxyribozymes were 
characterized. Different numbers of substrate nucleotides were retained in the unpaired 
region at the cleavage site, while the remaining nucleotides were systematically varied. 
The results showed that none of the 9NP deoxyribozymes were as sequence-tolerant as 
13PB2 (Figure 3.18). 9NP4, 9NP23, and 9NP29 required more than six substrate 
nucleotides. 9NP12, 9NP22, and 9NP36 required 46 substrate nucleotides. 
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Figure 3.18. Substrate sequence requirements of 9NP deoxyribozymes. The retained substrate 
nucleotides as well as different cleavage sites are denoted above the assays. Purple nucleotides denote 
the unpaired nucleotides in the substrate, and black nucleotides denote the nucleotides in the binding 
arms. Outside the retained nucleotides, the substrate sequences are systematically varied (Tv2, 
A↔T, G↔C), and the binding arms are changed accordingly to maintain WatsonCrick base 
pairing. The 9NP4, 9NP23, and 9NP29 deoxyribozymes showed little activity when 6 nucleotides are 
retained, indicating their recognition sites are longer than six nucleotides (red marker). 9NP12, 
9NP22, and 9NP36 showed little activity when only three nucleotides were retained, indicating their 
recognition sites are 46 nucleotides (grey marker). t = 2, 8, and 30 h. 
3.2.1.5 Confirmation of DNA Cleavage Sites and Mechanisms of PANP 
Deoxyribozymes 
Mass spectrometry was used to confirm the cleavage sites of deoxyribozymes (Table 
3.1). MALDI-MS assays were performed on the cleavage products using the parent 
substrate sequences along with each of the new deoxyribozymes 17PA1, 17PA19, 
13PB2, 11PC1, 13PD1, 9PD5, 9NP4, 9NP12, and 9NP22. For 17PA1 and 17PA19, the 
mass spectrometry results were consistent with deglycosylation of the DNA substrates 
(Figure 3.9B), but in all other cases, the mass spectrometry results were consistent with 
hydrolytic DNA cleavage at correspondingly assigned cleavage sites. 
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Table 3.1. MALDI mass spectrometry analysis of the cleavage products of the deoxyribozymes. L and 
R denote the 5ʹ and 3ʹ cleavage products, respectively. 
deoxyribozyme substrates a mass 
L calcd. 
mass 
L found 
L error, % 
(found –  
calcd.) 
mass 
R 
calcd. 
mass 
R found 
R error, % 
(found –  
calcd.) 
17PA1 
b
 Par 4903.2 4897.4 0.12 5083.3 5078.5 0.09 
17PA19 
b
 Par 5232.4 5217.7 0.28 4770.1 4760.2 0.21 
13PB2 Par C^G 
c
 5112.4 5112.7 0.006 5412.5 5411.8 0.01 
11PC1 Par TA^TGAT 4519.0 4526.2 0.16 6663.3 6669.8 0.10 
13PD1 Par ACTGC^T 6348.2 6360.0 0.19 5716.7 5728.2 0.20 
9PD5 Par AC^TGCT 
d
 5505.6 5514.5 0.16 6559.3 6567.3 0.12 
9NP4 
Par 
TGTCATC^AG 
6957.6 6961.5 0.06 6036.9 6059.8 0.38 
9NP12 
Par 
TGTCATCA^G 
7270.8 7283.2 0.17 5741.7 5748.6 0.12 
9NP22 
Par 
TGTCATC^AG 
d
 
7036.6 7049.0 0.18 5975.9 5983.5 0.13 
a Substrate sequences were parent as indicated in the caption. In addition, the unpaired nucleotides and 
cleavage sites were listed. 
b 
Both 17PA1 and 17PA19 catalyzed deglocosylation. Other deoxyribozymes catalyzed DNA 
hydrolysis. 
c The G directly to the 3ʹ-side of the cleavage site was base paired with the corresponding 
deoxyribozyme nucleotide. 
d The cleavage products were 3ʹ-phosphate and 5ʹ-hydroxyl. 
3.2.2 Establishing the Selection Approach to Identify DNA-Hydrolyzing 
Deoxyribozymes with Broad Substrate Sequence Generality 
With all the results collected from the set of selections with various lengths of 
unpaired nucleotides, it was concluded that selections with the DNA substrates that had 
one or possibly two unpaired nucleotides should be examined more comprehensively in 
subsequent selection experiments in order to identify DNA-hydrolyzing deoxyribozymes 
with broad substrate sequence generality. 
3.2.2.1 Systematic Selections Using DNA Substrates with One or Two Unpaired 
Nucleotides 
Two sets of four selection experiments were performed. One set of selections were 
done with each of the four possible single unpaired nucleotides, and the other set of 
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Figure 3.19. Outcomes of systematic selections with DNA substrates that have one or two 
unpaired nucleotides, as revealed by in trans assays of uncloned selection pools. (A) PAGE assays 
using 5ʹ-32P-radiolabeled substrates and standards. The unpaired nucleotides in the substrate are 
shown above each lane. The 3ʹ-OH standards are each designated with their 3ʹ-terminal 
nucleotide, where L1 is the first paired nucleotide immediate 5ʹ of the unpaired nucleotides, and 
R1 is the first paired nucleotide immediate 3ʹ of the unpaired nucleotides. (B) Representative 
MALDI mass spectrometry results for the two indicated uncloned pools. Each assigned peak has 
observed mass within 0.05% of the calculated value. DNA hydrolysis is predominant in each 
uncloned pool. (C) MALDI mass spectrometry result for uncloned round 7 pool of the selection 
with a single unpaired G nucleotide in the substrate. Both hydrolytic cleavage as well as strand 
excision via deglycosylation followed by -eleimination can be observed. 
selections were conducted with each of the four possible unpaired XG dinucleotide 
(where X = one of A, T, C, or G). The immediate goal of these selections was to 
determine the range of hydrolysis sites located in each resulting collection of 
deoxyribozymes. 
The four selection experiments with single unpaired nucleotides were named RV, 
RW, RX, and RY selections, and the four selections with unpaired XG dinucleotides 
were named RQ, RR, RS, and RT selections. The RVRY selections continued 7 rounds, 
and the in cis pool cleavage yields at round 7 were 37%, 27%, 37%, and 18%, 
respectively. The RQRT selections continued 8 rounds, and the in cis pool cleavage 
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yields of round 8 were 44%, 43%, 56%, and 28%. The cleavage activities of uncloned 
RVRY and RQRT pools were then assayed in trans to determine the cleavage sites. 
For all eight selections, cleavage by the uncloned pools was observed at various positions 
clustered near the middle of the substrate (Figure 3.19). Some of the deoxyribozymes led 
to 3ʹ-hydroxyl and 5ʹ-phosphate temini whereas others formed 5ʹ-hydroxyl and 3ʹ-
phosphate temini, as assessed by MALDI mass spectrometry (see Figure 3.19B for 
representative data). Arguably the former combination is more desired because of the 
compatibility with the termini formed by conventional restriction enzymes. In addition, 
for several of the selections with substrates that had one unpaired nucleotide, a small 
amount of substrate cleavage by deglycosylation followed by -eliminations was 
observed by the uncloned pools, along with hydrolytic cleavage (Figure 3.19C). Taken 
together, these findings indicated that a selection pressure must be developed for the 
systematic development of a full collection of DNA-hydrolyzing deoxyribozymes, such 
that the resulting catalysts hydrolyzed the substrate at a predetermined site rather than 
anywhere within a rather large region. Ideally, this selection pressure should also ensure 
that the catalysts uniformly provided 3ʹ-hydroxyl and 5ʹ-phosphate temini. 
3.2.2.2 Systematic Selections with Pressure for Predetermined Cleavage Site and 5ʹ-
Phosphate Product 
The necessary selection pressure was achieved by adding an additional step to each 
round of selection process (Figure 3.20). This step was performed immediately after the 
selection pool was allowed to cleave the attached DNA substrate at any central position. 
To the product mixture was added a DNA splint and acceptor oligonucleotide (with 3ʹ-
OH), and T4 DNA ligase. Only those deoxyribozymes that had created a 5ʹ-phosphate 
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Figure 3.20. Selection process that includes splint ligation pressure for DNA-catalyzed DNA 
hydrolysis at a particular predetermined site (X^G, where four different selections are performed 
with X = one of C, T, A, or G). The hydrolysis products are 3ʹ-hydroxyl and 5ʹ-phosphate products, 
as required by T4 DNA ligase. Note that the acceptor oligo-nucleotide, which has a 3ʹ-hydroxyl for 
joining to the 5ʹ-phosphate of the G nucleotide, has a long 5ʹ-extension that leads to a large upward 
PAGE shift upon splint ligation. 
terminus directly at the predetermined cleavage site would undergo ligation with the 
acceptor and therefore migrate much more slowly on PAGE.
16
  
The enhanced selection procedure incorporating the splint ligation pressure was 
performed with each of the four substrates that have XG unpaired nucleotides, with 
selection pressure that is selective for hydrolyzing between the unpaired nucleotides 
X^G. These selections were named VH, VJ, VL, and VK selections. 
The VH selection experiment used a DNA substrate that had C^G unpaired 
nucleotides, and the selection went on 8 rounds. 3.3 % in cis pool cleavage activity was 
first observed in round 4, and the selection was cloned at round 7 with 47% pool cleavage 
activity (Figure 3.21A). 
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Figure 3.21. Activity profiles of the four selections with DNA substrates that have X^G unpaired 
nucleotides. The arrows denote the rounds that cloning was performed. (A) VH selection with C^G 
unpaired substrate nucleotides. (B) VJ selection with T^G unpaired substrate nucleotides. (C) VK 
selection with A^G unpaired substrate nucleotides. (D) VL selection with G^G unpaired substrate 
nucleotides. 
A DNA substrate with T^G unpaired nucleotides was used in the VJ selection. 1.5 % 
pool cleavage activity was first observed at round 5, and the selection was cloned at 
round 8 with 40% in cis uncloned pool cleavage activity (Figure3.21B). 
The VK selection was performed using a DNA substrate with A^G unpaired 
nucleotides. Initial pool cleavage activity was observed in round 5 (2.4%), and round 7 
VK selection was cloned with 44% in cis pool cleavage activity (Figure 3.21C). 
The VL selection used a DNA substrate that had G^G unpaired nucleotides in the 
experiment. 3.8% pool cleavage activity was observed at round 6, and the selection was 
carried on for three more rounds. The VL selection was finally cloned at round 8 where 
44% in cis pool cleavage activity was observed (Figure 3.21D). 
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Figure 3.22. PAGE image of in trans assays of uncloned 7VH, 8VJ, 7VK, and 8VL selection pools. 
The unpaired nucleotides are marked above each lane. The 3ʹ-OH standards are each designated 
with their 3ʹ-terminal nucleotide, where L1 is the first paired nucleotide immediate 5ʹ of the 
unpaired nucleotides and R1 is the first paired nucleotide immediate 3ʹ of the unpaired nucleotides. 
The major cleavage site in each lane was the predetermined site. 
Single-turnover in trans assays were performed with the four uncloned pools each at 
indicated rounds that were cloned. PAGE experiments confirmed that the predominant 
cleavage site in each selection pool was the predetermined site (X^G, as seen in Figure 
3.22). However, minor cleavage products were also observed, probably due to the 
tolerance of T4 DNA ligase of unpaired nucleotides at the ligation sites. Further MALDI-
MS experiments confirmed the cleavage products as well as their hydrolytic mechanism. 
3.2.2.3 Cloning and Sequences of Selections with Pressure for Predetermined 
Cleavage Site and 5ʹ-Phosphate Product 
Individual clones from the 7VH selection using the substrate with C^G unpaired 
nucleotides were assayed for DNA cleavage activities. Each clone was initially tested as a 
PCR product prepared from the miniprep DNA. Out of the 29 clones, 21 showed 
cleavage activities, and 19 were hydrolyzing at the C^G site according to their PAGE 
shifts (Figure 3.23A) and further Mass spectrometry experiments (Table 3.2). 19 
individual clones were sequenced, resulting in eight unique sequences (Figure 3.23B). 
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Figure 3.23. Cleavage activities and sequences of the 7VH clones that are identified from the 
selection with C^G unpaired nucleotides. (A) Cleavage activities of two representative 7VH clones, 
7VH30 and 7VH31. Notice that 7VH31 catalyzes the cleavage at the primary site which is also the 
predetermined site, C^G. t = 0, 15 min, 2 h, and 22 h. (B) Sequences of the enzyme regions of 7VH 
clones. The checked sequences are the ones that are further characterized for their substrate 
sequence generalities. 
 
Figure 3.24. Cleavage activities and sequences of the 8VJ clones that are identified from the 
selection with T^G unpaired nucleotides. (A) Cleavage activities of two representative 8VJ clones, 
8VJ4 and 8VJ8. Notice that 8VJ4 catalyzes the cleavage at the primary site which is also the 
predetermined site, T^G. t = 0, 15 min, 2 h, and 22 h. (B) Sequences of the enzyme regions of 8VJ 
clones. The checked six sequences were synthesized as oligonucleotides and further characterized 
for their substrate sequence generalities. 
Four of these clones were further characterized for their substrate sequence generalities as 
solid-phase synthesized deoxyribozymes (Figure 3.23B, checked sequences). 
Of the 32 individual clones from the 8VJ selection using a substrate with T^G 
unpaired nucleotides, 21 showed cleavage activities, and 19 were cleaving at the T^G site 
according to their PAGE shifts (Figure 3.24A). All of the 19 active clones cleaving at the 
designed site were sequenced, giving 10 unique sequences (Figure 3.24B). Later on, six 
of these clones were further characterized for their substrate sequence generality as solid-
phase synthesized deoxyribozymes (Figure 3.24B, checked ones). 
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Figure 3.25. Cleavage assays and sequences of the 7VK clones that are identified from the selection 
with A^G unpaired nucleotides. (A) Cleavage activities of two representative 7VK clones, 7VK64 
and 7VK65. 7VK64 catalyzes the cleavage at the predetermined site, A^G. t = 0, 15 min, 2 h, and 22 
h. (B) Sequences of the enzyme regions of the 7VK clones. The checked sequences were further 
characterized for their substrate sequence generalities. 
63 clones from 7VK selection during which a DNA substrate that had unpaired A^G 
was used were initially tested for their cleavage. Of these clones, 59 were able to catalyze 
the cleavage of the DNA substrate, with only 6 clones cleaving at undesired sites (Figure 
3.25A). The hydrolytic cleavage was confirmed by further mass spectrometry experiment 
(Table 3.2) All 53 active clones with designed A^G cleavage site were sequenced and 24 
unique sequences were obtained (Figure 3.25B). 18 out of 24 sequences were synthesized 
as oligonucleotides and further characterized for sequence generalities (Figure 3.25B). 
Finally, 72 clones from the 8VL selection were initially tested, and 67 of them 
catalyzed the cleavage of the DNA substrate. Only one clone cleaved at a site other than 
the predetermined site (Figure 3.26A). Further mass spectrometry assays confirmed the 
cleavage at the primary site was via hydrolytic mechanism (Table 3.2). All 66 clones 
were sequenced, and 17 unique sequences were obtained (Figure 3.26B). 11 of these 
deoxyribozymes were characterized further (Figure 3.26B, checked ones). 
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Figure 3.26. Cleavage activities and sequences of the 8VL clones that are identified from the selection 
with G^G unpaired nucleotides. (A) Cleavage activities of two representative 8VL clones, 8VL51 and 
8VL52. Both clones catalyze the cleavage at the predetermined site, G^G. t = 0, 15 min, 2 h, and 22 h. 
(B) Sequences of the enzyme regions of 8VL clones. The checked sequences were further characterized 
for their substrate sequence generalities. 
 
Figure 3.27. Substrate sequence generality studies of the 7VH deoxyribozymes. Note that only 
7VH6 catalyzes the cleavage of its substrate at a relatively high yield. None of 7VH7, 7VH13, and 
7VH22 achieves substrate cleavage as high as observed initially. t = 0, 15 min, 2 h, and 22 h. 
3.2.2.4 Substrate Sequence Generality Studies of VHVL Deoxyribozymes 
The chosen deoxyribozymes from the four selections were prepared by solid-phase 
synthesis and assayed for their substrate sequence generalities. The binding arms of these 
deoxyribozymes were initially mutated to their transversion-2 version (Tv2: A↔T, 
C↔G), and the substrate nucleotides beyond the unpaired regions X^G, were varied 
accordingly to their Tv2 versions to maintain the WatsonCrick base pairing. Only the 
deoxyribozymes that retained relatively high catalytic activities were considered to have 
potentially high sequence generalities and require only the unpaired nucleotides. 
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Figure 3.28. Substrate sequence generality assays and kinetic profile of the 7VH6 deoxyribozyme. 
(A) PAGE image of 7VH6 cleaving parent substrate as well as substrates in which the nucleotides 
beyond C^G were systematically varied in three ways. The recognition site of 7VH6 was C^G. t = 
0, 15min, 2 h, and 22 h. (B) Kinetic profile of the 7VH6 deoxyribozyme reacting with the four 
substrates listed in panel A. kobs values (h
1
) are Par 0.20, Tv2 0.13, Tsn 0.095, Tv1 0.067. 
Of the four 7VH deoxyribozymes assayed with Tv2 binding arms, only one 
deoxyribozyme, 7VH6, was able to catalyze the cleavage of its substrate with a yield of 
about 45% in 22 h incubation (Figure 3.27).  
The sequence generality of 7VH6 was further characterized by assaying the cleavage 
activities of its parent substrate and substrates that were systematically mutated in other 
fashions, including Tsn (A↔G, T↔C) and Tv1 (A↔C, T↔G) (Figure 3.28). As 
predicted, 7VH6 was able to tolerate substrates that had all types of systematic variations 
beyond the unpaired C^G region with 4565% final cleavage yields, indicating that 
7VH6 had a relatively high substrate sequence generality. Furthermore, the substrate 
sequence tolerance of the 7VH6 deoxyribozyme within the unpaired nucleotides was 
assayed, and the binding arms were retained as the parent sequences. The 7VH6 
deoxyribozyme only catalyzed the hydrolysis of parent C^G substrate (Figure 3.29). It 
was then concluded that the 7VH6 deoxyribozyme had a recognition site of C^G. 
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Figure 3.29. Assays of 7VH6 for generality at the two nucleotides immediately at the cleavage site, 
N^N. For each assay, t = 0, 15 min, 2 h, and 22 h. Above each set of lanes are the N^N nucleotides 
at the cleavage site in the assay (black = nucleotide present in substrate as used during selection; 
red = nucleotide changed from selection substrate). 
 
Figure 3.30. Substrate sequence generality studies of the 8VJ deoxyribozymes. Only 8VJ17 was 
able to catalyze the cleavage of its substrate at a relatively high yield. None of the other five 
deoxyribozymes achieved cleavage as proficient as observed when they were tested initially. t = 0, 
15 min, 2 h, and 22 h. 
Similarly, the six 8VJ deoxyribozymes were assayed for their substrate sequence 
generalities. The substrate nucleotides beyond the unpaired T^G region and the binding 
arms of these deoxyribozymes were covaried in Tv2 fashion (Figure 3.30). All clones 
except 8VJ17 showed substantially reduced cleavage activities compared to their initial 
assays, indicating potential dependence of binding arm sequences. 8VJ17 was chosen for 
detailed characterization to determine its substrate sequence requirement. 
Four versions of the 8VJ17 deoxyribozyme were prepared, of which the binding arms 
were the systematically varied to react with substrates in which the nucleotides beyond 
the unpaired T^G were covaried to maintain WatsonCrick base pairing. The 8VJ17 
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Figure 3.31. PAGE image of 8VJ17 cleaving parent substrate as well as substrates in which the 
nucleotides beyond T^G were systematically varied in three ways. The recognition site of 8VJ17 was 
T^G. t = 0, 15min, 2, and 22 h. 
 
Figure 3.32. Assays of 8VJ17 for generality at the two nucleotides immediately at the cleavage site, 
N^N. For each assay, t = 0, 15 min, 2 h, and 22 h. Above each set of lanes are the N^N nucleotides at 
the cleavage site in the assay (black = nucleotide present in substrate as used during selection; red = 
nucleotide changed from selection substrate). 
deoxyribozyme tolerated all four types of covariations and was able to achieve 2025% 
cleavage yield in 22 h (Figure 3.31). However, the cleavage catalyzed by 8VJ17 was 
relatively low, so no further kinetic assays were carried out. 
Additionally, the tolerance of 8VJ17 within the unpaired dinucleotide region was 
assayed using the parent 8VJ17 deoxyribozyme to react with substrates in which the 
nucleotides immediately flanking the cleavage site were varied. The results showed that 
8VJ17 was only able to catalyze the cleavage of its parent substrate T^G. Therefore, the 
8VJ17 deoxyribozyme had a recognition site of T^G (Figure 3.32). 
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Figure 3.33. Substrate sequence generality studies of the 7VK deoxyribozymes. Only 7VK29, 7VK52, 
and 7VK55 were able to catalyze the cleavage of its substrate at a relatively high yield. t = 0, 15 min, 2, 
and 22 h. 
The 18 deoxyribozymes identified from 7VK selection were assayed to determine 
their substrate sequence generalities. Among these deoxyribozymes, only three showed 
relatively high cleavage activity compared to their initial assays, 7VK29, 7VK52, and 
7VK55. These deoxyribozymes were further characterized for their substrate sequence 
requirements (Figure 3.33). 
The three deoxyribozymes were then systematically tested for their sequence 
tolerance with four types of substrate that had the nucleotides beyond A^G region 
systematically varied. Neither 7VK29 nor 7VK52 were able to tolerate all four types of 
variations (Figure 3.34A), while the 7VK55 deoxyribozymes tolerated all four variations, 
with 3065% cleavage yield in 22 h (Figure 3.34B). 
Interestingly, the 7VK55 deoxyribozyme was able to catalyze the cleavage of 
substrates with certain mutations in the unpaired dinucleotide region, as shown in Figure 
3.35. It accepted substrates that had either A^G or C^G immediately flanking the 
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Figure 3.34. Substrate sequence generality assays of the 7VK29, 7VK52, and 7VK55 deoxyribozymes. 
(A) PAGE images of 7VK29 and 7VK52 cleaving parent substrate as well as substrates in which the 
nucleotides beyond C^G were systematically varied in three ways. t = 0, 15min, 2h, and 22 h. The 
cleavage yields of both 7VK29 and 7VK52 with Tsn and Tv1 substrates were greatly reduced. (B) 
Activity profile of 7VK55 reacting with the four substrates. kobs values (h
1
) are Par 0.094, Tv2 0.073, 
Tsn 0.13, and Tv1 0.083. 
cleavage site equally well. While retaining the C^G dinucleotide in the substrates, 7VK55 
still tolerated all four substrate-binding-arm covariations. Therefore, the 7VK55 
deoxyribozyme had a recognition site of M^G (M = A or C). 
Finally, of the 11 deoxyribozymes identified from 8VL selection, only two 
deoxyribozymes, 8VL4 and 8VL51, were able to retain cleavage activity when the 
substrate nucleotides beyond the unpaired G^G were varied in Tv2 fashion (Figure3.36). 
Both 8VL4 and 8VL51 were then tested with other three types of substrates. The 8VL51 
deoxyribozyme was able to accept all four types of co-variations with cleavage yield of 
3566% in 22 h, indicating it required at most the G^G dinucleotide in the substrate 
(Figure 3.37). 
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Figure 3.35. The unique M^G recognition site of the 7VK55 deoxyribozyme. (A) PAGE image of 
assays of 7VK55 for generality at the two nucleotides immediately at the cleavage site, N^N. For 
each assay, t = 0, 15 min, 2 h, and 22 h. Above each set of lanes are the N^N nucleotides at the 
cleavage site in the assay (black = nucleotide present in substrate as used during selection; red = 
nucleotide changed from selection substrate). Notice that greatly reduced activities are also 
observed in other substrates such as T^G, etc. (B) The sequence tolerance of 7VK55 with C^G 
substrate. t = 0, 15 min, 2 h, and 22 h. kobs values (h
1
) are Par 0.20, Tv2 0.098, Tsn 0.12, Tv1 
0.076.  
 
 
Figure 3.36. Substrate sequence generality studies of the 8VL deoxyribozymes. Note that only 
8VL4 and 8VL51 are able to catalyze the cleavage of their substrate at a relatively high yield. t = 
0, 15 min, 2 h, and 22 h. 
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Figure 3.37. Substrate sequence generality assays of the 8VL4 and 8VL51 deoxyribozymes. (A) 
PAGE image of 8VL4 cleaving the parent substrate as well as substrates in which the nucleotides 
beyond C^G were systematically varied in three ways. t = 0, 15min, 2 h, and 22 h. The cleavage 
activities of 8VL4 with Tsn and Tv1 substrates were greatly reduced. (B) Activity profile of 8VL51 
reacting with the four substrates. kobs values (h
1
) are Par 0.26, Tv2 0.16, Tsn 0.14, Tv1 0.22. 
 
Figure 3.38. PAGE image of assays of 8VL51 for generality at the two nucleotides at the cleavage 
site, N^N. For each assay, t = 0, 15 min, 2 h, and 22 h. Above each set of lanes are the N^N 
nucleotides at the cleavage site in the assay (black = nucleotide present in substrate as used during 
selection; red = nucleotide changed from selection substrate). 
The substrate sequence tolerance of 8VL51 at the two nucleotides at the cleavage site, 
N^N, was subsequently assayed. The 8VL51 deoxyribozyme only tolerated the parent 
G^G substrate, although trace amount of cleavage activity was still observed with other 
substrates such as T^G, A^G, and G^T substrates (Figure 3.38). Therefore, the 8VL51 
deoxyribozyme had a recognition site of G^G. 
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Figure 3.39. Activity profile of the YR reselection. The arrow denotes the rounds that were cloned. 
The substrate of YR selection is the same as in the VJ selection, and the same capture strategy is 
used during each round. 
 
 
Figure 3.40. Cleavage activities and sequences of the 6YR clones that are identified from the 
reselection of 8VJ17. (A) Cleavage activities of two representative 6YR clones, 6YR11 and 6YR25. 
Both clones catalyze the cleavage at the original T^G site with substantially increased yield and rate 
than the parent 8VJ17 deoxyribozyme. t = 0, 15 min, 2 h, and 22 h. (B) Sequences alignment of the 
enzyme regions of 8VJ17 as well as 6YR clones that were chosen for further characterizations. Dots 
denote the same sequence as 8VJ17. 
3.2.2.5 Reselection of the 8VJ17 Deoxyribozyme 
Because of the relatively low yield catalyzed by the 8VJ17 deoxyribozyme, a 
reselection experiment was performed using a pool that was partially (25%) randomized 
based on the 8VJ17 sequence. The reselection was named YR selection, and the same 
selection strategy was used as shown in Figure 3.20. 1.4% pool cleavage activity was 
immediately observed in round 2, and the reselection was cloned at round 6 (Figure 
3.39). 
Individual clones from 6YR selection were assayed to determine their cleavage 
activity. All of the 36 clones were able to cleave the substrate at the original T^G site, 
and the hydrolytic cleavage was also confirmed by further mass spectrometry experiment 
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Figure 3.41. Assays for substrate sequence generalities of the 6YR deoxyribozymes. (A) PAGE 
image of the six 6YR deoxyribozymes reacting with Tv2 substrate. t = 0, 15 min, 2 h, and 22 h. All 
six deoxyribozymes are able to catalyze the cleavage of the Tv2 substrate. (B) PAGE image of 
6YR11 reacting with the parent substrate as well as the other three substrates with systematic 
variations. t = 0, 15 min, 2 h, and 22 h. (C) Activity profile of 6YR25 reacting with substrates that 
have all four types of binding arms. kobs values (h
1
) are Par 1.0, Tv2 0.43, Tsn 0.30, Tv1 0.18. 
(Table 3.2). The yield and rate of the YR clones were substantially higher than the parent 
8VJ17 deoxyribozyme (Figure 3.40A). All 36 clones were sequenced and 28 different 
sequences were obtained, of which six were further assayed for their substrate sequence 
generality (Figure 3.40B). 
Interestingly, all six deoxyribozymes were able to catalyze the cleavage of the DNA 
substrate with Tv2 variations beyond the unpaired nucleotides (Figure 3.41A). Two 
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Figure 3.42. PAGE image of assays of 6YR25 for generality at the two nucleotides immediately at the 
cleavage site, N^N. For each assay, t = 0, 15 min, 2, and 22 h. Above each set of lanes are the N^N 
nucleotides at the cleavage site in the assay (black = nucleotide present in substrate as used during 
selection; red = nucleotide changed from selection substrate). Notice that greatly reduced activity 
was also observed in other substrates such as T^T and T^C, etc. 
chosen deoxyribozymes, 6YR11 and 6YR25 tolerated all four types of systematic 
variations (Figure 3.41B and C). Kinetic assays were also performed using the 6YR25 
deoxyribozyme (Figure 3.41C). 6YR25 was able to achieve hydrolytic cleavage of all 
four covariation substrates with yields of 6575% in 22 h. 
The reactivities of 6YR25 were assayed with substrates that had the nucleotides 
immediately flanking the cleavage site mutated. Similar to the parent 8VJ17 
deoxyribozyme, 6YR25 only accepted the parent substrate that had T^G at the cleavage 
site, and greatly reduced activity was also observed with other substrates (Figure 3.42). 
Therefore, the 6YR25 deoxyribozyme had a recognition site of T^G. 
3.2.2.6 Confirmation of DNA Cleavage Sites and Mechanisms for VHYR 
Deoxyribozymes 
MALDI mass spectrometry experiments were performed to characterize the cleavage 
products of all newly-identified deoxyribozymes. Each of the 7VH6, 6YR25, 7VK55 and 
8VL51 was assayed with both the parent X^G substrate as well as the Tv2 substrate in 
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which the nucleotides beyond the X^G were systematically varied. In all cases, the mass 
spectrometry results were consistent with hydrolytic cleavage (Table 3.2). 
Table 3.2. Mass spectrometry assays to validate DNA hydrolysis catalyzed by sequence-general 
deoxyribozymes. Each listed deoxyribozyme was used to cleave the substrate with the indicated 
unpaired nucleotides, where the binding arms were either the parent nucleotide sequences (Par) or 
systematically changed by transversions (Tv2; AT, GC). 
deoxyribozyme substrates 
a
 mass 
L calcd. 
mass 
L found 
L error, % 
(found –  
calcd.) 
mass 
R calcd. 
mass 
R found 
R error, % 
(found –  
calcd.) 
7VH6 Par C^G 5112.4 5111.8 –0.01 5741.7 5739.8 –0.03 
 Tv2 C^G 5223.5 5222.4 –0.02 5465.5 5464.4 –0.02 
6YR25 Par T^G 5127.4 5126.2 –0.02 5741.7 5740.2 –0.03 
 Tv2 T^G 5238.5 5237.4 –0.02 5465.5 5464.4 –0.02 
7VK55 Par A^G 5136.4 5136.5 +0.002 5741.7 5738.9 –0.05 
 Tv2 A^G 5247.5 5246.7 –0.02 5465.5 5464.9 –0.01 
 Par C^G 5112.4 5112.1 –0.006 5741.7 5741.4 –0.005 
 Tv2 C^G 5223.5 5222.9 –0.01 5465.5 5463.7 –0.03 
8VL51 Par G^G 5152.4 5152.1 –0.006 5741.7 5739.4 –0.04 
 Tv2 G^G 5263.5 5262.5 –0.02 5465.5 5464.3 –0.02 
a
 Substrate sequences were either parent (Par) or transversions-2 (Tv2) as indicated in the caption. 
In addition, the two unpaired nucleotides immediately at the cleavage site (X^G) are listed. 
The results from comprehensive VHVL selections and the identifications of 
VHYR deoxyribozymes demonstrated that site-specific DNA-hydrolyzing 
deoxyribozymes with short 2-nt recognition sites can be identified, establishing an 
approach to identify substrate sequence general DNA-hydrolyzing deoxyribozymes. 
The four deoxyribozymes 7VH6, 6YR25, 7VK55, and 8VL51 collectively allow site-
specific hydrolysis of any arbitrarily chosen single-stranded DNA substrate that includes 
an N^G cleavage site. With the established in vitro selection approach, systematic 
identification of a complete collection of at most 16 deoxyribozymes is feasible to 
achieve hydrolysis of any predetermined site within any single-stranded DNA substrate. 
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Figure 3.43. Selection procedure used in V1 and W1 selections, which includes a splint ligation 
pressure for DNA-catalyzed DNA hydrolysis at a particular predetermined site. The hydrolysis 
products are 3ʹ-hydroxyl and 5ʹ-phosphate products, as required by T4 DNA ligase. The substrate 
has 5ʹ-phosphate and 3ʹ-dideoxycytidine. A donor oligonucleotide, which has a 5ʹ-phosphate for 
joining to the 3ʹ-hydroxyl of the X nucleotide, has a long 3ʹ-extension that leads to a large upward 
PAGE shift upon splint ligation. 
3.2.3 Efforts Toward Identification of the Complete Collection of Sequence-General 
DNA-hydrolyzing Deoxyribozymes 
3.2.3.1 New Selections Using Substrates with Other Unpaired Dinucleotides 
In order to identify more sequence-general DNA-hydrolyzing deoxyribozymes, four 
new selections (S1, T1, V1, and W1 selections) were performed. The four selections were 
divided into two sets (S1/T1 and V1/W1), and each set of two selections were performed 
with DNA substrates that had C^C or T^T unpaired nucleotides. During the S1 and T1 
selections, the selection procedures were essentially the same as the VHVL selections 
(Figure 3.20), and the key step after selection was included to capture specifically any 5ʹ-
phosphate products formed at the designed cleavage site. The V1 and W1 selections were 
performed differently as shown in Figure 3.43. The DNA substrates used in these 
selections had their 5ʹ ends phosphorylated to enable ligation between the deoxyribozyme 
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Figure 3.44. Activity profiles of the four selections with DNA substrates that have C^C or T^T 
unpaired. The arrows denote the selection rounds that are cloned. (A) S1 selection with C^C 
unpaired substrate nucleotides. (B) T1 selection with T^T unpaired substrate nucleotides. (C) V1 
selection with C^C unpaired substrate nucleotides. (D) W1 selection with T^T unpaired substrate 
nucleotides. Note that V1 and W1 selections are essentially the repeat of S1 and T1 selection, 
respectively. 
pools and the substrates. The 3ʹ ends of the substrates were blocked by dideoxycytidine to 
prevent any undesired modifications to the substrates. The oligonucleotide used in the 
key capture step was a 5ʹ-phosphate donor oligo instead of 3ʹ-hydroxyl acceptor oligo. 
Only those deoxyribozymes that had created a 3ʹ-hydroxyl by hydrolysis directly at the 
predetermined cleavage site would undergo ligation with the donor oligo and therefore 
separated from substrate and other possible cleavage products (e.g., deglycosylation 
followed by -eliminations). 
The S1 selection was performed with a DNA substrate that had C^C unpaired 
dinucleotide. 1.1% pool cleavage was first observed in round 5. After three rounds, the 
pool activity increased to 47%. The 8S1 selection pool was assayed in trans and cloned 
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Figure 3.45. PAGE image of in trans cleavage assays of uncloned 8S1, 8T1, 8V1, and 8W1 pools. 
The unpaired nucleotides of the substrates are shown above each assay. The 3ʹ-OH standards are 
each designated with their 3ʹ-terminal nucleotide, where L1 is the first paired nucleotide immediate 
5ʹ of the unpaired nucleotides and R1 is the first paired nucleotide immediate 3ʹ of the unpaired 
nucleotides. Notice the presence of cleavage at predetermined site in each selection pool even though 
in most cases the primary cleavage site was the wrong site. 
(Figure 3.44A). Individual deoxyribozymes were then further studied. Similarly, a DNA 
substrate that had T^T unpaired nucleotides was used in the T1 selection. At round 5, 2.4 
% cleavage was observed in the pool. The selection went on three more rounds. At round 
8, 47% pool cleavage was observed, therefore in trans pool assay as well as cloning were 
performed using round 8 deoxyribozyme pool (Figure 3.44B). The V1 selection was 
essentially a repeat of the S1 selection. Initially, 11% pool cleavage was observed at 
round 5, but by round 8, the pool cleavage increased to 61% (Figure 3.44C). The pool 
cleavage activity was then assayed in trans, but none of the V1 selection rounds were 
cloned. The W1 selection was essentially the repeat of T1 selection. The selection pool 
first showed 3.5% cleavage activity at round 6, and the activity increased to 24% at round 
8 (Figure 3.44D). In trans assay was then performed using round 8 pool, but no cloning 
was performed for W1 selection. 
Single-turnover in trans cleavage assays were performed with the four selection pools 
from round 8 (Figure 3.45). PAGE shifts confirmed that the presence of deoxyribozymes 
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Figure 3.46. Cleavage activities and sequences of the 8S1 clones. (A) Cleavage activities of two 
representative 8S1 clones, 8S109 and 8S110. Although the cleavage site of 8S110 was the primary 
cleavage site of the pool, the cleavage catalyzed by 8S109 was at the predetermined site, C^C. t = 0, 15 
min, 2 h, and 22 h. (B) Sequences alignment of the enzyme regions of 8S109, 8S130, and 8S138. 
that cleaved at predetermined sites in each selection pool (X^Z, as seen in Figure 3.43). 
However, substantial side products were also observed. For example, in 8S1, 8T1, and 
8W1 pools, the predominant cleavage products were at the wrong site XZ^G. The relaxed 
control of cleavage sites of the deoxyribozyme pool was probably due to the idiosyncratic 
tolerance of T4 DNA ligase of a normally disfavored nucleotide overhang at the ligation 
site during the key capture step. Further MALDI-MS experiments confirmed the cleavage 
products as well as their hydrolytic mechanisms. 
3.2.3.2 Cloning and Sequences of the 8S1 and 8T1 Deoxyribozymes 
The cleavage activities of individual clones from 8S1 selection round were assayed. 
As observed in the pool assay, the majority of the clones catalyzed the cleavage at the 
undesired site. Out of the 50 clones, only nine clones catalyzed the cleavage at the 
desired C^C site (Figure 3.46A). All of the nine clones were sequenced, giving only three 
different sequences (Figure 3.46B). The three deoxyribozymes 8S109, 8S130, and 8S138 
were further characterized as solid-phase synthesized oligonucleotides. 
Furthermore, individual clones from the 8T1 selection were assayed for their cleavage 
activity. Although the in trans pool cleavage assay showed a roughly 1:1 distribution of 
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Figure 3.47. Cleavage activities and sequences of the 8T1 clones (A) Cleavage activities of two 
representative 8T1 clones, 8T102 and 8T107. Although the cleavage site of 8S107 was the primary 
cleavage site of the pool, the cleavage catalyzed by 8S102 was at the predetermined site, T^T. t = 0, 15 
min, 2, and 22 h. (B) Sequences alignment of the enzyme regions of 8T102 and 8T125. 
two cleavage sites, only four out of 23 clones were cleaving at the desired T^T site 
(Figure 3.47A). Sequencing of the four clones resulted in only two unique sequences, 
8T102 and 8T125 (Figure 3.47B). Both deoxyribozymes were then assayed to determine 
their substrate sequence generalities. 
3.2.3.3 Sequence Generality Studies of 8S1 and 8T1 Deoxyribozymes 
The five chosen deoxyribozymes identified from 8S1 and 8T1 selections were further 
characterized to determine their substrate sequence generalities. The experiments 
designed for these enzymes were essentially the same as in the studies of VHYR 
deoxyribozymes. The deoxyribozymes were initially synthesized with Tv2 binding arms 
and tested with Tv2 substrates. Only the enzymes that had substantial tolerance of the 
Tv2 substrates would move to systematic assays where they were tested with their parent 
substrates as well as all other substrates that were systematically varied. 
The three 8S1 deoxyribozymes were assayed with the DNA substrate that had all 
nucleotides beyond the unpaired C^C region varied to their Tv2 versions. However none 
of these enzymes tolerated the Tv2 substrate, indicating they were probably not 
sequence-general in the desired way (Figure 3.48A). Furthermore, only one 
deoxyribozyme from the 8T1 selection, 8T125, tolerated the Tv2 substrate with 75% 
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Figure 3.48. PAGE images of the 8S1 and 8T1 deoxyribozymes reacting with Tv2 substrates. t = 0, 
15 min, 2 h, and 20 h. (A) The 8S1 deoxyribozymes reacting with the Tv2 substrate that retained 
C^C dinucleotide. None of the enzymes tolerated Tv2 variation in the substrate. (B) The 8T1 
deoxyribozymes reacting with Tv2 substrate that retained T^T dinucleotide. Only 8T125 accepted 
Tv2 substrate with little reduction of cleavage yield. 
 
Figure 3.49. PAGE image of 8T125 reacting with the parent substrate as well as substrates with all 
three systematic variations. t = 0, 15 min, 2 h, and 22 h. 8T125 was able to achieve 6075% cleavage 
yield with all four substrates, showing its high substrate sequence generality of recognizing only the 
unpaired dinucleotide. 
cleavage yield in 20 h incubation (Figure 3.48B). The 8T125 deoxyribozyme was further 
characterized to determine its substrate sequence requirement. 
The 8T125 deoxyribozymes with four types of binding arms (Par, Tv2, Tsn, and Tv1) 
were then assayed with corresponding substrates that had all four types of nucleotide 
sequences beyond the retained T^T dinucleotide. The results showed that 8T125 was able 
to tolerate all four types of systematic variations, maintaining a cleavage yield of 6075% 
in 22 h (Figure 3.49). 
Additionally, the tolerance of 8T1 within the dinucleotide region was also tested. The 
two nucleotides immediately flanking the cleavage site were systematically mutated to 
other sequences, while the nucleotides beyond the unpaired dinucleotide were retained as 
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Figure 3.50. PAGE image of assays of 8T125 for generality at the two nucleotides immediately 
flanking the cleavage site, N^N. For each assay, t = 0, 15 min, 2 h, and 22 h. Above each set of lanes 
are the N^N nucleotides at the cleavage site in the assay (black = nucleotide present in substrate as 
used during selection; red = nucleotide changed from selection substrate). Substantial cleavage 
activity was also observed in T^G substrate. 
parent sequences. 8T125 showed substantial cleavage activity with substrate that had 
T^G unpaired as well as the parent T^T substrate (Figure 3.50). It was then concluded 
8T125 had a recognition site of T^K (K = T or G). 
Closer examination of the sequences of 8T125 deoxyribozyme and its substrate 
revealed two potential base pairing interactions that could contribute to substrate 
recognition of 8T125 (Figure 3.51A, red lines). To determine the role of these potential 
base pairing interactions, three A1B single mutants and three A40B single mutants of 
8T125 were synthesized, and their cleavage activities were tested with corresponding 
substrates in which the either nucleotide at the cleavage site was mutated to maintain the 
potential base pair. Surprisingly, the overall cleavage yields of 8T125 single mutants with 
corresponding single-mutant substrates were substantially higher than those of the parent 
8T125 deoxyribozyme with the single-mutant substrates (Figure 3.51B). In the cases of 
8T125-A1G with the C^T substrate, 8T125-A1T with the A^T substrate, and 8T125-
A40T with the T^A substrate, 5580% cleavage yields were observed. Although the 
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Figure 3.51. Assays to study the potential base pairing interactions between the N1 and N40 
nucleotides in 8T125 with the unpaired dinucleotide in the substrate. (A) Schematic of the potential 
base pairing interactions between 8T125 and the substrate. Notice that the A1 and A40 in 8T125 
can potentially base pair with the T^T dinucleotide. The red lines denote the potential base pairs. 
(B) Assays of A1B and A40B single mutants of 8T125 with single-mutant substrates. The unpaired 
nucleotides were listed above each assay. (Red denotes the mutation in the substrate. The 
corresponding nucleotide in 8T125 is mutated to maintain the base pair. Black denotes the retained 
nucleotide). t = 0, 15 min, 2 h, and 22 h. Notice that the cleavage yields were substantially higher in 
most cases compared to assays in Figure 3.50. (C) Assays of A1K/A40Y double mutants of 8T125 
with double-mutant substrates. The unpaired nucleotides were listed above each assay. (Red 
denotes the mutation in the substrate, and the corresponding nucleotides in 8T125 were mutated to 
maintain the base pair.). t = 0, 15 min, 2 h, and 22 h. 
parent 8T125 already tolerated the T^G substrate, 8T125-A40C substantially increased 
the rate of the cleavage reaction with T^G substrate. In the cases of 8T125-A1C with 
G^T substrate and 8T125-A40G reacting with T^C substrate, only modest increase in 
cleavage yield was observed. 
From the observations, it was speculated that the base pairing interactions of the first 
and 40th nucleotides in 8T125 with the unpaired dinucleotide in the substrate probably 
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contributed to the substrate recognition process. However, only A1G, A1T, A40T, and 
A40C mutations were well accepted by 8T125, but A1C and A40G mutations were not 
tolerated, possibly because these mutations disrupted with catalysis. Encouraged by these 
findings, four double mutants of 8T125, 8T125-A1G/A40T, 8T125-A1G/A40C, 8T125-
A1T/A40T, and 8T125 A1T/A40C, were synthesized and assayed to explore any 
additional substrate tolerance of 8T125 (Figure 3.51C). Interestingly, all four double 
mutants of 8T125 function very well with the corresponding double-mutant substrates, 
with only little relaxation of site specificity. However, the tolerances of systematic 
binding arm variations of 8T125 mutants were not assayed. 
3.2.3.4 Final Efforts to Identify the Complete Collection of ssDNA-Hydrolyzing 
Deoxyribozymes 
After series of selection experiments, a set of five deoxyribozymes have been 
identified that collectively recognize and cleave at 10 out of 16 dinucleotide sites (Figure 
3.52A). In order to complete the collection of DNA-hydrolyzing deoxyribozymes that 
can cleave any single-stranded DNA substrate at any predetermined site, a final set of 
new selection and reselection experiments were designed and performed. Two new 
selections were performed with substrates that had unpaired G^C and C^C, respectively, 
and six reselections were performed to improve the cleavage activities of 7VH6 with 
parent C^G substrate, 7VK55 with parent A^G substrate, 8VL51 with parent G^G 
substrate, 8T125 with parent T^T substrate, 8T125-A40T with A^T substrate, as well as 
8T125-A1T/A40T with A^A substrate. The key capture step was revised to take 
advantage of imperfection of T4 DNA ligase, so that only deoxyribozymes that catalyzed 
hydrolysis at the predetermined site would be captured (Figure 3.52B). 
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Figure 3.52. The complete set of substrate dinucleotide combinations and revised selection 
procedure. (A) The 16 possible substrate dinucleotides that ssDNA-hydrolyzing deoxyribozymes 
should collectively recognize and cleave. The blue boxes are the five dinucleotide recognition sites 
that have been covered by five ssDNA-hydrolyzing deoxyribozymes, 7VH6, 6YR25, 7VK55, 8VL51, 
and 8T125. The pink boxes are new dinucleotide recognition sites covered by 8T1 single mutants. 
The purple boxes are new recognition sites covered by 8T1 double mutants. The white boxes are the 
dinucleotide recognition sites that haven’t been covered. (B) The revised selection procedure. The 
blue line in the substrate denotes the desired cleavage site. The green and red lines denote the 
undesired cleavage sites one nucleotide to the 5ʹ or 3ʹ of the predetermined site. Notice that the 
splint in the capture step is designed to ligate the predetermined cleavage product to the acceptor 
oligonucleotide specifically. 
The new selection with a DNA substrate that had G^C unpaired was named BX1. 
3.2% cleavage was first observed at round 8, and round 13 pool was cloned with in cis 
pool activity of 42% (Figure 3.53A). The other new selection with C^C substrate was 
named BY1. The 6th round pool started showing 1.0% cleavage, which increased to 24% 
at round 9 (Figure 3.53B). The round 9 BY1 pool was then cloned. The reselection of 
7VH6 was named YQ selection and was cloned at round 4 (selection progression not 
shown). The reselection of 7VK55 was named as CA1 selection and was cloned at round 
8 with 43% pool cleavage activity (Figure 3.53C). The reselection of 8VL51 was named 
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Figure 3.53. Activity profiles of the new selections BX1 and BY1, as well as reselections CA1CE1. 
The arrows denote the rounds that are cloned. The activity profile of YQ is not shown here. (A) 
BX1 selection with G^C unpaired substrate nucleotides. (B) BY1 selection with C^C unpaired 
substrate nucleotides. (C) CA1 selection with A^G unpaired substrate nucleotides, which is the 
reselection of 7VK55. (D) CB1 selection with G^G unpaired substrate nucleotides, which is the 
reselection of 8VL51. (E) CC1 selection with T^T unpaired substrate nucleotides, which is the 
reselection of 8T125. (F) CD1 selection with A^T unpaired substrate nucleotides, which is the 
reselection of 8T125-A40T. (G) CE1 selection with A^A unpaired substrate nucleotides, which is 
the reselection of 8T125-A1T/A40T. 
CB1 selection, and was cloned at round 9 with 48% cleavage observed in the pool 
(Figure 3.53D). The three reselections of 8T125 and its single or double mutants were 
named CC1, CD1, and CE1, respectively. The CC1 selection was cloned at round 8 with 
46% pool yield (Figure 3.53E), the CD1 selection was cloned at round 11 with 28% pool 
activity (Figure 3.53F), and the CE1 selection was cloned at round 10 with 45% pool 
cleavage yield (Figure 3.53G). 
The individual clones from BX1-CE1 selections were assayed for their cleavage 
activities. Although a more stringent capture step was used to capture predetermined 
cleavage products, a substantial number of clones were still cleaving at sites other than 
the predetermined sites. Unfortunately, sequencing results of all the active clones with the 
correct cleavage sites showed significant signs of cross-contamination, probably because 
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all the selections shared the same design (same binding arms and very similar substrates 
which differed in two nucleotides at most). Only four unique sequences, 13BX103, 
9BY103, 8CA102, and 8CC101, were obtained and characterized further. However, none 
of these four deoxyribozymes showed any signs of high substrate sequence generalities. 
At this point, no promising approaches have been established to enable dsDNA 
substrate hydrolysis using ssDNA-hydrolyzing deoxyribozymes (Figure 3.1), even 
though extensive efforts toward efficient invasion of dsDNA hydrolysis with 
deoxyribozymes have been made. Meanwhile, in order to identify the complete set of 
sequence-general ssDNA-hydrolyzing deoxyribozymes, extensive selection and 
reselection experiments are still required with more complicated selection design, but the 
potential application of these ssDNA-hydrolyzing deoxyribozymes alone are limited. 
After evaluating the potential high risk and relatively low rewards, no more efforts are 
made to identify any new ssDNA-hydrolyzing deoxyribozymes.  
3.3 Summary 
Encouraged by the identification of the 10MD5 deoxyribozyme and the family of 
10MD5 variants, new selection experiments were designed and performed aiming for 
developing an in vitro selection approach to identify ssDNA-hydrolyzing 
deoxyribozymes that required recognizing only a few substrate nucleotides, while 
separate efforts were made in our lab to establish a strategy to enable dsDNA cleavage 
using ssDNA-hydrolyzing deoxyribozymes (Figure 3.1). 
A set of comprehensive selections were performed with substrates that had 09 
unpaired nucleotides between the two binding arms (Figure 3.2), in order to optimize the 
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number of unpaired substrate nucleotides for ssDNA-hydrolyzing deoxyribozymes. 
Except that the 17PA deoxyribozymes from the selection with a DNA substrate that had 
0 unpaired nucleotides were catalyzing deglycosylation reactions (Figure 3.9), all of the 
newly-identified deoxyribozymes catalyzed DNA hydrolysis (Table 3.1). The 13PB2 
deoxyribozyme identified from the selection with 1 unpaired substrate nucleotide had a 
2-nt substrate recognition site of C^G (Figure 3.15), but the deoxyribozymes identified 
from selection with substrates that had 3, 6, or 9 unpaired nucleotides clearly had longer 
substrate recognition sites (Figure 3.16, 3.17, and 3.18), indicating further selection 
experiments should be performed using DNA substrates that had 1 or 2 unpaired 
nucleotides. 
Two sets of four new selections were performed to determine the distribution of 
potential cleavage sites. Each set of four selections were performed with substrates that 
had either X or X^G unpaired nucleotide(s) (X = any of A, T, C, G). Several cleavage 
sites were observed in each new selection (Figure 3.19), suggesting that selection 
pressures for predetermined cleavage sites were required. A set of four new selections 
were then performed with a revised selection procedure with a key capture step specific 
for deoxyribozymes that catalyzed cleavage around the predetermined site with the 
formation of 5ʹ-phosphate (Figure 3.20). As a result, a set of four ssDNA-hydrolyzing 
deoxyribozymes were identified, which recognized merely the unpaired dinucleotide in 
the substrate. The 7VH6 deoxyribozyme had a dinucleotide recognition site of C^G 
(Figure 3.28). The 8VJ17 deoxyribozyme had a recognition site of T^G (Figure 3.31). 
The reselected 8VJ17 variant, 6YR25 showed significantly improved cleavage activity 
while retaining the recognition site of T^G (Figure 3.41). The 7VK55 deoxyribozyme 
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tolerated both A^G and C^G substrates, indicating its recognition site was M^G (M = A 
or C, Figure 3.34). Additionally, the 8VL51 deoxyribozyme required recognizing only 
G^G in the substrates (Figure 3.37). In general, an in vitro selection approach was 
established to identify ssDNA- hydrolyzing deoxyribozymes that recognized at most two 
nucleotides in the substrates. The initial set of four deoxyribozymes collectively 
recognized N^G sites in any single-stranded DNA substrates. 
Two additional sets of two new selection were performed with DNA substrates that 
had C^C or T^T unpaired nucleotides. The essentially same selection procedure was 
applied to one set of two selections, while a revised selection procedure was applied to 
one set of selections which specifically captured deoxyribozymes hydrolyzing DNA 
substrates at the predetermined site (Figure 3.43). However, only the selections using the 
original selection strategy were cloned, and the resulting deoxyribozymes were 
characterized to determine their substrate sequence generalities. Although none of the 
8S1 deoxyribozymes were sequence general, the 8T125 deoxyribozyme had a 
recognition site of T^K (K = T or G, Figure 3.49 and 3.50). Further examination of the 
enzyme sequence revealed two potential base pairs between the N1 and N40 positions 
and unpaired dinucleotide in the substrate (Figure 3.51A). It was shown that the A1 
position of 8T125 could be mutated to G or T, and the A40 position of 8T125 could be 
mutated to T or C (Figure 3.51B). And 8T125 tolerated substrates that had unpaired C^T, 
A^T, T^A, T^G, C^A, C^G, A^A, and A^G dinucleotides (Figure 3.51C). 
At this point, five deoxyribozymes have been identified that collectively recognized 
10 out of 16 possible sites (Figure 3.52A). Although extensive new selection and 
reselection experiments were performed, significant cross-contamination was observed 
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among all selection experiments, and no new sequence-general DNA-hydrolyzing 
deoxyribozymes were identified. The efforts to identify new sequence-general 
deoxyribozymes were then stopped because of the lack of promising strategy of dsDNA 
hydrolysis by ssDNA-hydrolyzing deoxyribozymes and the limited application of 
ssDNA-hydrolyzing deoxyribozymes alone. The research focus was shifted to targeting 
the intact double-stranded DNA substrates for hydrolysis. 
3.4 Materials and Methods 
3.4.1 Oligonucleotides and In Vitro Selections 
All standard oligonucleotides were prepared by solid-phase synthesis at IDT 
(Coralville, IA) and purified by denaturing 20% or 8% PAGE. The selection pools were 
prepared by solid-phase synthesis on an ABI 394 DNA synthesizer, similarly to the 
procedure described in Chapter 2, except that the pre-mixture was made by mixing four 
phosphoramidites equally. The pool strand for the PAPD and RQRT selections was 5ʹ-
CGAAGTCGCCATCTCTTC-N40-ATAGTGAGTCGTATTA-3ʹ. The pool strand for the NN, NP, 
RVRY, VHVL, S1-V1, BX1 and BY1 selections was 5ʹ-CGAAGTCGCCATCTCTTC-N40-
ATAGTGAGTCGTATTAAGCTGATCCTGATGG-3ʹ. The reselection pool was synthesized the same 
way as described in Chapter 2. The reselection pool strand was 5ʹ-CGAAGTCGCCATCTCTTC-
partially randomized region-ATAGTGAGTCGTATTAAGCTGATCCTGATGG-3ʹ.The pools were purified 
by 8% denaturing PAGE. 
All selections described in this chapter were performed essentially the same way as 
described previously in Chapter 2. For selections PANP, the substrate sequences were 
5ʹ-TAATACGACTCACTAT-(unpaired)-GAAGAGATGGCGACgga-3ʹ, where the unpaired nucleotides 
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were as listed in Figure 3.2. These were the parent substrate sequences, whereas the 
nucleotides in the binding arms were different in the substrates with systematic sequence 
changes as described in the assays. The two PCR primers used during selection were 5ʹ-
CGAAGTCGCCATCTCTTC-3ʹ (5ʹ-phosphorylated) and 5ʹ-(AAC)4XCCATCAGGATCAGCT-3ʹ.The 
substrates for RVRY, RQRT, VHVL, YR, S1T1, and BX1CE1 were similar to the 
substrates used in PANP selections, and the unpaired nucleotides were as listed in the 
corresponding activity profiles. The sequence of the substrates used in V1 and W1 
selections were 5ʹ-GGATAATACGACTCACTAT-(unpaired)-GAAGAGATGGCGACddC-3ʹ (5ʹ-
phosphorylated to enable T4 DNA ligation, and 3ʹ blocked from further modifications). 
For the selections that incorporated splint ligation pressure (VHVL, YR, Figure 
3.20), the splint ligation step was performed as follows. The selection sample was 
precipitated with ethanol and redissolved in 17 L total volume containing 5 mM Tris, 
pH 7.5, 15 mM NaCl and 0.1 mM EDTA along with 50 pmol of splint oligonucleotide 
and 75 pmol of acceptor oligonucleotide. The sample was annealed by heating at 95 ºC 
for 3 min and cooling on ice for 5 min. The sample was then brought to 20 L total 
volume containing 1× T4 DNA ligase buffer and 1 U of T4 DNA ligase (Fermentas), 
incubated for 1 h at 37 ºC, and separated by 8% PAGE. The splint was 5ʹ-
TTCGTCCCAGCGGTAGAGAAC-(C)-GCGCTGTCTGATGCGGC-3ʹ, where the unpaired C was 
complementary to the single unpaired 5ʹ-G that remained on the DNA substrate after 
DNA-catalyzed hydrolysis at the X^G position. The acceptor oligonucleotide for the 
splint ligation reaction was 5ʹ-(AAC)5AAGGCCGCATCAGACAGCGC-3ʹ, where the underlined 
nucleotides were complimentary to the splint. For the S1T1 selections, the same capture 
 142 
reaction protocol and acceptor oligonucleotide were used, but the splint had different 
unpaired nucleotides G or A instead of C. 
For the V1 and W1 selections that incorporated a modified splint ligation pressure as 
depicted in Figure 3.43, the splint ligation step was performed essentially the same as 
described above. Instead of an acceptor, a donor oligonucleotide was used. The splint was 
5ʹ-ATCCTGATAACGAGAGGC-(X)-ATAGTGAGTCGTATTATCCTCCATCAGGATCAGCT-3ʹ, where X is G 
or A to base pair with the 3ʹ-C or T remained on the DNA substrate after cleavage at the 
X^Z site. The donor oligonucleotide was 5ʹ-GCCTCTCGTTATCAGGAT(AAC)6-3ʹ (5ʹ-
phosphorylated to enable splint ligation), where the underlined nucleotides were 
complimentary to the splint. 
For selections BX1-CE1, another modified splint ligation pressure was applied as 
depicted in Figure 3.51B. The splint ligation reaction was performed essentially the same 
as described above. The splint was 5ʹ-TTCGTCCGTCGCCATCTCTTC-(T)-GTGCTGTCTGATGCGGC-
3ʹ, where T was specially introduced to capture predetermined hydrolysis product 
preferably. The acceptor oligonucleotide was 5ʹ-(AAC)5AAGGCCGCATCAGACAGCAC-3ʹ, where 
the underlined nucleotides were complimentary with the splint. 
The pool cloning, initial screening and sequencing procedures were the same as 
described in Chapter 2.  
3.4.2 Single-Turnover In Trans Cleavage Assays of the Pools 
The DNA substrate was 5′-32P-radiolabeled using -32P-ATP and T4 PNK 
(Fermentas). The PCR reactions of the uncloned pools were performed in 200 L volume 
containing both primers, 0.2 mM each of dATP, dTTP, dGTP, and dCTP, 1× Taq buffer 
and Taq polymerase. The PCR reaction repeated 30 cycles of 94 ºC, 30 s; 47 ºC, 30 s; 72 
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ºC, 30 s. The PCR products were purified by 8% denaturing PAGE and extracted with 
TEN buffer, ethanol precipitated, and redissolved in 8 L of water. 
A 10 L sample containing 0.2 pmol of DNA substrate and 4 L of redissolved pools 
was annealed in 5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 
95 °C for 3 min and cooling on ice for 5 min. The cleavage reaction was initiated by 
addition of metal stock solutions, so that the 20 L final sample contained 70 mM 
HEPES at pH 7.5, 150 mM NaCl, 40 mM MgCl2, 20 mM MnCl2, and 1 mM ZnCl2. 
MnCl2 was added from a 10× stock solution of 200 mM MnCl2. ZnCl2 was added from a 
10× stock solution containing 20 mM ZnCl2, 20 mM HNO3, and 200 mM HEPES at pH 
7.5. The stock was freshly prepared from 100× stock solution of 100 mM ZnCl2 in 200 
mM HNO3. The metal stocks were added last to the final samples, and the reactions were 
incubated at 37 °C overnight. The reactions were quenched with 20 L of stop solution. 
The samples were separated by 20% PAGE and quantified with a PhosphorImager. 
3.4.3 Single-Turnover Cleavage Assays of Individual Deoxyribozymes 
The single-turnover cleavage assays of individual deoxyribozymes were performed 
similarly as the uncloned pool. A 10 L sample containing 0.2 pmol of DNA substrate 
(parent or systematically varied as designed) and 20 pmol of deoxyribozymes (parent, 
systematically varied, or mutants as designed) was annealed in 5 mM HEPES, pH 7.5, 15 
mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min and cooling on ice for 5 min. 
The cleavage reaction was initiated by addition of metal stock solutions, so that the 20 L 
final sample contained 70 mM HEPES at pH 7.5, 150 mM NaCl, 40 mM MgCl2, 20 mM 
MnCl2, and 1 mM ZnCl2. MnCl2 was added from a 10× stock solution containing 200 
mM MnCl2. ZnCl2 was added from a 10× stock solution containing 20 mM ZnCl2, 20 
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mM HNO3, and 200 mM HEPES at pH 7.5. The stock was freshly prepared from 100× 
stock solution of 100 mM ZnCl2 in 200 mM HNO3. The metal ion stocks were added last 
to the final sample, which was divided into 2 L aliquots that were incubated at 37 °C. At 
appropriate times, aliquots were quenched with 5 L of stop solution. Samples were 
separated by 20% PAGE and quantified with a PhosphorImager. Values of kobs and final 
yield were obtained by fitting the yield versus time data directly to first-order kinetics, 
i.e., yield = Y(1 - e
-kt
), where k = kobs and Y = final yield. 
3.4.4 Mass Spectrometry Experiment Procedure 
Larger-scale cleavage reactions of the substrates provided the products for MALDI 
mass spectrometry analysis. The procedure for large-scale cleavage reactions was as 
follows. A 20 L sample containing 100 pmol of substrate and 200 pmol of 
deoxyribozyme (or the PCR reaction product of an uncloned pool) was annealed in 5 mM 
HEPES at pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min and 
cooling on ice for 5 min. The cleavage reaction was initiated by addition of metal stock 
solutions, so that the 40 L final sample contained 70 mM HEPES at pH 7.5, 150 mM 
NaCl, 40 mM MgCl2 20 mM MnCl2, and 1 mM ZnCl2. The reaction was incubated at 
37 °C for 12 h, and the sample was precipitated by adding 60 L of water, 10 L of 3M 
NaCl, and 330 L of ethanol. A portion of the redissolved sample was zip-tipped and 
used directly for MALDI mass spectrometry analysis in 3-hydroxypicolinic acid (3-HPA) 
matrix. All MALDI mass spectrometry analysis was performed in the mass spectrometry 
laboratory of the UIUC School of Chemical Sciences. 
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Figure 4.1. Strategies proposed and tested for double-stranded DNA invasion. (A) Invasion of a 
PNA (peptide nucleic acid) oligonucleotide assisted by SSB (ssDNA-binding protein). Because PNA 
binds DNA tighter than conventional DNA, the PNA oligonucleotide will invade the double-
stranded DNA, and the SSB will bind the other single-stranded DNA to stabilize the invasion. (B) 
Invasion by targeting oligonucleotide assisted by RecA (recombination protein A). The targeting 
oligonucleotide can be conventional DNA, or other synthetic nucleic acids. (C) Strategy of double-
stranded DNA linearization using two ssDNA-hydrolyzing deoxyribozymes that have LNA (locked 
nucleic acid) modifications in the binding arms. Similar to PNA, LNA is also known to bind DNA 
tighter. The deoxyribozymes function with only one binding arm, and the design minimizes the 
undesired interaction between the two deoxyribozymes. 
Chapter 4: Current Efforts Toward Targeting Intact Double-Stranded 
DNA Substrates for Hydrolysis 
4.1 Introduction 
In this project, systematic experiments are performed in order to develop an in vitro 
selection approach to identify deoxyribozymes that target an intact double-stranded DNA 
substrate for hydrolysis. The designed selection approach includes the incorporation of a 
dsDNA-binding protein to assist the targeting of the double-stranded DNA substrate. 
The previously designed strategy of hydrolyzing a double-stranded DNA substrate 
using ssDNA-hydrolyzing deoxyribozymes requires the separation of the double-stranded 
DNA substrate into two single-stranded DNA substrates (Figure 3.1). This separation 
process cannot be achieved with plain deoxyribozymes because it is energetically 
disfavored. Several strategies to enable double-stranded DNA invasion have been 
proposed and tested, including invasion assisted by PNA oligonucleotide and ssDNA-
binding protein (Figure 4.1A),
1
 invasion assisted by recombination protein (Figure 
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Figure 4.2. Three strategies of targeting intact double-stranded DNA substrate for cleavage. (A) 
Targeting double-stranded DNA substrate by small molecule-DNA interaction. The dsDNA-
cleaving deoxyribozyme has a small-molecule dsDNA binder incorporated to bind the substrate, 
whereas the enzyme region is responsible for the cleavage of the substrate. (B) Targeting by triplex 
formation. The binding arm of the dsDNA-cleaving deoxyribozyme is specially designed to bind a 
specific double-stranded DNA sequence via triplex interaction. (C) Targeting by proteinDNA 
interaction. A dsDNA-binding protein is incorporated to the dsDNA-cleaving deoxyribozyme to 
enable the binding of the substrate, while the deoxyribozyme catalyzes the cleavage reaction. 
4.1B),
2
 and invasion by ssDNA-hydrolyzing deoxyribozymes that have LNA 
modifications in the binding arm (Figure 4.1C),
3
 etc. However, none of these strategies 
result in promising double-stranded DNA invasion due to various practical reasons. 
An alternative strategy to enable double-stranded DNA cleavage is to target the intact 
double-stranded DNA for cleavage. In order to achieve this objective, a completely 
different basis of substrateenzyme interaction is required, which does not rely on 
WatsonCrick base pairing. There are three ways to target double-stranded DNA: 
targeting based on small moleculeDNA interactions (Figure 4.2A), targeting via triplex 
formation (Figure 4.2B), and targeting assisted by dsDNA-binding protein (Figure 4.2C). 
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Figure 4.3. Natural small-molecule dsDNA binders. (A) Actinomycin D that preferably binds GC-
rich DNA. (B) Echinomycin that intercalates into DNA at two specific sites to block the binding of 
hypoxia factor 1 (HIF). (C) A representative calicheamicin molecule, calicheamicin 1. It binds 
with DNA in the minor groove, where it undergoes a reaction analogous to Bergman cyclization, 
generating diradicals to cause DNA strand scission. 
Nature has evolved a number of small molecules, such as actinomycin, echinomycin, 
and calicheamicins, which bind to specific DNA sequences (Figure 4.3).
4
 These small 
molecules are antibiotics that usually also show anti-cancer activities by inhibiting 
transcription or DNA replication. These small molecules have inspired scientists to 
develop new synthetic small-molecule dsDNA intercalators and dsDNA groove binders. 
Of all the synthetic dsDNA binders, DNA-binding polyamides are the most well 
known. These polyamides recognize the DNA minor groove sequence specifically.
5
 The 
polyamide DNA binders consist of N-methylimidazole (Im), N-methylpyrrole (Py), and 
N-methyl-3-hydroxy-pyrrole (Hp). These monomers can be combined to recognize 
specifically each of the four Watson-Crick base pairs. The Im/Py is specific for G·C and 
Hp/Py is specific for T·A. (Figure 4.4).6 The binding to DNA is driven by a combination 
of van der Waals and hydrogen-bonding interactions. The polyamides are highly 
modular, so a specific binder can be designed to interact with a specific double-stranded 
DNA sequence. Covalently linking the two antiparallel polyamide strands results in 
stronger binding and higher specificity. The currently standard motif is the eight-ring 
hairpin, in which a -aminobutyric acid linker connects the carboxylic terminus of one 
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Figure 4.4. Binding model of a representative polyamide conjugate. The two polyamide molecules are 
linked by a -aminobutyric acid linker. Hydrogen bonds are shown as dashed lines. Adapted from 
Ref. 6 with permission.  
polyamide to the amino terminus of another (Figure 4.4). Eight-ring hairpins that bind six 
base pairs have been shown to have affinity and specificity similar to those of DNA-
binding proteins (i.e. Kd < 1 nM).
7
 
Polyamide DNA binders have been shown to modify gene expression by inhibiting 
key transcription factorDNA complex which interferes with the recruitment of RNA 
polymerases.
8
 They have also been shown to upregulate transcription by either depression 
or recruitment of transcriptional machinery.
9
 However, the application of polyamides is 
still limited due to the extensive organic synthesis required to produce large quantities of 
customized binders. Solid-phase synthesis methods of polyamides have been 
developed,
10
 but the methods require complicated synthetic work to produce the 
monomers. The inconvenience of obtaining polyamides limited their applications in 
biological labs. 
In addition to small-molecule DNA-binders, specific DNA oligonucleotides also have 
the ability to recognize double-stranded DNA by forming stable triplex structure. It has 
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Figure 4.5. Base triads of triplexes. (A) Canonical base triads of YR*Y triplexes: TA*T and CG*C
+
. 
(B) Base triads of YR*R triplexes: CG*G, TA*A, TA*T, and CG*A
+
. Reprinted from Ref. 13 with 
permission. 
been shown that double helices containing only purines in one strand can bind to a third 
polynucleotide containing either pyrimidines [YR*Y, Figure 4.5A]
11
 or purines (YR*R, 
Figure 4.5B).
12
  
The building blocks of YR*Y triplexes are the canonical CG*C and TA*T triads 
shown in Figure 4.5A. The triplex-forming strand must be located in the major groove of 
the double helix and forms Hoogsteen hydrogen bonds with the purine strand of the 
duplex. The dual requirements limit YR*Y triplexes to homopurine-homopyrimidine 
sequences in the DNA. An important feature of the YR*Y triplexes is that the formation 
of CG*C
+
 triad requires the N3 of cytosine in the triplex-forming strand to be protonated, 
so such triplexes are favorable under acidic conditions. 
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YR*R triplexes are more versatile than YR*Y triplexes, as shown in Figure 4.5B. Not 
only the canonical CG*G and TA*A base triads can be incorporated into triplexes, TA*T 
and CG*A
+
 base triads can also be incorporated.
12
 Therefore, in YR*R triplexes, the third 
strand may consist of three bases, G, A, and T, where the guanines oppose guanines in 
the duplex, while adenines or thymines must oppose adenines of the duplex. CG*G, 
TA*A, and TA*T triads require reverse Hoogsteen base pairs to form reasonable stacking 
interactions. The stability of YR*R triplexes is dependent on the triplex sequence. For 
example, the stability of triplexes composed of alternating CG*G and TA*T triads is 
higher than of triplexes built of CG*G and TA*A triads. Additionally, the stability of 
YR*R triplexes greatly depends on the presence of divalent metal ions.
14
 
The high specificity of triplex formation offers a useful approach for the modification 
of gene structure and function both in vitro and in vivo. In fact, triplex formation can be 
applied to modulate transcription in vitro by interfering with either the binding of 
transcription factors
15
 or the formation of the initiation complex.
16
 It can also arrest 
transcription elongation by binding to the transcribed position of the targeted gene.
17
 
Triplex-forming oligonucleotides have also been shown to inhibit the DNA replication 
process,
18
 and to induce site-specific DNA damage.
19
 
However, the application of triplex formation is also limited. First of all, the 
formation of triplexes is limited to the homopurine-homopyrimidine sequences or to 
sequences with adjacent oligopurine/oligopyrimidine clusters. Therefore, triplex 
interactions can only be used to target a small amount of specific sequences. 
Additionally, triplexes, especially YR*R triplexes, require high concentrations of divalent 
metal ions which are not likely in cells. Numerous ways to stabilize triplex interactions 
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Figure 4.6. Common structural domains of dsDNA-binding proteins. (A) Zinc finger domain. Shown 
here is the Zif-268 protein (PDB ID: 1ZAA), which consists of three C2H2 zinc finger domains and 
recognizes 5ʹ-GCG TGG GCG-3ʹ. (B) Helix-turn-helix domain. Shown here is the Antp homeodomain 
(PDB ID: 9ANT), which recognizes 5ʹ-TAATGG-3ʹ region of DNA. (C) Helix-loop-helix domain. 
Shown here is the basic/helix-loop-helix/leucine zipper domains of the heterodimer of Myc-Max and 
Mad-Max (PDB ID: 1NKP), which target 5ʹ-CACGTG-3ʹ. (D) Leucine zipper domain. Shown here is 
the GCN4 basic region leucine zipper (PDB ID: 1YSA) that recognizes 5ʹ-ATGACTCAT-3ʹ (E) TALE 
domain. Shown here is dHax3-TALE protein (PDB ID: 4GG4) that recognizes 5ʹ-TCCCTTTA-
TCTCT-3ʹ. 
with low concentrations of metal ions have been developed, but these methods make 
triplex formation in vivo more complicated. 
In nature, the most predominant way to target double-stranded DNA is by dsDNA-
binding proteins. These proteins, such as transcription factors, polymerases, nucleases, 
and histones, generally interact with double-stranded DNA to support further cellular 
processes or further functions of particular enzymes. Many DNA-binding proteins 
incorporated structural domains such as zinc finger (Figure 4.6A),
20
 helix-turn-helix 
(Figure 4.6B),
21
 helix-loop-helix (Figure 4.6C),
22
 and leucine zipper (Figure 4.6D).
23
 
Recently, the determination of structures of transcription activator like effectors (TALEs) 
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introduces a new type of DNA binding domain (Figure 4.6E).
24
 The recognition of DNA 
sequences by dsDNA-binding proteins is usually achieved by a series of interactions such 
as hydrogen bonding and van der Waals interactions. 
Of all types of dsDNA-binding proteins, zinc-finger proteins and TALE proteins are 
of special interest due to their modular structure. Zinc fingers are the most common 
DNA-binding motifs in the human genome and consist of 30 amino acids in a 
configuration stabilized by chelation of a zinc ion by the conserved Cys2His2 
residues, where the  helix projects into the major groove of DNA and recognizes 3 
contiguous nucleotide bases (Figure 4.6A). Due to its relatively simple structure and short 
recognition code, scientists have been working on potential general recognition codes of 
zinc finger proteins. In fact, it has been shown that zinc finger proteins are highly 
modular.
25
 The key amino acid residues that are responsible for sequence-specific 
interactions with the DNA target can be changed to generate different recognition 
sequences. Since then, the DNA-binding specificities of synthetic zinc finger domains 
have been extensively engineered through site-directed mutagenesis, rational design or 
the selection of large combinatorial libraries. Collectively, these efforts have yielded 
unique zinc finger domains with specificity for almost all of the 64 (4
3
) possible 
nucleotide triplets.
26
 The modular structure of the zinc finger motif permits the 
conjugation of several motifs in series and the recognition of extended sequences in 
multiples of triplets. It also offers wide applications such as construction of artificial 
transcription factors and development of customized artificial nuclease composed of 
targeting zinc finger motifs and general nuclease such as FokI. These artificial nucleases 
are called zinc-finger nucleases (ZFNs). 
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Engineered zinc-finger nucleases have been successfully applied to gene editing in 
many species and cell types. However, there are still several problems with this 
technology. First of all, a collection of 64 specific zinc finger motifs are needed to 
recognize all possible DNA triplets, but extensive zinc finger protein engineering is 
required to reach that goal. Only big companies like Sigma-Aldrich (CompoZr ZFNs) 
and collaborated academic teams have the resources to perform the extensive protein 
engineering. As a result, the commercially available zinc-finger nucleases are usually 
extremely expensive. Secondly, although zinc finger proteins have modular structure, it is 
not very possible to target any desired DNA sequences. Currently the zinc finger proteins 
used as engineering scaffolds all have G-rich consensus sequences, because G-rich 
sequences are the natural preference of zinc fingers. Assembly of fingers for other types 
of targets is frequently unsuccessful.
27
 Furthermore, it is also very difficult to conjugate 
several zinc finger domains together to achieve recognition of longer DNA sequences, 
because individual zinc finger domains have to be positioned in the appropriate 
orientation, with correct spacing. Finally, the gap between the recognition sequences of 
zinc finger domains is usually 5 to 7 bp, which also constraints the engineering of zinc 
finger nucleases. In order to relax the constraint, a longer linker between zinc finger 
protein and the nuclease can be used, at the expense of increasing binding promiscuity 
resulted from accompanying many different gap lengths.
28
 The restriction of target choice 
can also lead to potential off-target cleavage which is not desirable when targeting an 
exact base position is required. 
The recent discovery of recognition codes of TALE proteins has offered an 
alternative option of customizable dsDNA-binding protein engineering.
29
 In contrast with 
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Figure 4.7. TALE DNA recognition. Shown here are the DNA-targeting domain of TALE PthXo1 of 
X. oryzae and its target in the rice genome. The yellow texts are different pairs of repeat-variable 
diresidues at position 12 and 13 that associate preferably with one or more of the four nucleotides. 
Adapted from Ref. 30 with permission. 
zinc finger domains of 30 amino acids that recognize three base pairs, each TALE 
domain consists of 34 amino acids and recognizes only a single base pair. Interestingly, 
the DNA binding preference by each domain is determined by only two hypervariable 
amino acids in positions 12 and 13, called repeat-variable diresidues (Figure 4.6E and 
Figure 4.7).
30
 Similar to zinc finger proteins, TALEs are highly modular, and TALE 
domains can be conjugated together to recognize extended DNA sequences. The 
engineered TALE assemblies can be used to construct artificial transcription factors and 
artificial nucleases. The high sequence conservation among different TALE repeats as 
well as the unique single base pair recognition have led many to think TALE may be 
more amenable to reengineering. In fact, methods have been developed to enable the 
assembly of custom TALE arrays.
31
 
Artificial nucleases constructed with custom TALEs and general nucleases have been 
successfully engineered, and they have demonstrated the great potential in targeted 
genome engineering.
31b, 32
 However, there are still some concerns about TALE nucleases 
because TALEs are not as thoroughly studied as zinc finger proteins. For example, TALE 
nucleases also face the similar off-target problem due to the dimerization of natural 
nucleases or the linker between the recognition domain and the nuclease. Although the 
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nuclease has been engineered,
33
 and the linker length between the nuclease and TALE 
has been optimized,
34
 the off-target problem is only reduced but not eliminated. 
Additionally, the whole genome specificity of TALE proteins has not been established. 
Recent studies have shown that TALEs tolerate mismatches in their respective 
recognition sequences.
35
 
The identification of series of ssDNA-hydrolyzing deoxyribozymes has shown that 
DNA has the capability of catalyzing sequence-specific DNA hydrolysis. The ultimate 
goal of this project is to identify deoxyribozymes that hydrolyze double-stranded DNA 
sequence-specifically with the aid of targeting molecules. The ideal dsDNA-hydrolyzing 
deoxyribozymes should be able to cleave the intact double-stranded DNA and recognize 
only a couple of nucleotides at the cleavage site. Compared to current ZFNs and 
TALENs, the chimeric nucleases constructed by dsDNA-hydrolyzing deoxyribozymes 
and targeting molecules have some advantages. First of all, dsDNA-hydrolyzing 
deoxyribozymes function as monomers, so double-stranded DNA targets can be chosen 
with fewer constraints. Additionally, the deoxyribozymes themselves are sequence-
specific, so the off-target activity due to the lack of specificity of natural nucleases can be 
greatly reduced. However, the proposed chimeric nucleases have big limitations because 
they only function in vitro. 
In order to achieve double-stranded DNA hydrolysis by deoxyribozymes, two 
targeting strategies, triplex formation (Figure 4.2B) and dsDNA-binding protein (Figure 
4.2C), have been designed and applied, but only the targeting strategy using dsDNA-
binding protein is discussed here. The chosen dsDNA-binding protein is dHax3-TALE 
protein that recognizes 5ʹ-TCCCTTTATCTCT-3ʹ. 
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Figure 4.8. Design of in vitro selection experiment for double-stranded DNA hydrolysis with the aid 
of dHax3-TALE protein. The selection pool has a random region of 20, 30, or 40 nucleotides. The 5ʹ 
end of the pool is modified to enable conjugation with the protein. The substrate is a long stem-loop 
containing the designed cleavage site (C^G, purple), the TALE binding region (blue), and a 
stabilizing tetra loop (red). The TALE protein needs to be modified to introduce a functional tag to 
enable conjugation with the DNA pool. After conjugation, selection is performed, followed by splint 
ligation capture by T4 DNA ligase with a donor oligonucleotide.  
4.2 Results and Discussion 
4.2.1 In Vitro Selection Strategy to Identify Deoxyribozymes that Hydrolyze Double-
Stranded DNA with the Aid of dHax3-TALE 
In order to identify deoxyribozymes that hydrolyze double-stranded DNA substrates 
with the aid of dHax3-TALE protein, an in vitro selection strategy was designed (Figure 
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4.8). The concept of this strategy is similar to the one used for identification of ssDNA-
hydrolyzing deoxyribozymes, but the exact procedure is different.  
The pools of in vitro selections for double-stranded DNA hydrolysis with the aid of 
the TALE protein are specially designed. The random region of the pool can be 20, 30, or 
40 nucleotides long, based on a recent report that ssDNA-hydrolyzing deoxyribozymes 
were more readily identified from selection pools that have 20-, 30-, and 40-nt random 
regions.
36
 The 5ʹ end of the pool is modified to enable conjugation between the pool and 
the TALE protein. The substrate is a specially designed stem-loop containing a 
predetermined cleavage site C^G (purple nucleotides in Figure 4.8), the TALE 
recognition region (blue nucleotides in Figure 4.8), and a stabilizing tetra loop (red loop 
in Figure 4.8). The substrate also has a 3-nt overhang and 5ʹ-phosphate to enable ligation 
to the pool by T4 DNA ligase. 
The TALE protein will be chemically treated to introduce a functional tag to enable 
further bio-conjugation and then reacted with the ligated pool to form the poolprotein 
conjugate. The complex will be incubated in a certain buffer with various metal ions to 
allow DNA hydrolysis. After the selection, the reaction mixture will be purified to 
remove the protein and the uncleaved starting material. A splint ligation by T4 DNA 
ligase will then occur to capture 3ʹ-hydroxyl terminus at the predetermined cleavage site 
using a 5ʹ phosphorylated donor oligonucleotide. The selection pools will be regenerated 
by PCR, during which a modified forward primer will be used to regenerate the 5ʹ 
modification on the pool. 
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Figure 4.9. Assays to validate splint ligation of double-stranded DNA substrate to the selection 
pools. Splint ligations under round 1 and round 2+ conditions are tested. In round 1assays, 100 
pmol of the dsDNA substrate is ligated to 200 pmol of the pools. In round 2+ assays, 20 pmol of the 
substrate is ligated to 75 pmol of the pools. t = 30s, 1 h, 2 h, and 14 h. 
4.2.2 Validation of Selection Procedures Excluding the Protein 
The selection steps during which the TALE protein was not involved were validated. 
First of all, the designed splint ligation between the stem-loop substrate and the selection 
pool was feasible. The ligation reactions were complete in 1 h (Figure 4.9). 
To validate the splint ligation capture step, various capture reactions were tested with 
three potential hydrolysis products (one predetermined product and two side products that 
were one nucleotide away from the predetermined site) and four different splints, each of 
which has one of A, T, C, and G opposing the 3ʹ-C remained at the predetermined site. 
The purpose of the test was to determine the sequence of the splint that can capture as 
many hydrolysis products as possible to increase the chance of identifying dsDNA-
hydrolyzing deoxyribozymes. The results showed that none of the four splints were able 
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Figure 4.10. Validation of capture reactions with three potential hydrolysis products and four 
splints. The nucleotides in the splint (N) are marked above each assay. Each combination is tested 
with N20, N30, or N40 pool. t = 30 s, 1 h, and 3 h. (A) Capture reaction of side product with 3ʹ-T. The 
hydrolysis site is one nucleotide to the 5ʹ end of the predetermined site. (B) Capture reaction of side 
product with 3ʹ-TCG. The hydrolysis site is one nucleotide to the 3ʹ end of the predetermined site. 
(C) Capture reaction of predetermined site with 3ʹ-TC. 
to capture either side product very well (Figure 4.10A and B). The only splint that 
captured predetermined hydrolysis product with high efficiency was the splint that had G 
to base pair with terminal C in the product (Figure 4.10C). Therefore, the G-splint was 
chosen in the selections to ensure efficient capture of the predetermined product. 
4.2.3 Verification of Selection Conditions 
The previously established selection condition to identify ssDNA-hydrolyzing 
deoxyribozymes is 1 mM Zn
2+
, 40 mM Mg
2+
, and 20 mM Mn
2+
 in 70 mM HEPES pH 7.5 
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Figure 4.11. Fluorescence anisotropy assays to determine pH and metal ion dependence of the 
TALE protein. Fluorescence anisotropy (A) is a quantitative measurement of polarization. The 
higher the value, the more polarized the emitted light is. In this case, the higher the anisotropy is, 
the stronger the binding interaction is between the DNA duplex and the TALE protein. The data 
points are fit to mA = 1000×[Af +(Ab-Af)×RT/(Kd+RT)], where Af is the anisotropy of free duplex, Ab 
is anisotropy of duplex-protein complex, RT is the total concentration of TALE protein, and Kd is 
the dissociation constant of TALE. In the assay, the duplex concentration is fixed at 20 nM, and the 
concentration of buffer is fixed at 0.1 M. The counter-ion of metal ions is OAc
-
 due to the sensitivity 
of TALE to Cl
-
. The incubation temperature is 37 °C. (A) pH dependence of TALE protein. The 
reported condition of TALE is 0.1 M MES pH 6.0. Increasing the pH of buffer decreases the binding 
of TALE to the target DNA duplex. (B) Binding assays of TALE with different metal ions at pH 7.5. 
Increasing the pH from 6.0 (blue) to 7.5 (yellow) decreases the binding, but the addition of 1 mM 
Zn
2+
 boosts the binding (pink). However, the addition of 150 mM Na
+
 greatly reduced the binding of 
TALE (green).  
at 37 °C. It has also been shown that ssDNA-hydrolyzing deoxyribozymes can also 
function with 1 mM Zn
2+
 alone. However, ssDNA-hydrolyzing deoxyribozymes have 
only been successfully identified at pH 7.5.The ideal selection conditions should contain 
preferably 1 mM Zn
2+
 alone, or with 20 mM Mn
2+
 and 40 mM Mg
2+
, in buffer at pH 7.5. 
Because the reported condition of TALE protein binding to its target is different from 
selection conditions,
24
 it is necessary to verify that the designed selection conditions are 
compatible with the TALE protein. 
A series of fluorescence anisotropy assays were designed and performed with a 
fluorescein-modified target DNA duplex and wild-type TALE protein to determine the 
compatible selection conditions. During the fluorescence anisotropy assays, the excitation 
light was polarized, and the emitted light would be depolarized due to the rapid tumbling 
of DNA duplex when it was not bound to protein. When the TALE protein bound to the 
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Figure 4.12. Fluorescence anisotropy assays to study the divalent metal ion tolerance of TALE in 
the presence of 1 mM Zn
2+
. The assays are performed under similar conditions as in Figure 4.11, 
and the data points are fit to the same equation. (A) Mn
2+
 tolerance of TALE in 0.1 M HEPES pH 
7.5 in the presence of 1 mM Zn
2+
. Notice that the binding of TALE to the duplex is not influenced 
by the addition of Mn
2+
. (B) Mn
2+
 and Mg
2+
 tolerance of TALE in 0.1 M MOPS pH 7.5 in the 
presence of 1 mM Zn
2+
. Similar to panel A, the addition of Mn
2+
 did not influence the affinity of 
TALE, but the addition of 20 mM Mg
2+
 greatly reduces the binding of TALE. 
target DNA duplex, the tumbling of the duplex would be much slower, so the emitted 
light would be polarized. By measuring the anisotropy of the emitted light, the affinity of 
TALE to the target duplex could be determined. It was shown that TALE protein 
functioned preferentially in slightly acidic conditions (Figure 4.11A). The binding of 
TALE to its target decreased with increasing pH. However, the addition of 1 mM Zn
2+
 
restored the binding of TALE at higher pH (Figure 4.11B), indicating that Zn
2+
 enhanced 
binding of TALE. However, high concentration of Na
+
 seemed to inhibit the binding of 
TALE (green line in Figure 4.11B), suggesting that TALE was sensitive to Na
+
. 
The binding affinity of TALE protein was then assayed with various concentrations 
of divalent metal ions. In the presence of 1 mM Zn
2+
, the addition of Mn
2+
 did not 
influence the binding at all (Figure 4.12), but the affinity of TALE greatly reduced with 
the addition of even low concentration of Mg
2+
 (Figure 4.12B, black line), indicating that 
Mn
2+
 did not interfere with the binding of TALE, but Mg
2+
 inhibited binding. 
Finally, the Na
2+
 tolerance of TALE in the presence of various concentrations of 
divalent metal ions was assayed. In the presence of 1 mM Zn
2+
 alone, the affinity of 
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Figure 4.13. Fluorescence anisotropy assays to test Na
+
 tolerance of TALE in the presence of 
divalent metal ions. The assays are performed under similar conditions as in Figure 4.11, and the 
data points are fit to the same equation. (A) The Na
+
 tolerance of TALE in the presence of 1 mM 
Zn
2+
 alone. (B) The Na
+
 tolerance of TALE in the presence of 1 mM Zn
2+
 and 20 mM Mn
2+
. 
TALE gradually decreased with increasing concentration of Na
+
. Additional Na
+
 
concentrations of up to 70 mM were tolerated (Figure 4.13A). In the presence of both 1 
mM Zn
2+
 and 20 mM Mn
2+
, the TALE was more sensitive to Na
+
. The affinity of TALE 
drastically decreased with increasing Na
+
 concentration (Figure 4.13B). In conclusion, 
TALE protein was compatible with conditions established from ssDNA hydrolysis 
selections. Two sets of selection conditions were chosen: (1) 70 mM HEPES pH 7.5, 1 
mM Zn(OAc)2 with additional 20 mM NaOAc at 37 °C; (2) 70 mM HEPES pH 7.5, 1 
mM Zn(OAc)2 and 20 mM Mn(OAc)2 with no additional NaOAc at 37 °C. 
4.2.4 Development of Strategies to Conjugate TALE Protein and DNA Pools 
The remaining step in the selection experiments to be developed is the TALE protein-
DNA pool conjugation (Figure 4.8). This step includes a site-specific modification of 
TALE to introduce a functional tag, a high-yielding conjugation of the TALE and DNA 
pool, and an efficient removal of unreacted TALE protein after the conjugation. There are 
a lot of constraints for choosing a feasible conjugation strategy. First of all, the 
conjugation reaction condition has to be mild so that the TALE protein still functions 
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after the reaction. Ideally, the reaction should occur in aqueous solution at near-
physiological pH. Second of all, the modification on the TALE protein has to be site-
specific but not interfering with the function of the TALE protein. Ideally, the number of 
modifications on the protein should be controllable to ensure that only one DNA 
sequence can conjugate with one TALE protein. Third of all, the conjugation reaction 
should be reliably high-yielding on both large (conjugation with ~1 nmol of DNA pool in 
round 1) and small scale (conjugation with ~510 pmol of DNA pool in rounds 2+). 
Finally, a feasible method to remove excess of modified protein is also required to 
prevent unconjugated protein from displacing the conjugated protein during selection 
incubation. Additionally, all the steps mentioned here should be relatively fast so that 
each selection round can be performed on a reasonable time frame. In summary, four 
conjugation strategies have been designed and tested with different results. 
4.2.4.1 The Conjugation Strategy Based on Disulfide Exchange Reaction 
The first conjugation strategy came to our mind was based on disulfide exchange 
reaction. The dHax3-TALE protein had 11 cysteine residues in its sequence (Figure 
4.14A), but the functions of these residues are not known. Brief examination of the 
solvent-accessible area of the protein showed that the cysteine residues were only 
partially exposed (Figure 4.14B), so it was assumed the cysteine residues on the protein 
would not be very reactive. An additional cysteine residue was introduced to either the N- 
or C-terminus of the protein so that the conjugation would preferentially occur on the 
introduced cysteine residue. 
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Figure 4.14. Amino acid sequence of dHax3-TALE and an image depicting solvent-accessible surface 
of the protein. (A) Amino acid sequence of dHax3-TALE. The shaded sequence is the dHax3-TALE 
sequence. The remaining amino acids are generated from the expression vector. The 11 cysteine 
residues are highlighted in yellow. (B) Solvent-accessible surface of dHax3-TALE. Molecular 
graphics images are produced using the Chimera package from the Computer Graphics Laboratory, 
University of California, San Francisco (supported by NIH P41 RR-01081). The blue color denotes 
nitrogen atom, the red color denotes oxygen atom, and the yellow color denotes sulfur from cysteine. 
Notice that the cysteine residues are partially buried. 
Two mutants of dHax3-TALE, A3C and A428C, were expressed and purified, while 
a thiol modifier was introduced to the 5ʹ ends of the deoxyribozymes pools and forward 
primers by solid-phase DNA synthesis. Disulfide exchange reactions would be performed 
with activated DNA and TALE protein (Figure 4.15A),
37
 and the excess protein could be 
removed by running the reaction mixture through covalent chromatography column that 
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Figure 4.15. Disulfide exchange reaction of TALE with activated DNA (A) Disulfide exchange 
reaction between an activated DNA sequence and a cysteine-containing protein. (B) The proposed 
strategy to remove excess unreacted protein. Ideally, only the unreacted protein should be captured 
by the gel. (C) SDS-PAGE image of disulfide exchange reactions of wild-type (WT) and two 
mutants (A3C and A428C) of dHax3-TALE with activated DNA pool. is the negative control, 
where only WT-TALE is reacted with plain DNA. Each set of assays are performed with 500 pmol 
of activated DNA and 250 pmol of protein at either room temperature (left) or 37 °C (right). 
contained activated thiol groups (Figure 4.15B). Ideally, only the unreacted protein would 
be captured by the resin while the protein-DNA conjugate should be recovered. 
To validate the disulfide exchange reaction, both A3C and A428C mutants as well as 
the wild-type dHax3-TALE were reacted with activated DNA pool under various 
conditions. However, the wild-type protein showed similar reactivity as both mutants 
(Figure 4.15C), indicating that the 11 cysteine residues on the protein were still reactive 
although they were only partially exposed. The strategy based on disulfide exchange 
reaction was not feasible because site-specific conjugation could not be achieved. 
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Figure 4.16. Conjugation strategy based on FBDPtyrosine reaction. (A) FBDP reaction on the 
tyrosine residue of the protein. (B) Conjugation of modified protein with hydrazide-containing DNA. 
(C) Designed strategy to remove unreacted protein. 
4.2.4.2 The Conjugation Strategy Based on FBDPTyrosine Reaction 
The recent report that 4-formylbenzene diazonium hexafluorophosphate (FBDP)
38
 
can selectively modify tyrosine residues on a protein offers us another strategy to enable 
site-specific conjugation between the TALE protein and the DNA pool, because the wild-
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type TALE protein does not have any tyrosine residues (Figure 4.14A). By site-directed 
mutagenesis, a tyrosine residue was introduced to the protein, and the FBDP reagent 
should then selectively modified the tyrosine residue to attach an aldehyde tag on the 
protein (Figure 4.16A). The modified protein could then react with a hydrazide-
containing DNA pool to achieve conjugation (Figure 4.16B). The excess modified 
protein could be removed by running the reaction mixture through a column of 
hydrazide-activated resin. Ideally, only the unreacted protein would be captured by the 
column, while the DNA-protein conjugate should be recovered. 
The FBDP reagent was efficiently synthesized following the reported procedures.
38
 
The tyrosine-containing mutants A3Y- and A428Y-TALE were expressed and purified. 
The hydrazide-containing DNA pools and forward primer were prepared by solid-phase 
synthesis. To validate the conjugation strategy, both mutants as well as the wild-type 
TALE protein were reacted with FBDP and then conjugated with the hydrazide-
containing forward primer. 
The reaction of FBDP with TALE protein was optimized first. Comprehensive assays 
showed that reducing agents such as DTT, TCEP, or BME would interfere with the 
FBDP reaction and should be avoided in the reaction. Additionally, non-denaturing 
detergent such as 0.2% (V/V%) Triton X-100 or 5% (V/V%) CHAPS should be included 
to increase the solubility of protein in the presence of FBDP reagent. The FBDP reaction 
only worked in sodium phosphate buffer at pH > 6.0. Furthermore, 20-50 mM of 5-
methoxyanthranilic acid (5-MA) should be included in the conjugation reaction of the 
modified protein and hydrazide-containing DNA to increase the reaction yield for small 
scale (conjugation with 510 pmol of DNA) conjugation.39 The optimized conjugation 
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Figure 4.17. Site specificity of FBDP reaction with the TALE protein. (A) SDS-PAGE image of 
systematic assays to determine optimal FBDP reaction condition. The gels are imaged to trace the 
DNA migration using PhosphorImager. Both wild-type and A428Y TALE proteins are assayed 
under various conditions including different protein:FBDP ratios and reaction pH values. The 
protein concentration in FBDP reaction is fixed to be 50 M. For each assay, two reactions are 
done. One is using excess of modified protein (DNA:protein = 1:4, 12.5 pmol of DNA is used , left 
lane), and other is using excess of hydrazide DNA (DNA:protein = 4:1, 50 pmol of DNA was used, 
right lane). In all cases, wt-type protein is reactive. Increasing the pH of the reaction or the amount 
of FBDP leads to over-modification of the protein. (B) Reported selectivity of FBDP to various 
amino acids (Adapted from Ref. 38 with permission). Notice that His, Cys, and Trp also show some 
reactivities, even though FBDP is more selective for Tyr. 
procedure was as follows. After reacting with various amounts of FBDP for 30 min, 50 
pmol of modified protein was allowed to reaction with 12.5 pmol of hydrazide DNA in 1 
L total volume containing 50 mM 5-MA and buffer at pH 5.6. 
The site-specificity of the conjugation strategy based on FBDPtyrosine reaction was 
assayed. Systematic assays were performed to determine the optimal FBDP reaction 
condition. Different protein:FBDP ratios were tested in combination with different 
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reaction pH values, but none of the conditions resulted in site-specific conjugation 
(Figure 4.17A). In all cases, modification of wild-type TALE protein was also observed, 
indicating that residues other than tyrosine were also reactive to FBDP. Further 
examination of the protein sequence revealed 37 potential reaction sites (24 histidines, 11 
cysteines, 1 tryptophan, and 1 tyrosine). Although FBDP was reported to be highly 
selective toward tyrosine (Figure 4.17B), too many nucleophiles on the protein prevented 
FBDP to react site-specifically with the tyrosine residue. Therefore, a different strategy 
was still needed to achieve site-specific modification of the protein. 
4.2.4.3 The Conjugation Strategy Based on PTADTyrosine Reaction 
In order to achieve site-specific conjugation, another strategy has been designed 
based on another tyrosine-specific reaction. It has been reported that 4-phenyl-1,2,4-
triazole-3,5-dione (PTAD) and its derivatives react selectively with tyrosine over other 
amino acids.
40
 Compared to FBDP reagent, PTAD reagent is even more specific to 
tyrosine, because PTAD does not react with histidine or cysteine, and it only has trace 
reactivity towards tryptophan or lysine.
40a
 The tyrosine-containing mutants of dHax3-
TALE protein were the same as used in the strategy based on FBDP reaction. The PTAD-
alkyne reagent was obtained to introduce an alkyne group to the protein (Figure 4.18A). 
Accordingly, azido groups would be introduced to the 5ʹ ends of the deoxyribozyme 
pools and the forward primer. After PTAD-alkyne treatment, the modified protein would 
be conjugated to the derivatized DNA pools via CuAAC click reaction (Figure 4.18B). 
The excess unconjugated protein would be removed by covalent chromatography through 
a column containing azide-activated resin (Figure 4.18C). 
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Figure 4.18. Conjugation strategy based on PTADtyrosine reaction. (A) PTAD-alkyne reaction 
with the protein. The PTAD reagent needs to be oxidized by DBDMH right before the reaction. (B) 
Conjugation of modified protein with DNA by CuAAC click reaction. (C) The proposed strategy for 
removal of excess of unconjugated protein. Ideally only the excess protein would be captured. 
The site specificity of PTAD reaction was tested by MALDI-MS assays, where the 
wild-type as well as tyrosine-containing mutants of TALE protein were treated with 
various amounts of PTAD-alkyne reagents under different conditions. The Proteins were 
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Figure 4.19. Decomposition of PTAD reagent and the resulting non-specific reaction with amines 
on the protein (N-terminal amine and lysine side chain). 
then purified and digested with either trypsin or Glu-C. The resulting polypeptide 
fragments were monitored by MALDI-MS for potential modifications. 
Activated PTAD reagent has been known to decompose rapidly in aqueous solution 
with the formation of a reactive isocyanate intermediate that non-specifically reacts with 
amines such as N-terminal amine and lysine side chain (Figure 4.19).
40b,41
 It has been 
reported that performing the PTAD reaction in Tris buffer can prevent non-specific 
modifications on the target protein. Therefore, the PTAD reactions were performed in 
Tris buffer of different concentrations at different pH values. 
While 0.2 M Tris buffer did not prevent the non-specific modification from occurring, 
PTAD reaction in 1 M Tris led to no reactivity on N-terminal amine or lysine residues on 
the protein (Figure 4.20A). Furthermore, the reaction yield increased with increasing 
incubation time, but after 30 min, the reaction yield did not increase more, indicating the 
PTAD reaction was complete in 30 min. It was also shown that the reaction was not 
sensitive to buffer pH. The reaction yield did not change much in buffers at pH 7.5 or 8.0 
(Figure 4.20B). In general, site-specific modification on the tyrosine residue with a final 
yield of ~50% was achieved in 1 M Tris pH 7.5 after 30 min room temperature 
incubation (Figure 4.20C). However, efforts to increase the reaction yield by increasing 
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Figure 4.20. MALDI-MS assays to validate PTAD-tyrosine reaction. (A) Establishing the site 
specificity of tyrosinePTAD reaction. Shown here is wt-TALE protein reacting with PTAD-alkyne 
in 0.2 M Tris (top) or 1.0 M Tris (bottom) at pH 7.5. The protein:PTAD ratio was 1:10. After 
reaction, the protein is purified and digested with trypsin. The orange marker denotes the N-
terminal fragment of wt-TALE. The blue marker denotes the non-specific modification of N-
terminal amine. The green markers denote the other digestion fragments. Note that very little non-
specific modification is observed when 1.0 M Tris is used. No modifications are observed on lysine 
residues. (B) Assays to show pH independence of PTAD reaction. The A428Y-TALE protein is 
treated with 10 eq. of PTAD-alkyne in 0.2 M Tris pH 7.5 (top) or 8.0 (bottom) for 45 min. The 
protein is then digested with Glu-C. The fragment bearing the tyrosine of interest is marked in grey, 
and the desired modification peak is marked in red. Note that the reaction yields in both scenarios 
are around 50%. (C) A representiative MALDI-MS result of A428Y reacting with PTAD-alkyne. 
The reaction is carried out similarly as panel B, except that the concentration of Tris is 1 M. 
the amount of PTAD reagent did not lead to higher yields. Surprisingly, higher 
PTAD:protein ratio than 10:1 led to no modification on the protein in most cases. Further 
optimization is still needed to increase the efficiency of PTAD modification. In the 
meantime, further assays are also needed to validate the conjugation reaction and 
purification step. 
4.2.4.4 The Conjugation Strategy Based on N-Terminal Threonine Oxidation 
Closer examination of the amino acid sequence of wt-TALE protein revealed that the 
second amino acid in the sequence was threonine, which could undergo oxidation to 
generate an aldehyde group only when the terminal methionine was removed. It was 
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Figure 4.21. Conjugation strategy based on N-terminal threonine oxidation. (A) Oxidation of N-
terminal threonine followed by hydrazone formation between the protein and DNA. (B) The designed 
strategy to remove excess protein. 
reported that N-terminal methionine would be excised during translation if the following 
amino acid had a small side chian.
42
 The process was named N-terminal methionine 
excision (NME) and identified in all organisms or compartments in which protein 
synthesis occurred. Once the methionine residue was removed, a conjugation strategy 
based on N-terminal threonine oxidation would become possible. The wt-TALE protein 
would be oxidized by NaIO4 and then conjugated to hydrazide-containing pools as 
described in FBDP based strategy (Figure 4.21A). The removal of excess protein would 
also be the same as designed in the strategy based on FBDP reaction (Figure 4.21B). 
 176 
 
Figure 4.22. Assays to validate the conjugation strategy based on N-terminal threonine oxidation. 
(A) MALDI-MS verification of the N-terminal sequence of wt-TALE. The protein is digested with 
trypsin and then assayed via MALDI-MS experiment. The orange marker denotes the peak that 
correspondes to N-terminal sequence starting at threonine. The brown marker denotes the peak 
that correspondes to N-terminal sequence starting at methionine. (B) Optimization of hydrazone 
formation between oxidized protein and hydrazide-containing DNA. The image on the left is a 
representative SDS-PAGE image for the conjugation reaction. Lane 1 is a small-scale conjugation 
reaction, in which 1 L sample of 12.5 pmol of hydrazide DNA and 50 pmol of oxidized protein is 
incubated at room temperature with 50 mM 5-MA at pH 5.6. Lane 2 is the conjugation reaction 
where 50 pmol of DNA is incubated with 12.5 pmol of protein. Lane 3 is the incubation of oxidized 
protein with plain DNA. Lane 4 is the DNA standard. The SDS-PAGE gel image on the right shows 
the catalyst concentration dependence of conjugation reaction. The protein concentration is 200 
M. The concentrations of 5-MA were 50 mM, 100 mM, and 200 mM. 
The N-terminal sequence of wt-TALE was confirmed by MALDI-MS experiment. 
The majority of wt-TALE has N-terminal methionine removed, exposing the threonine 
residue (Figure 4.22A). The oxidation and conjugation protocol was established, so only 
a few optimization experiments were performed to increase the conjugation yield. It was 
shown that increasing the protein concentration as well as the catalyst concentration 
significantly increased the conjugation yield (Figure 4.22B). However, an unexpected 
side product was observed in all small-scale (12.5 pmol of DNA) reactions, but it was not 
observed in large-scale reactions where excess DNA was used. In general, a final 
conjugation yield around 30% could be reliably achieved (Figure 4.22B). At this point, 
validation of the purification step is still needed before selections can be performed. 
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4.3 Summary and Future Directions 
In this project, a selection strategy was designed to target intact double-stranded DNA 
for hydrolysis, in which the deoxyribozymes pool would be linked with a dsDNA-
binding protein, dHax3-TALE protein (Figure 4.7). The dHax3-TALE would recognize 
and bind to a specific region in the substrate, while the deoxyribozyme would catalyze 
the site-specific hydrolysis of the substrate. The substrate ligation step (Figure 4.9) as 
well as the key capture step (Figure 4.10) were validated, and a set of two selection 
conditions were chosen, which were well tolerated by dHax3-TALE protein (Figure 
4.13). Furthermore, four strategies were designed to enable efficient site-specific 
conjugation between the protein and the DNA pool. The strategy based on disulfide 
exchange reaction failed due to the reactivities of 11 cysteine residues on the protein, 
even though they were partially buried (Figure 4.15). The strategy based on 
FBDPtyrosine reaction also failed because the protein contained too many nucleophiles 
that FBDP could react, even though FBDP was reported to be much less reactive to those 
nucleophiles (Figure 4.17). An alternative strategy was then designed based on 
PTADtyrosine reaction because PTAD was more specific to tyrosine than FBDP. After 
comprehensive optimization, PTAD was able to modify tyrosine selectively with a 
reliable ~50% yield (Figure 4.20). Additionally, it was found that the N-terminal 
methionine in wt-TALE protein was removed by the universal NME process, leaving an 
N-terminal threonine that could be oxidized to enable site-specific conjugation with 
hydrazide-activated DNA. Several experiments showed that the threonine oxidation 
followed by hydrazone formation could reliably achieve a final 30% conjugation yield 
(Figure 4.22). 
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Future efforts will continue to optimize the PTADtyrosine reaction and N-terminal 
threonine oxidation strategy. Additionally, the corresponding steps to remove excess 
unreacted protein also need to be validated before the systematic selection experiments 
are performed. The identified deoxyribozymes will then be characterized for their double-
stranded DNA hydrolysis activities, substrate sequence requirement, and TALE protein 
requirement. The key deoxyribozymes will also be evaluated with large double-stranded 
DNA substrates such as plasmids to fulfill their potentials for practical applications. 
4.4 Materials and Methods 
4.4.1 Oligonucleotides 
All standard oligonucleotides were prepared by solid-phase synthesis at IDT 
(Coralville, IA). The selection pools and derivatized primers (except the hydrazide-
containing pools and primer) were synthesized on an ABI 394 DNA synthesizer, 
similarly to the procedure described in Chapter 2 and Chapter 3. For the derivatized pools 
and primers, the corresponding modifier phosphoramidite was purchased from Glen 
Research and incorporated to the 5ʹ terminis by standard coupling procedure. All 
oligonucleotides were purified by denaturing 20% or 8% PAGE. The pool strand for the 
selections was 5ʹ-CGAACGAAAGCCTCCTTC-NXX-ATACGCATAAAGGTAGAGCTGATCCTGATGG-3ʹ, 
where xx can be 20, 30 or 40. The modifications were as listed in the description of each 
strategy. The forward and reverse primer sequences were 5ʹ-CGAACGAAAGCCTCCTTC-3ʹ and 
5ʹ-CCATCAGGATCAGCT-3ʹ. The substrate sequence was 5ʹ-GGAACTCACTATCGGAAGAGATGGTCCCT-
TTATCTCTCGGCAGAGAGATAAAGGGACCATCTCTTCCGATAGTGAGT-3ʹ, of which the 5ʹ end was 
phosphorylated. The underlined nucleotides base paired with each other. The sequence 
 179 
for substrate ligation was 5ʹ-CCATCTCTTCCGATAGTGAGTTCCCCATCAGGATCAGCTCTACCTTTATGC-
GTAT-3ʹ. The final capture splint was 5ʹ-CTCGAATAGCAGAGGCGATAGTGAGTTCCTCCATCAGGATCAGCT-
3ʹ, in which the underlined G opposed the 3ʹ-C remained at the predetermined cleavage 
site. The sequence of donor oligonucleotide in the capture reaction was 5ʹ-GCCTCT-
GCTATTCGAGAACAACAACAACAAC-3ʹ, the 5ʹ terminus of which was phosphorylated. 
The hydrazide modifier was introduced to DNA pools and forward primers manually. 
After synthesizing the plain DNA oligonucleotides by automatic solid-phase synthesis on 
ABI 394 DNA synthesizer, the synthesis column was vacuum dried overnight before the 
manual coupling. One fifth of a bottle of 3ʹ caroxy-modifier was dissolved in 0.2 mL of 
dry acetonitrile, and added to 0.5 mL of activator solution. The mixture was immediately 
applied to the column under argon and agitated for 12 min. The column was then washed 
three times, each with 1 mL of dry acetonitrile. 0.7 mL of oxidizer solution was 
subsequently applied to the column for 15 min, and the column was again washed three 
times, each with 1 mL of acetonitrile. Finally, the column was dried and the CPG beads 
were transferred to a vial of solution that contained 25 L of hydrazine, 75 L of water 
and 100 L of ethanol for deprotection. The mixture was incubated at room temperature 
for 5 h, desalted by Bio-Rad P6 spin column, and then purified by 8% or 20% denaturing 
PAGE. 
The forward mutagenic primers for A3C, A428C, A3Y, and A428Y were 5ʹ-
GGAGATATACATATGACTTGTGTCGAAGCCGTTCATGCATGGCG-3ʹ, 5ʹ-CACGACCTGATCCCGCTCTTTG-
CGCATTGACAAACGATC-3ʹ, 5ʹ-GGAGATATACATATGACTTATGTCGAAGCCGTTCATGCATGGCG-3ʹ, and 
5ʹ-CTATCACGACCTGATCCCGCTCTTTACGCATTGACAAACGATC-3ʹ, respectively. The reverse 
mutagenic primers were 5ʹ-CGCCATGCATGAACGGCTTCGACACAAGTCATATGTATATCTCC-3ʹ, 5ʹ-
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GATCGTTTGTCAATGCGCAAAGAGCGGGATCAGGTCGTG-3ʹ, 5ʹ-CGCCATGCATGAACGGCTTCGACATAA-
GTCATATGTATATCTCC-3ʹ, and 5ʹ-GATCGTTTGTCAATGCGTAAAGAGCGGGATCAGGTCGTGATAG-3ʹ, 
respectively. 
4.4.2 Site-Directed Mutagenesis and Over-Expression of Wild-Type and Mutant 
dHax3-TALE Proteins 
Site-directed mutagenesis was performed according to instruction in QuikChange
®
 
Site-Directed Mutagenesis Kit (Stratagene). First of all, PCR reactions were performed 
using pairs of the forward and reverse mutagenic primers. The PCR was performed in 50 
L volume of 1× Pfu polymerase buffer with 125 ng of each primer, 25 ng of wt-dHax3-
TALE plasmid, 0.5 L of dNTPs, and 2.5 units of Pfu polymerase (Stratagene). The PCR 
was performed following the procedure: 95 °C for 30 s, 55 °C for 1 min, 68 °C for 5 min 
for 16 cycles. The PCR reactions were purified on 1% agarose gel. The purified PCR 
products were then digested with DpnI in 45 L reaction with 1×NEB buffer 4 and 10 
units of DpnI (New England Biolab). 
The DH5cells were transformed with the digestion reactions. Briefly, 3 L of 
digestion reaction was mixed with 50 L of cells and incubated on ice for 30 min. The 
cells were then heat-shocked at 42 °C for 1 min and shaken horizontally in 500 L of 
SOC medium at 220 rpm 37 °C for 1 h. 200 L of cells were spread on LB + ampicillin 
agar plates and incubated at 37 °C overnight. Individual colonies were picked and 
cultured in 5 mL of LB medium containing 50 g/mL of ampicillin overnight. Plasmids 
were harvest via miniprep as described in Chapter 2. The plasmids were sequenced using 
T7 promoter and terminator primers to confirm the mutations. 
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Over-expression of the proteins started with transformation of the BL21(DE3) cells 
(Bioline) with the wild-type or mutant plasmids. Briefly, 1 L of the plasmid was added 
to 50 L of BL21(DE3) cells. The mixture was incubated on ice for 30 min, and then 
heat-shocked at 42 °C for 1 min, and shaken horizontally in 500 L of SOC medium at 
220 rpm 37 °C for 1 h. 200 L of cells were spread on LB + ampicillin agar plates, and 
incubated at 37 °C overnight. Individual colonies were picked and cultured in 5 mL of 
LB medium containing 50 mg/mL of ampicillin overnight. 
The 1 L large culture with LB medium and 100 g/mL was inoculated with 2 mL of 
starter culture, and shaken at 220 rpm and 37 °C. The culture was then induced with a 
final concentration of 0.2 mM IPTG when OD600 reached 0.8, and allowed shaking at 22 
°C for 16 h. The cells from each culture were harvested by centrifuging at 6000 rpm and 
4 °C for 10 min. 
The purification of TALE proteins were performed as reported and as described in the 
instructions of Thermo Scientific HisPur
®
 Ni-NTA resin.
24
 Briefly, 20 mL of 
resuspension buffer containing 25 mM Tris pH 8.0 and 150 mM NaCl was added to the 
cell pellets. The cells were then resuspended and lysed via sonication (Amplitude: 35%; 
Sonication time: 5 min; Pulse on: 4 s; Pulse off: 9.9 s). Then cell lysate was then 
centrifuged at 10,000 g for 30 min at 4 °C. The supernatant was transferred to a 50-mL 
tube to determine the volume so that equal volume of equilibration buffer was added, 
containing 20 mM Na3PO4 pH 7.5, 300 mM NaCl, and 10 mM imidazole pH 7.4. The 
protein purification was then performed at 4 °C. To a 1.0 × 10 cm chromatography 
column, 2 mL of well-mixed Ni-NTA resin slurry was added. The storage buffer was 
allowed to drain from the resin before the column was equilibrated with 4 mL of 
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equilibration buffer. The prepared protein extract was loaded to the column. The flow-
through was collected in a fresh tube and re-applied to the column to maximize the 
binding. The loaded column was washed with 10 mL of wash buffer which contained 20 
mM Na3PO4, 300 mM NaCl, and 25 mM imidazole pH 7.4. The follow-through was 
collected as 1-mL fractions and monitored by measuring UV absorbance at 280 nm. 
Washing step could be stopped after the UV absorbance reached baseline. The protein 
was finally eluted with a buffer containing 20 mM Na3PO4, 300 mM NaCl, and 250 mM 
imidazole pH 7.4. The flow-through was also collected in 1-mL fractions. UV absorbance 
at 280 nM of each fraction was measured, and fractions with high UV absorbance were 
combined and exchanged into storage buffer by PD-10 column. The storage buffer was 
0.1 M Na3PO4 pH 8.0. For long-term storage, glycerol should be added to a final 
concentration of 50%. 
Bradford assay was used to determine protein concentration, and the assay was 
performed according to the instructions of Bio-Rad Quick Start
®
 Bradford Protein Assay. 
Briefly, the protein assay reagent concentrate was diluted 5 times with DDI water. BSA 
standards of 0 (buffer blank), 20 g/mL, 50 g/mL, 100g/mL, 200 g/mL, 500 g/mL, 
and 1 mg/mL were generated. 50 L of each standard and protein sample solution was 
added to 2.5 mL of diluted protein assay reagent. The mixture was vortexed briefly and 
allowed to incubate at room temperature for 5 min. The absorbance of each BSA standard 
at 595 nM was measured and the protein sample concentrations were determined by 
Bradford Assay Module in Nanodrop 2000c. 
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4.4.3 Fluorescence Anisotropy Assays 
The fluorescence anisotropy assays were performed in 96-well plates. Each well 
contained 100 L of sample containing 20 nM fluorescein-labeled DNA duplex (the 
sequence was 5ʹ-TGGTCCCTTTATCTCTCGGCAGAGAGATAAAGGGACCA-3ʹ, the 5ʹ end of the oligo 
was modified with fluorescein), various concentrations of wt-dHax3-TALE protein, and 
various concentrations of different metal ions in different buffers. The details of the 
compositions of samples were described in Section 4.2.3. A FilterMax F5 microplate 
reader (Molecular Devices, CA) was used to measure the intensities of emission light. 
The excitation wavelength was 485 nm, and the emission wavelength was 535 nm. The 
milli-anisotropy values were calculated using the formula mA = 
1000×(I∥G×I⊥)/(I∥+2G×I⊥), where I∥ was the intensity of parallel emission light, I⊥ was 
the intensity of perpendicular emission light, and G is the grating factor that was 0.65 for 
the instrument. Then mA values were plotted against protein concentration and fitted to 
the function mA =1000×[Af+(Ab-Af)×RT/(Kd+RT)], where Af was the anisotropy of free 
DNA, Ab was the anisotropy of DNA-protein complex, RT was the concentration of total 
protein, and Kd was the dissociation constant. 
4.4.4 Assays to Validate the Four Designed Conjugation Strategies 
The modified DNA oligonucleotides were radiolabeled at their 3ʹ ends by terminal 
deoxynucleotide transferase. Briefly, 20 pmol of DNA and 20 pmol of -32P dCTP 
(Perkin Elmer) were incubated in 20 L containing 0.25 mM CoCl2, 10 units of terminal 
deoxynucleotide transferase (New England Biolab) and 1×NEB buffer 4 at 37 °C for 
30min. The reaction was then purified by 8% or 20% denaturing PAGE. The typical 
procedures for conjugation reactions were described below. However, during the assays 
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to validate the conjugation strategies, buffer concentration, pH, and protein/DNA 
concentrations were varied.  
4.4.4.1 The Conjugation Strategy Based on Disulfide Exchange Reaction 
The thiol-modified DNA oligonucleotides were first deprotected by DTT and then 
activated with 2,2′-dipyridyl disulfide. 500 pmol of unradiolabeled PyS-DNA, 0.2 pmol 
of radiolabeled PyS-DNA, and 250 pmol of protein were then mixed in the presence of 
50 mM MOPS pH 7.0 and incubated at room temperature or 37 °C overnight. The 
reactions were stopped by loading solution that contained 50 mM Tris-HCl pH 6.8, 100 
mM DTT, 2% SDS, 0.1% bromophenol blue, and 10% glycerol. The samples were then 
separated on a 12% SDS-PAGE gel. The gel was stained with Coomassie Brilliant Blue 
R-250 and imaged by phosphorImager.  
4.4.4.2 The Conjugation Strategy Based on FBDPTyrosine Reaction 
The synthesis of FBDP was done according to protocol in Ref. 38. To a suspension of 
4-aminobenzaldehyde polymer (5.00 g, 41.3 mmol, TCI America, Portland, OR) in 12 N 
HCl (85 mL) was added the solution of NaNO2 (3.42 g, 49.5 mmol) in water (67 mL) at 
−10 °C. The resulting solution was stirred at −10 °C. After 1.5 h, 60% HPF6 in water 
(10.3 mL, 70.2 mmol, Alfa Aesar, Ward Hill, MA) was added at −10 °C and stirred for 
30 min. Then, the reaction mixture was stirred at room temperature for 30 min. The 
resulting solids were collected by filtration and washed with water and AcOEt to give a 
yellow solid. 
The modification of TALE protein by FBDP was carried out as follows. 1 L of 50 
mM FBDP dissolved in acetonitrile was added to a 100 L sample containing 50 M 
TALE protein solution (protein:FBDP = 1:10) in 0.1 M Na3PO4 buffer pH 7.4 and 0.2% 
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Triton X-100. The sample was incubated at room temperature for 30 min and desalted 
using an Amicon Ultra-0.5 column (Millipore) with Ultracel-10 membrane. The protein 
sample was then concentrated five times and exchanged into reaction buffer of 0.1 M 
MES pH 5.6 and 10 mM DTT. 12.5 pmol of unradiolabeled hydrazide-containing DNA 
was mixed with 0.2 pmol of radiolabeled hydrazide-containing DNA and 50 nmol of 5-
methoxyantranilic acid (5-MA). The mixture was vacuum dried and added 1 L of 
concentrated TALE protein solution. The reaction was incubated at room temperature 
overnight, and stopped with 50 mM Tris-HCl pH 6.8, 100 mM DTT, 2% SDS, 0.1% 
bromophenol blue, and 10% glycerol. The samples were then separated on a 12% SDS-
PAGE gel. The gel was stained with Coomassie Brilliant Blue R-250 and imaged by 
phosphorImager. 
4.4.4.3 The Conjugation Strategy Based on PTADTyrosine Reaction 
The PTAD-alkyne reagent was purchased from Sigma-Aldrich (St. Louis, MO). The 
reagent was dissolved in acetonitrile to make 100 mM stocks. Before the modification, 5 
L PTAD stock was activated by adding 5 L of 98 mM DBDMH in acetonitrile. The 
activated PTAD reagent had a cranberry color and was immediately transferred on ice. 
The reagent should be used up in 30 min. Two doses of 0.5 L of activated PTAD 
reagent were added in 10 s to 100 L of 50 M protein in Tris-HCL buffer. The reaction 
was incubated at room temperature for 3045 min. 
The digestion of protein by trypsin or Glu-C was carried out according to 
manufacturer’s instruction. The modification reaction was desalted with Bio-Rad P6 gel 
and exchanged into 50 mM NH4HCO3 pH 7.8 buffer containing 10 mM DTT. 10 L of 
the protein sample was added 0.2 g of trypsin or Glu-C (Sequecing grade, Promega), 
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and the digestion reaction was incubated at 37 °C for 1 h. The digestion reaction was zip-
tipped and assayed by MALDI-MS. 
4.4.4.4 The Conjugation Strategy Based on N-Terminal Threonine Oxidation 
The MALDI-MS experiment of wt-TALE protein was carried out similarly as 
described in Section 4.4.4.3. Briefly, 500 pmol of wt-TALE protein was diluted with 50 
L of 50 mM NH4HCO3 and added 0.2 g of trypsin (Sequecing grade, Promega). The 
digestion reaction was incubated at 37 °C for 1 h and zip-tipped for MALDI-MS assay. 
The oxidation reaction was started by adding freshly-made 200 mM NaIO4 solution to 
500 L of 50 M wt-TALE protein, so that the final concentration of NaIO4 was 5 mM. 
The sample was then incubated in dark at room temperature for 10 min. The reaction 
mixture was desalted and exchanged into 0.2 M MES pH 6.0 buffer containing 10 mM 
DTT by Bio-Rad P6 gel. The protein sample was then concentrated 10 times by an 
Amicon Ultra-0.5 column with Ultracel-10 membrane. 12.5 pmol of unradiolabeled 
hydrazide-modified DNA was mixed with 0.2 pmol of radiolabeled hydrazide-modified 
DNA and 200 nmol of 5-methoxyantranilic acid (5-MA). The mixture was vacuum dried 
and added 1 L of concentrated TALE protein solution. The reaction was incubated at 
room temperature overnight, and stopped with 50 mM Tris-HCl pH 6.8, 100 mM DTT, 2% 
SDS, 0.1% bromophenol blue, and 10% glycerol. The samples were then separated on a 
12% SDS-PAGE gel. The gel was stained with Coomassie Brilliant Blue R-250 and 
imaged by phosphorImager. 
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